intelligenthealth.ai Open in urlscan Pro
3.9.252.129  Public Scan

Form analysis
0 forms found in the DOM

Text Content

This website stores cookies on your computer. These cookies are used to improve
your website and provide more personalized services to you, both on this website
and through other media. To find out more about the cookies we use, see our
Cookie Policy.

We won't track your information when you visit our site. But in order to comply
with your preferences, we'll have to use just one tiny cookie so that you're not
asked to make this choice again.

Accept Decline

Speakers - Intelligent Health Intelligent Health | September 2024 | Speakers
 * Programme
 * Speakers
 * Accelerator
 * Commercial Partners
 * Community Partners
 * Attendees
 * All Events
 * MORE
   CPD PointsGet involvedAbout usContact usNews HubIH AmbassadorsIntelligent
   Health UK

Tickets

Our speakers are shaping the future of AI


INTERESTED IN SPEAKING AT INTELLIGENT HEALTH?


APPLY HERE


TAKE A SNEAK PEEK AT OUR 2024 SPEAKERS




PRATHIBHA VARKEY

PRESIDENT

MAYO CLINIC HEALTH SYSTEM




DR TAMARA SUNBUL

MEDICAL DIRECTOR OF CLINICAL INFORMATICS

JOHNS HOPKINS ARAMCO HEALTHCARE (JHAH)

 



SUNIL DADLANI

EVP, CHIEF INFORMATION & DIGITAL OFFICER & CHIEF CYBER SECURITY OFFICER

ATLANTIC HEALTH SYSTEM




DR. NICOLAS LÖFFLER-PEREZ

DATA SCIENTIST

SWISSMEDIC 4.0

THE INNOVATION UNIT FROM

SWISSMEDIC 

 



RACHEL DUNSCOMBE

CEO

OPENEHR




PETER VAN OOIJEN

PROFESSOR OF AI IN RADIOTHERAPY, DEPARTMENT OF RADIOTHERAPY; MACHINE LEARNING
EXPERT & COORDINATOR MACHINE LEARNING LAB, DATA SCIENCE CENTER IN HEALTH (DASH)

UNIVERSITY MEDICAL CENTER GRONINGEN




PETER GROLIMUND

MANAGING DIRECTOR

SWISS HEALTH DATA SPACE




DR BERNARD GOUGET

PRESIDENT

NATIONAL COMMITTEE OF REFERENCE LABORATORIES, MINISTRY OF HEALTH AND PREVENTION,
FRANCE & IFCC - EMERGING TECHNOLOGIES DIVISION




NOAM SHOMRON

PROFESSOR OF GENOMICS

TEL AVIV UNIVERSITY




DR MAGÍ LLUCH-ARIET

DATA MANAGER & ANALYST

EIT HEALTH




BART SCHEERDER

BUSINESS DEVELOPER DATA SCIENCE & AI

UNIVERSITY MEDICAL CENTER GRONINGEN INNOVATION CENTER




RAUL V. RODRIGUEZ

VICE PRESIDENT

WOXSEN UNIVERSITY









MEET OUR PREVIOUS AI BRAINS

DR ANN AERTS

HEAD OF NOVARTIS FOUNDATION

NOVARTIS FOUNDATION

 



ROLAND ROTT

PRESIDENT & CEO ULTRASOUND

 GE HEALTHCARE




MONA FLORES

GLOBAL HEAD OF MEDICAL AI

NVIDIA




MARCO GIANNITRAPANI

VP GLOBAL DATA & ANALYTICS (COMMERCIAL)

ROCHE




ELENA BONFIGLIOLI

GLOBAL BUSINESS LEADER FOR HEALTHCARE, PHARMA AND LIFE SCIENCES

MICROSOFT




OZANAN MEIRELES 

SURGEON AT MASSACHUSETTS GENERAL HOSPITAL

DIRECTOR MGH SURGICAL ARTIFICIAL INTELLIGENCE AND INNOVATION LABORATORY (SAIIL)

ASSISTANT PROFESSOR OF SURGERY

HARVARD MEDICAL SCHOOL

 



DR AISHA RAHIM 

MEDICAL EXECUTIVE AND DIRECTOR

JOHNS HOPKINS HEALTHCARE




AQUIL HARJIVAN

R&D HEAD - DIGITAL HEALTH

BAYER




NICHOLAS KELLEY

DATA SCIENCE & A.I. INNOVATION, CHIEF DIGITAL OFFICE

NOVARTIS

 



DR SUJOY KAR 

CHIEF MEDICAL INFORMATION OFFICER & VICE PRESIDENT

APOLLO HOSPITALS




ELIZABETH HAMPSON

PARTNER - LIFE SCIENCES AND HEALTH CARE STRATEGY AND ANALYTICS

DELOITTE




NICHOLAS ACCOMANDO

VP, CHIEF COMPLIANCE & PRIVACY OFFICER AT

FLATIRON HEALTH (AFFILIATE OF THE ROCHE GROUP)




KATIE BACA-MOTES

CO-FOUNDER

SCRIPPS DIGITAL TRIAL CENTER

SR. DIRECTOR, STRATEGIC INITIATIVES

SCRIPPS RESEARCH

 



PROFESSOR SHAFI AHMED

FUTURIST AND INNOVATOR

CONSULTANT SURGEON

BARTS HEALTH NHS TRUST

CEO

MEDICAL REALITIES

 



DR DARREN GATES

CLINICAL INNOVATION CONSULTANT

ALDER HEY INNOVATION SERVICE

CONSULTANT PAEDIATRIC INTENSIVIST

ALDER HEY CHILDREN'S HOSPITAL

 



FRANCESCA CIPOLLI

ASSOCIATE DIRECTOR GLOBAL REGULATORY PRECISION MEDICINE

BRISTOL MYERS SQUIBB




SUSAN TILLMANN

HEAD DATA, ANALYTICS AND DIGITAL GLOBAL MANUFACTURING & SUPPLY

TAKEDA




ALBERTO TOZZI

HEAD OF PREDICTIVE AND PREVENTIVE MEDICINE RESEARCH UNIT,

BAMBINO GESÙ CHILDREN’S HOSPITAL, ROME

 



DR ELISABETH ZEAITER

HEALTH DATA INSIGHTS DIRECTOR, GLOBAL CLINICAL OPERATIONS

NOVARTIS




CLARE BORNSTEIN

ADVANCED ANALYTICS PLATFORM LEAD, GLOBAL MANUFACTURING & SUPPLY

TAKEDA




PETER SPEYER 

HEAD OF DATA, ANALYTICS & AI

NOVARTIS FOUNDATION

 



ELIJAH APPIUS

MANAGER DIGITAL INNOVATION, DEPARTMENT OF ECONOMIC, SOCIAL AND ENVIRONMENTAL
AFFAIRES

CANTON OF BASEL-STADT




MATTHIAS PFISTER 

HEAD OF DEVELOPMENT TEAM, OPTICAL DATA SCIENCE

HELBLING TECHNIK




JOHANNES BOCH

DIRECTOR OF POPULATION HEALTH

NOVARTIS FOUNDATION

 



GAURICA CHACKO 

VICE PRESIDENT AND GLOBAL HEAD, LIFE SCIENCES CONSULTING

WIPRO

 



PROF. DR: MILAN PETKOVIC

HEAD OF AI & DATA SCIENCE R&D, CONNECTED CARE, 

PHILIPS






SOFIA MARTINEZ GOMEZ 

CYBER SECURITY EXPERT

ROCHE DIAGNOSTICS

 



JAN BEGER

SENIOR DIRECTOR DIGITAL ECOSYSTEM

GE HEALTHCARE

 



FRANCINE DE STOPPELAAR

HEALTHCARE DIRECTOR, HOSPITAL OPERATIONS & ACTIVATION

CLEVELAND CLINIC LONDON




JIANGTAO WANG 

ASSOCIATE PROFESSOR OF HEALTH DATA SCIENCE, RESEARCH CENTRE FOR INTELLIGENT
HEALTHCARE

COVENTRY UNIVERSITY




SARAH DES ROSIERS 

DIRECTOR, HEALTH EQUITY

NOVARTIS FOUNDATION

 



DR. IR. HERMEN JAN VAN REE MBA

DIRECTOR DIGITAL HEALTH

UMC UTRECHT




CAOIMHE VALLELY-GILROY

DIRECTOR OF HEALTHCARE INNOVATION

DAYONE



DR SAHAR HASHMI

FOUNDER AND CEO

MYRIAD CONSULTING LLC




LINA ECHEVERRI

MEDICAL DOCTOR, MSC IN DISASTER MEDICINE, CONSULTANT, HEALTH EMERGENCIES

CRIMEDIM - CENTER FOR RESEARCH AND TRAINING IN DISASTER MEDICINE, HUMANITARIAN
AID AND GLOBAL HEALTH




KATRIN CRAMERI

DIRECTOR PERSONALIZED HEALTH INFORMATICS 

SIB SWISS INSTITUTE OF BIOINFORMATICS




DR. FRED MPALA

CHIEF SECURITY OFFICER

 EVIDATION




BRENNA LOUFEK

SAMD REGULATORY AFFAIRS LEAD, CENTER FOR DIGITAL HEALTH

MAYO CLINIC

 



FELICE BURN 

HEAD OF ARTIFICIAL INTELLIGENCE & DATA SCIENCE

KANTONSSPITAL AARAU AG




ADITYA KUDUMALA

PRINCIPAL (PARTNER)

DELOITTE




HELGE BUESS 

ASSOCIATE DIRECTOR POPULATION HEALTH

NOVARTIS FOUNDATION

 



PROF SOMAYA BEN ALLOUCH

HEAD OF DIGITAL LIFE RESEARCH GROUP, AMSTERDAM UNIVERSITY OF APPLIED SCIENCES

ENDOWED PROFESSOR OF HUMAN-SYSTEM INTERACTION FOR HEALTH & WELLBEING

UNIVERSITY OF AMSTERDAM




VEYSEL KOCAMAN

HEAD OF DATA SCIENCE (HEALTHCARE)

JOHN SNOW LABS

     



MOSTAFA AJALLOOEIAN

ENGAGEMENT DIRECTOR, SENIOR DATA SCIENTIST

UNIT8 SA




ANTONIO RUSSO

PARTNER, INNOVATION LEADER AND PARTNER, HEAD OF ANALYTICS & COGNITIVE

DELOITTE SWITZERLAND

       



MAXINE MACKINTOSH

CO- FOUNDER

ONE HEALTHTECH




ALEXANDER FINLAYSON

CEO & FOUNDER

NYE HEALTH

NHS PRIMARY CARE DOCTORS & DOLL FELLOW

OXFORD UNIVERSITY




DR BETHEL DEREJE 

GYNECOLOGIC ONCOLOGIST

FOUNDER AND CEO

WECARE DIGITAL HEALTH

 



NICOLE SPIEKER

CHIEF EXECUTIVE OFFICER

PHARMACCESS 




PAU RUE, PHD

VP OF ARTIFICIAL INTELLIGENCE

INFERMEDICA




HANNO RONTE

PARTNER

DELOITTE




BERIT GERRITZEN, PH.D.

DIRECTOR, AI & DATA

DELOITTE CONSULTING AG

 



MATTHEW ARENTZ MD MPH

LEAD – DIGITAL HEALTH VALIDATION PROGRAM; SENIOR TECHNICAL CONSULTANT

FIND




RETO HAENI

PARTNER CYBER RISK SERVICES, DIGITALIZATION AND CLOUD TRANSFORMATION LEADER

DELOITTE

 



PAUL DE BLASI

HEAD DELOITTE LEGAL & PRIVATE, PARTNER

DELOITTE SWITZERLAND

 



PEACE NDOLI IRAGUHA

COO & CO-FOUNDER

LIFESTEN

 



DR. ANDREA BIASIUCCI

CEO

CONFINIS

 



KENN MILTON

CEO AND FOUNDER

MYBLUELABEL 

 



NISHANT SINHA

DIRECTOR, AI & AUTOMATION

DELOITTE SWITZERLAND




LISA FALCO 

LEAD CONSULTANT AI & DATA

ZÜHLKE GROUP

 



BENJAMIN VON DESCHWANDEN 

CO-FOUNDER AND CHIEF PRODUCT OFFICER (CPO)

ACODIS AG




NELSON IGBIRIKI

CEO & CO-FOUNDER 

MEDTECH AFRICA




WOLFRAM VON EHREN

SENIOR DIRECTOR

DELOITTE

 



STEFAN NAEFF

DIGITAL HEALTH CARE LEAD FOR SWITZERLAND

DELOITTE CONSULTING AG




GABRIEL KRUMMENACHER

HEAD OF DATA SCIENCE

ZÜHLKE GROUP

 



VINCENT DE CRAYENCOUR 

HEAD OF INTERNATIONAL DEVELOPMENT

CYBERPEACE INSTITUTE

 



WIM KEES JANSSEN

CO-FOUNDER & CEO

SYNTHO

 



FRANK DANNACHER

DIRECTOR, LEAD AI & DATA FOR LIFE SCIENCE AND HEALTHCARE

DELOITTE SWITZERLAND

 



SANATH KUMAR

CEO

SMITCH




BABAJIDE OKE

CEO & FOUNDER

RENDER HEALTH

 



RODRIGO SAUCEDO-MARTINEZ 

HEAD OF DIGITAL HEALTH

CARLOS SLIM FOUNDATION






YURII KRYVOBORODOV

HEAD OF AI & DATA CONSULTING

UNICSOFT

 



DR ZAID AL-FAGIH

CO-FOUNDER & CEO

RHAZES AI






SHARON BATAMURIZA

PROGRAM DIRECTOR

BRIDGE FOR BILLIONS

 

 

 



CHRIS MCKEE

MANAGING DIRECTOR

BETTER MEDICINE




DR WILLIAM MAPHAM

CEO

VULA MOBILE




JENNIE NWOKOYE

FOUNDER CEO

CLAFIYA




SAMI CHAGAR

COO & CO-FOUNDER

DOCTHUS HEALTHTECH




DR ROB KOROM

CHIEF MEDICAL OFFICER

PENDA HEALTH




CONRAD TANKOU

CEO

GIC SPACE



DR JOSEPH OLOWE

FOUNDER & CEO

DOKTORCONNECT




KIDIST TESFAYE

CHIEF EXECUTIVE OFFICER

YENEHEALTH




NAOM MONARI

FOUNDER

BENA CARE




JELLE SCHUITEMAKER

CMO & CO-FOUNDER

GOAL 3




ELIZABETH ADESHINA

FOUNDER

WAZIMA HEALTH




DR. JEROME NSHIMIYIMANA

FOUNDER AND CEO

JO GRP LTD



FABIAN SCHEUGENPFLUG

SENIOR ASSOCIATE VENTURE CAPITAL

PLUG AND PLAY TECH CENTER




LUCA EMILI

CEO & FOUNDER 

INSILICOTRIALS

   



VASILEIOS DIMAKOPOULOS

CO-FOUNDER & COO

AISTHESIS MEDICAL




DR. JANIS REINELT

CHIEF MEDICAL OFFICER

AICURA MEDICAL




VOLKER RUDOLPH

FOUNDER & DEVELOPER

MEDREPO




ANA BERNARDO GANCEDO

ASSOCIATE

AMADEUS CAPITAL PARTNERS




KATHRIN BIERNAT

CEO

123 SONOGRAPHY GMBH




SHUBHA KONERU 

SVP - HEALTHCARE STRATEGY & PARTNERSHIPS

MACHANI ROBOTICS




MAYORO DIAGNE

COO

BAAMTU




MARK PINNES

DIRECTOR - STRATEGIC PARTNERSHIPS (EUROPE & MIDDLE EAST)

INDIVILLAGE PVT LTD




RASMUS STEN ANDERSEN

PRINCIPAL DATA SCIENTIST

AMSTERDAM DATA COLLECTIVE

 



CHRISTOFFER EKSTROM

CEO

AI MEDICAL TECHNOLOGY




DR DARIO MOTTI

HEAD OF DIGITAL HEALTH

CONFINIS




DR CARL LEITNER

TECHNICAL OFFICER - DIGITAL HEALTH & INNOVATION

WORLD HEALTH ORGANISATION

   



DR ANN AERTS

HEAD OF NOVARTIS FOUNDATION

NOVARTIS FOUNDATION

 



NICHOLAS KELLEY

DATA SCIENCE & A.I. INNOVATION, CHIEF DIGITAL OFFICE

NOVARTIS

 



DR LUKAS ENGELBERGER

MEMBER OF THE GOVERNMENT, CANTON BASEL-STADT

HEAD OF THE PUBLIC HEALTH DEPARTMENT

   



ELENA BONFIGLIOLI

GM, GLOBAL HEALTHCARE STRATEGY LEAD, PHARMA AND LIFE SCIENCES

MICROSOFT 

 



DR. SUMEET S. CHUGH

MEDICAL DIRECTOR

HEART RHYTHM CENTER, SMIDT HEART INSTITUTE

DIRECTOR

DIVISION OF ARTIFICAL INTELLIGENCE IN MEDICINE; CEDARS-SINAI HEALTH SYSTEM, LOS
ANGELES, CA, USA




KELLY MCCAIN

HEAD OF HEALTH AND HEALTHCARE INITIATIVES

WORLD ECONOMIC FORUM




VICKY LEVY

DELOITTE GLOBAL LIFE SCIENCES SECTOR LEADER

DELOITTE

   



MARCO GIANNITRAPANI

HEAD OF GLOBAL GO TO MARKET DATA & ANALYTICS

ROCHE

   



BRUNO VILLETELLE

HEAD OF DATA AND DIGITAL

NOVARTIS GLOBAL DRUG DEVELOPMENT

   



DR. JOHN HALAMKA

PRESIDENT

MAYO CLINIC PLATFORM

   



MENI STYLIADOU

VP DISTINGUISHED FELLOW, DATA SCIENCE INSTITUTE

TAKEDA R&D

FOUNDER & CO-LEAD

H2O ENTERPRISE

     



YARON ILAN

DIRECTOR OF THE DEPARTMENT OF MEDICINE

HEBREW UNIVERSITY-HADASSAH MEDICAL CENTER




CAOIMHE VALLELY-GILROY

FORMER GLOBAL HEAD OF DIGITAL HEALTH & THERAPEUTICS

 HEALTHCARE BUSINESS OF MERCK




PROF. S. YUNKAP KWANKAM, PH.D.

EXECUTIVE DIRECTOR

INTERNATIONAL SOCIETY FOR TELEMEDICINE AND EHEALTH (ISFTEH)

     



DR DANIEL KNECHT

VP, CHIEF CLINICAL INNOVATION OFFICER 

CVS CAREMARK

   



ACHIM PLUECKEBAUM

HEAD DATA42

NOVARTIS

   



STEFAN GERMANN

CEO

FONDATION BOTNAR




DR IMRAN SIDDIQUI

UK/I RADIOLOGY MEDICAL ADVISOR

BAYER PLC




LUCIEN ENGELEN

EDGE FELLOW, DELOITTE CENTER FOR THE EDGEX

DELOITTE 

     



DR. JIM RITCHIE

CONSULTANT RENAL PHYSICIAN; CHIEF CLINICAL INFORMATION OFFICER; DEPUTY DIRECTOR
FOR RESEARCH AND INNOVATION

NORTHERN CARE ALLIANCE NHS FOUNDATION TRUST

   



NATASHA SUNDERJI

GLOBAL HEALTH LEAD, ACCENTURE DEVELOPMENT PARTNERSHIPS 

ACCENTURE

   



ARNAUD RUNGE

MEDICAL ENGINEER

EUROPEAN SPACE AGENCY

   



ELIF OZKIRIMLI

HEAD OF DATA SCIENCE AND ADVANCED ANALYTICS - PHARMA INTERNATIONAL DATA AND
ANALYTICS CHAPTER

ROCHE AG

 



CAROLINE PERRIN, PH.D.

EXECUTIVE DIRECTOR 

GENEVA DIGITAL HEALTH HUB (GDHUB)

   



VALENTINA SARTORI

PARTNER, LEADER OF QUANTUMBLACK IN SWITZERLAND

QUANTUMBLACK, AI BY MCKINSEY




PETER HACKEL

HEAD OF DATA PRODUCTS

TAKEDA PHARMA

   



JUAN GUTIERREZ ALLIENDE

MEDICAL LEAD EMEA DIGITAL SOLUTION BUSINESS, RADIOLOGY

BAYER AG

   



VICTOR SAVEVSKI

CHIEF INNOVATION OFFICER AND AI CENTER DIRECTOR

HUMANITAS RESEARCH HOSPITAL




MARCO OBISO

CHIEF AI OF THE DIGITAL NETWORKS & SOCIETY DEPARTMENT, TELECOMMUNICATION
DEVELOPMENT BUREAU

INTERNATIONAL TELECOMMUNICATION UNION (ITU)

 



DR AENGUS TRAN

CO-FOUNDER AND CLINICAL AI DIRECTOR

ANNALISE.AI 

   



GIUSEPPE MARCO RANDAZZO

HEAD OF AI AND CHEMINFORMATICS

ENDOGENA THERAPEUTICS, INC

   



PATRICIA GEE

PARTNER IN LIFE SCIENCES AND LEADER FUTURE OF HEALTH INITIATIVES

DELOITTE SWITZERLAND

   



DR ANDREW SOLTAN

NIHR ACADEMIC CLINICAL FELLOW

UNIVERSITY OF OXFORD & OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

 



DR. SABINA MAGALINI

PANACEA COORDINATOR; SENIOR SURGEON OF EMERGENCY TRAUMA

GEMELLI UNIVERSITY HOSPITAL




JACQUES GILBERT

SENIOR DIRECTOR STRATEGY – HEALTHCARE 

NUANCE COMMUNICATIONS

   



DR EWELINA TURK

SVP MEDICAL PRODUCTS

ADA HEALTH

   



BABITA SHARMA

BROADCASTER AND AUTHOR




NISHANT SINHA

DIRECTOR, AI & AUTOMATION

DELOITTE SWITZERLAND




RICHARD PLUMB

CYBER THREAT INTELLIGENCE LEAD

NHS DIGITAL

     



LOUBNA BOUARFA

CEO & FOUNDER

OKRA TECHNOLOGIES




ALEX ZHAVORONKOV

FOUNDER AND CEO 

INSILICO MEDICINE

   



THOMAS LINDAHL

CHIEF MEDICAL OFFICER

UNILABS SWEDEN

   



DR ARNAUD WILMET

MD, CHIEF MEDICAL INFORMATION OFFICER

NUANCE

   



ARDY ARIANPOUR

CEO & CO-FOUNDER

SEQSTER

 



OMAR KHAWAJA

CHIEF INFORMATION SECURITY OFFICER

HIGHMARK HEALTH

   



DR JACOB J VISSER

RADIOLOGIST & CMIO, ASSISTANT PROFESSOR VALUE-BASED IMAGING

ERASMUS MEDICAL CENTER

   



PRATEEK BHARADWAJ

GLOBAL MARKET ACCESS MANAGER, RADIOLOGY

BAYER AG

 



PROF DR STANISA RASPOPOVIC

PROFESSOR, DEP. OF HEALTH SCIENCES AND TECHNOLOGY

ETH ZÜRICH

   



ERIC DURAND

SVP DATA SCIENCE

OWKIN

   



RIGVEDA KADAM

HEAD OF DIGITAL HEALTH

FIND, THE ALLIANCE FOR DIAGNOSTICS

   



REUVEN ARONASHVILI

FOUNDER & CHIEF EXECUTIVE OFFICER

CYE

   



DR ANITA PRINZIE

PRODUCT MANAGER

OMINA TECHNOLOGIES

   



LUKE MARKHAM

ML ENGINEER 

GRAPHCORE

 



SAMUEL DEMHARTER

PHD, HEAD OF BIOINFORMATICS, TARGET & BIOMARKER DISCOVERY

ABZU




DR. SURAJ KAPA

SVP HEALTHCARE

TRIPLEBLIND

   



ANTONIO RUSSO

PARTNER, INNOVATION LEADER AND PARTNER, HEAD OF ANALYTICS & COGNITIVE

DELOITTE SWITZERLAND

       



SOFIAT AKINOLA

HEALTH POLICY LEADER

ROCHE




CECILE TARDY-SRINIVASAN

DAYONE HEALTH 4.0 ACCELERATOR MANAGER

DAYONE - HEALTHCARE INNOVATION

   



EDWIN GELEIJN

PHYSIOTHERAPIST / HEALTHCARE INNOVATOR

AMSTERDAM UMC

     



MICHAEL BLANKENBURG

MARKET ACCESS MANAGER, RADIOLOGY

BAYER AG

   



VALERY LASRY

DIRECTOR, EUROPE, MIDDLE EAST, AFRICA AND LATIN AMERICA

NURALOGIX CORPORATION

     



MATHIEU MORAND

SENIOR MANAGER, DIGITAL & HEALTH FINANCING

CITY CANCER CHALLENGES

   



DR NOA HURVITZ

RESIDENT, DEPARTMENT OF MEDICINE

HEBREW UNIVERSITY-HADASSAH MEDICAL CENTER

 



JÜRG HUTTER

SENIOR PRODUCT MANAGER DIGITAL HEALTH

SWISS POST COMMUNICATION SERVICES LTD

   



VEYSEL KOCAMAN

HEAD OF DATA SCIENCE (HEALTHCARE)

JOHN SNOW LABS

     



DR SANDEEP REDDY

DIRECTOR, HEALTHCARE MANAGEMENT PROGRAM 

DEAKIN UNIVERSITY

   



MICHAEL ZAIAC

ORE MEDICAL AFFAIRS HEAD

NOVARTIS

   



MUKESH BANSAL

CHIEF OPERATING OFFICER & CO-FOUNDER

PHABLE

   



ANURAAG DUBEY

CHIEF PRODUCT OFFICER

PHABLE




BLAISE THOMSON

CEO & FOUNDER

BITFOUNT

   



MAME DABA DIOUF

BUSINESS UNIT & PROJECT MANAGER

IT4LIFE

     



HANNAN HASHMI

C0-CEO

KAPSULE 

   



FEMI AMOO

CTO & HEAD OF ENGINEERING

KAPSULE 




GINYU INNOCENTIA KWALARTOH

CEO & FOUNDER 

KLARAH



 



NIELS VAN ESPEN

HEALTH INNOVATION & DESIGN DIRECTOR

MADE

 






JOHN SHOBOIKI

CMO 

RENDER HEALTH 

   



THEOPHILA HURIRO UWACU

DIRECTOR 

E-HEZA DATA SOLUTIONS

   



ALOYS RUKUNDO

FOUNDER & CEO

HELLOMED

   



CHRIS MULLHALL

CEO & FOUNDER 

REMOTE DOCTORS FOR ALL

   



PETER HURST

BDM

REMOTE DOCTORS FOR ALL

   



MOSES MUKUNDI

CEO 

EDEN CARE

   



CLIVATE MAIBA

CEO 

DENGA LOGISTICS LTD

   



AFFIONG OSUCHUKWU

CO-FOUNDER 

DIGI-DIBIA HEALTH-TECH LTD

   



AUDACE NAKESHIMANA

FOUNDER 

INSIGHTIV

 



LUCAS SCHERDEL

DIRECTOR 

DAYONE - HEALTHCARE INNOVATION

   



AMOS ANKRAH

BOSTON SOLUTION SPECIALIST

BOSTON LIMITED 

   



JENNIFER GOODALL

CEO 

MINDAFFECT 

   



LUCA JAHREISS

CO-FOUNDER & CHIEF MARKETING OFFICER

ANCORA.AI 

   



ANTON BALAKIREV

CTO

ACRUX CYBER SERVICES

   



YANA KOZIS

CEO & FOUNDER 

DEBABY 

   



RISHI DAS-GUPTA

CO-FOUNDER 

NODENS 

   



RENE GILVERT

FOUNDER AND CEO

OPTICHRONIX




ANCA DEL RIO

LEAD HEALTH TECH COMMUNITY & STAKEHOLDER RELATIONS

DAYONE - HEALTHCARE INNOVATION




JISKIA REIS

CORPORATE INNOVATION LEAD, HEALTH

PLUG AND PLAY GMBH




FABIAN SCHEUGENPFLUG

INVESTOR & SENIOR VENTURES ASSOCIATE

PLUG AND PLAY HEALTH EMEA




KARTHIK KANNAN

CO-FOUNDER & CTO

ENVISION




JULIE AGEZ

PROJECT MANAGER ANTOINE LACASSAGNE CENTRE FOR THE FIGHT AGAINST CANCER

UNICANCER NETWORK




MICHAL DUBNO

HEAD OF OUTPATIENT SCHEDULING

LUX MED




ROHIT GHOSH

CHIEF STRATEGY OFFICER, FOUNDING MEMBER

QURE.AI




STEVEN TRUONG

FOUNDER & CEO 

VINBRAIN

   



LUCA EMILI

CEO & FOUNDER 

INSILICOTRIALS

   



DR GEORGE CHATZIPIRPIRIDIS

COO & CO-FOUNDER 

MAGNES AG

   



SEVERIN KAPPELER

PRODUCT MANAGER 

ACODIS 

   



DYLAN JOHNSTON

CHIEF EXECUTIVE OFFICER

MOD1 AG

   



ANDRÉ DIAS

CHIEF COMMERCIAL OFFICER

GIOTTO.AI

   



DR MATTEO TOGNINALLI

CHIEF OPERATIONAL OFFICER

VISIUM




MARK CHALMERS

LIFE SCIENCES CONSULTING, PARTNER

EY




MAURICE PERRINJAQUET

LIFE SCIENCES CONSULTING, PARTNER

EY




SEAN O'PRAY

HEALTH OUTCOMES PLATFORM DIRECTOR

EY




BINARA RUPASINGHE

LIFE SCIENCES CONSULTING, DIRECTOR

EY




THERESA REIKER

ASSOCIATE DIRECTOR OF POPULATION HEALTH

NOVARTIS FOUNDATION




ANDREW ADDISON

SENIOR TECHNOLOGIST

BOSTON




RACHEL DUNSCOMBE

CEO

OPENEHR




 

DR. ERIC TOPOL

EXECUTIVE VICE-PRESIDENT | SCRIPPS RESEARCH INSTITUTE

DIRECTOR & FOUNDER | SCRIPPS RESEARCH TRANSLATIONAL INSTITUTE




LAURA MATZ

CHIEF SCIENCE & TECHNOLOGY OFFICE

MERCK KGAA




DR. GREG MOORE

CVP

MICROSOFT HEALTH & LIFE SCIENCES

             


CAROLYN STARRETT

CEO

FLATIRON HEALTH




DR. LE LU (TIGER)

SENIOR DIRECTOR

ALIBABA DAMO ACADEMY PHD






JEROEN TAS

STRATEGIC BUSINESS DEVELOPMENT

PHILIPS




PROFESSOR SIR NIGEL SHADBOLT

PROFESSOR OF COMPUTING SCIENCE | UNIVERSITY OF OXFORD

CHAIRMAN AND CO-FOUNDER | OPEN DATA INSTITUTE




DR. JUNAID BAJWA

CHIEF MEDICAL SCIENTIST

MICROSOFT




DR MATTHEW LUNGREN

CO-DIRECTOR | STANFORD CENTER FOR ARTIFICIAL INTELLIGENCE IN MEDICINE AND
IMAGING 

ASSOCIATE PROFESSOR | STANFORD UNIVERSITY




PROFESSOR DR EFFY VAYENA

DEPUTY HEAD OF INSTITUTE OF TRANSLATIONAL MEDICINE

ETH ZURICH




DR OLIVER MORGAN

DIRECTOR OF HEALTH EMERGENCY AND RISK ASSESSMENT - WHO HEALTH EMERGENCIES
PROGRAM

WORLD HEALTH ORGANIZATION




PIETER JEEKEL

CHAIRMAN

NETHERLANDS AI COALITION FOR WELL-BEING & HEALTHCARE




ELEONORA HARWICH

HEAD OF COLLABORATIONS 

NHS AI LAB AT NHSX




PROFESSOR DR MAX WELLING

DISTINGUISHED SCIENTIST | MICROSOFT RESEARCH

RESEARCH CHAIR IN MACHINE LEARNING | UNIVERSITY OF AMSTERDAM




NAOMI LEE

SENIOR EXECUTIVE EDITOR

THE LANCET




STEFAN GERMANN

CEO

FONDATION BOTNAR




EMMANUEL AKPAKWU

CHIEF COMMERCIAL OFFICER

NOVARTIS SSA




SEBASTIEN BURNETT

GENERAL MANAGER OF CONVERGEHEALTH

DELOITTE EUROPE




BABITA SHARMA

BROADCASTER AND AUTHOR




DR. CHRIS BATES

DIRECTOR OF RESEARCH & ANALYTICS

TPP




PROF DR. MAURICE VAN DEN BOSCH

CEO

OLVG




MERI PETROVSKA

KNOWLEDGE MANAGEMENT (KM) DIRECTOR

ASTRAZENECA




DR EMMA LAWRANCE

MENTAL HEALTH INNOVATIONS FELLOW, INSTITUTE OF GLOBAL HEALTH INNOVATION

IMPERIAL COLLEGE LONDON




PROF. DR. AMEEN ABU-HANNA

DEPARTMENT OF MEDICAL INFORMATICS

AMSTERDAM UNIVERSITY MEDICAL CENTERS - UNIVERSITY OF AMSTERDAM




PROF. ANDRÉ DEKKER

PROFESSOR OF CLINICAL DATA SCIENCE

MAASTRICHT UNIVERSITY MEDICAL CENTER




MARLOES POMP

INTERNATIONAL PARTNERSHIPS

NETHERLANDS AI COALITION & STEERING COMMITTEE EUROPEAN AI FORUM




REZA KHORSHIDI

CHIEF SCIENTIST

AIG




BART-JAN VERHOEFF

DIRECTOR (CEO)

EXPERTISECENTRUM ZORGALGORITMEN



DR JILDAU BOUWMAN

SENIOR SCIENTIST AND PROGRAMME LEADER DIGITAL HEALTH TECHNOLOGIES

TNO




DR ALEX ZHAVORONKOV

CHIEF LONGEVITY OFFICER | DEEP LONGEVITY

FOUNDER & CEO | INSILICO MEDICINE

 



DR. ALLISON GARDNER

LECTURER IN DATA SCIENCE, SCHOOL OF MATHS AND COMPUTING | KEELE UNIVERSITY

CO-FOUNDER | WOMEN LEADING IN AI




DR BART GEERTS

ADVISOR AI / DIGITAL HEALTH | NLC - THE EUROPEAN HEALTHTECH VENTURE BUILDER

FOUNDER | HEALTHPLUS.AI




FARINA SCHURZFELD

CO-FOUNDER | SELFAPY

SOCIAL ENTREPRENEUR & GROWTH EXPERT




JEN HORONJEFF

PATIENT ADVOCATE AND FOUNDER

SAVVY




DR BAHER AL HAKIM

CEO

MEDICUS AI




PETRA HOOGENDOORN

LEAD EXPERT ISO 82304-2; PATIENT ADVOCATE; FOUNDER

GOINGS-ON AND REMIND APP




GEORGE AFFUL

MANAGER OF MED4ALL

PHARMACCESS GROUP GHANA



LOUBNA BOUARFA

CEO & FOUNDER

OKRA TECHNOLOGIES




MICHAEL MITTLEMAN

AMBASSADOR

PATIENT-CENTRED OUTCOMES RESEARCH INSTITUTE




KUMARA PALANIVEL

CO-FOUNDER AND CBDO

PATCHAI




CHAITH KONDRAGUNTA

CEO

AIRA MATRIX




VALERIE LASRY

DIRECTOR, EUROPE, MIDDLE EAST, AFRICA AND LATIN AMERICA

NURALOGIX CORPORATION




RITSAART VAN MONTFRANS

CEO

INCISION




FLORIAN ROESSLER

LEAD DATA SCIENTIST

UNIT8




OLIVIANA BAILEY

HEAD OF BRAND & COMMUNITY | ESCHERCLOUD

NL AMBASSADOR | WOMEN IN AI




MOSES BRAIMAH

NASOPHARYNGEAL CANCER SURVIVOR; EXECUTIVE PROJECT DIRECTOR | PACIFIC MESSAGES

CEO | COMPUTICS




MACIEJ MALENDA

CO-FOUNDER AND CEO | K.I.D.S

HEAD OF PARTNERSHIPS | INFERMEDICA




JAN BOT

HEAD OF ENGINEERING

OKRA TECHNOLOGIES




YAHYA ANVAR

HEAD OF DATA SCIENCE

OKRA TECHNOLOGIES




MILOSZ WICIŃSKI

BUSINESS DEVELOPMENT EXECUTIVE

INFERMEDICA






BAS JANSEN

HEAD OF AI IN LIFE SCIENCES

OMNIA TECHNOLOGIES




ELYES BEN MANSOUR

FOUNDER & CEO

EPINEST




PROF. ABDERRAHIM EL MOATAZ BILLA

PROFESSOR OF APPLIED MATH-COMPUTER SCIENCE

UNIVERSITY OF CAEN BASSE NORMANDIE




JUSTIN ANDERSON

CEO | XPERT AI

MANAGING PARTNER | ANDERSON STRATEGY




YONI SCHIRRIS

PHD CANDIDATE AI FOR COMPUTATIONAL PATHOLOGY

NETHERLANDS CANCER INSTITUTE & UNIVERSITY OF AMSTERDAM




DERICK MONTAQUE

CO-FOUNDER & CEO

WSK MEDICAL B.V.




YOSEF SAFI HARB

FOUNDER & CEO

HAPPITECH




MIGUEL MASCARENHAS SARAIVA, MD. MSC.

GASTROENTEROLOGY; CEO

DIGESTAID




DR. SURAJ KAPA

SVP HEALTHCARE

TRIPLEBLIND

   



ANTONIO RUSSO

PARTNER, INNOVATION LEADER AND PARTNER, HEAD OF ANALYTICS & COGNITIVE

DELOITTE SWITZERLAND

       



 

 

 

YAN HUANG

GENERAL MANAGER - INTELLIGENT HEALTHCARE

BAIDU

                     



DR. ROBERT CALIFF

FORMER COMMISSIONER FDA & HEAD OF HEALTH AND POLICY 

ALPHABET (GOOGLE HEALTH AND VERILY LIFE SCIENCES)

     



DR. JOHN HALAMKA

PRESIDENT

MAYO CLINIC PLATFORM

   



WENJUN XIE

HEAD OF AI HEALTHCARE STRATEGY

TENCENT

       



DR. PETER LEE

CORPORATE VICE PRESIDENT, HEALTHCARE

MICROSOFT



DR. TOBY COSGROVE

EXECUTIVE ADVISOR AND FORMER PRESIDENT & CEO

GOOGLE & CLEVELAND CLINIC




BERNARDO MARIANO JUNIOR

DIRECTOR, DIGITAL HEALTH & INNOVATION, CHIEF INFORMATION OFFICER

WORLD HEALTH ORGANIZATION

   



VANESSA CANDEIAS

FORMER HEAD, GLOBAL HEALTH AND HEALTHCARE; MEMBER OF THE EXECUTIVE COMMITTEE

WORLD ECONOMIC FORUM




DR. FREDDY ABNOUSI

INTERVENTIONAL CARDIOLOGIST AND HEAD OF HEALTH TECHNOLOGY

FACEBOOK

                 



KIMBERLY POWELL

VICE PRESIDENT HEALTHCARE

NVIDIA




JOHN NOSTA

PRESIDENT

NOSTALAB

         



DR. GREG MOORE

CVP

MICROSOFT HEALTH & LIFE SCIENCES

             


BAKUL PATEL

ASSOCIATE CENTRE DIRECTOR FOR DIGITAL HEALTH

FDA




DR. SEMA SGAIER

CO-FOUNDER & EXECUTIVE DIRECTOR | SURGO FOUNDATION

ADJUNCT ASSISTANT |HARVARD TH CHAN SCHOOL OF PUBLIC HEALTH 




MARK O'HERLIHY

MANAGING DIRECTOR EMEA

IBM WATSON HEALTH




PROF. GARY MARCUS

PROFESSOR OF PSYCHOLOGY AND NEURAL SCIENCE

NEW YORK UNIVERSITY




PROF. DR. EFFY VAYENA

PROFESSOR

INSTITUTE OF TRANSLATIONAL MEDICINE




DR. RAMYA PALACHOLLA

LEAD SCIENTIST & FACULTY

PARTNERS HEALTHCARE & HARVARD MEDICAL SCHOOL




PROF. WEIHONG HUANG

MOBILE HEALTH MINISTRY OF EDUCATION - CHINA MOBILE LAB

XIANGYA HOSPITAL CENTRAL SOUTH UNIVERSITY




ANNE O'RIORDAN

SENIOR MANAGING DIRECTOR

ACCENTURE LIFE SCIENCES




DR. ASIF JAN

GROUP DIRECTOR OF ANALYTICS IN PERSONALISED HEALTHCARE

ROCHE 






ALLESANDRO CURIONI

IBM FELLOW, VICE PRESIDENT EUROPE AND DIRECTOR

IBM RESEARCH




DR. NATALIE BANNER

UNDERSTANDING PATIENT DATA LEAD

WELLCOME TRUST






DR. STEPHANIE KUKU

SENIOR CONSULTANT

HARDIAN HEALTH

                               



SALVATORE SCALZO

POLICY AND LEGAL OFFICER

EUROPEAN COMMISSION




AMIR SAFFARI

SVP OF AI

BENEVOLENTAI




DANIEL NATHRATH

CO-FOUNDER AND CEO

ADA HEALTH




CHRIS GIBSON

CO-FOUNDER AND CEO

RECURSION PHARMA




DR. FARZANA RAHMAN

CONSULTANT RADIOLOGIST UCLH | NHS DIGITAL

CLINICAL ADVISOR, DATA AND DIGITAL STRATEGY LEAD | THE ACADEMY OF MEDICAL ROYAL
COLLEGES




DR. SATCHIT BALSARI

ASSISTANT PROFESSOR IN EMERGENCY MEDICINE

HARVARD MEDICAL SCHOOL (BETH ISRAEL DEACONESS MEDICAL CENTER)

 



JOSE PEDRO ALMEIDA

DIRECTOR OF BIG DATA ANALYTICS AND MACHINE LEARNING

SÃO JOÃO HOSPITAL CENTER






HUGUETTE DIAKABANA

CO-FOUNDER

AFRICAN ALLIANCE OF DIGITAL HEALTH NETWORKS




DR. DIVYA CHANDER

FACULTY CHAIR IN NEUROSCIENCE & FACULTY IN MEDICINE

SINGULARITY UNIVERSITY

     



JUNAID BAJWA

CHIEF MEDICAL SCIENTIST

MICROSOFT RESEARCH

         



 



RAMATOULIE JALLOW

CONNECTOR AND ADMINISTRATOR

PAN AFRICAN WOMEN IN HEALTH

         



 



BONIFACIA AGYEI

COUNTRY DIRECTOR OF SAFECARE, PHARMACCESS GHANA

PHARMACCESS GROUP

         



 


PROF LUCIANO FLORIDI

PROFESSOR OF PHILOSOPHY AND ETHICS OF INFORMATION AND DIRECTOR

THE UNIVERSITY OF OXFORD AND DIGITAL ETHICS LAB




PROF. MARCE SALATHE

ASSOCIATE PROFESSOR

EPFL

 



HILA AZADZOY

MANAGING DIRECTOR, GLOBAL HEALTH INITIATIVE

ADA HEALTH

         



 



DR. ALISON DARCY

FOUNDER AND PRESIDENT

WOEBOT HEALTH

         



 



JOÃO ARTHUR REIS

DIRECTOR - SCIENCE, TECHNOLOGY AND INNOVATION COORDINATION

SÃO PAULO STATE GOVERNMENT

         



 



LAURA MCGORMAN

POLICY LEAD, DATA FOR GOOD

FACEBOOK

         



 



DR. ANDRE CHOW

CO-FOUNDER

DIGITAL SURGERY




DR. JAY MANDREKAR

PROFESSOR OF BIOSTATISTICS & NEUROLOGY

MAYO CLINIC

   



RACHEL SIBANDE

PROGRAM DIRECTOR - DATA FOR DEVELOPMENT

DIGITAL IMPACT ALLIANCE, AT THE UNITED NATIONS FOUNDATION

         



 



DR. DANIEL VERES

CHIEF MEDICAL OFFICER

TURBINE




CHARLES ROBERTS

CO-FOUNDER AND CHIEF PARTNERSHIPS OFFICER

FREENOME




EYAL TOLEDANO

CO-FOUNDER AND CTO

ZEBRA MEDICAL VISIONVISION




MAGNUS CONTEH

EXECUTIVE DIRECTOR, COMMUNITY HEALTH ACADEMY

LAST MILE HEALTH






DR. JON SORENSON

HEAD OF CHEMINFORMATICS

ATOMWISE






DR. BORIS BOGDAN

MANAGING DIRECTOR, LEAD - GLOBAL PRECISION ONCOLOGY AND PERSONALIZED HEALTHCARE
(PHC)

ACCENTURE LIFE SCIENCES




DR. OLIVER MORGAN

DIRECTOR OF HEALTH EMERGENCY AND RISK ASSESSMENT

WORLD HEALTH ORGANIZATION




JENNY BARNETT

CHIEF SCIENTIFIC OFFICER

CAMBRIDGE COGNITION




STEVE GUISE

GLOBAL HEAD OF INFORMATICS

ROCHE PHARMACEUTICALS 




DR. ALLISON GARDNER

LECTURER IN DATA SCIENCE, PROGRAMME DIRECTOR FOR THE INTEGRATED DEGREE
APPRENTICESHIP IN DATA SCIENCE

KEELE UNIVERSITY

         



 



ANDREAS CLEVE

CO-FOUNDER AND CEO

CORTI

         



 



DR. ROOPA DHATT

EXECUTIVE DIRECTOR & CO-FOUNDER

WOMEN IN GLOBAL HEALTH

         



 



DR. MARCO MARSELLA

HEAD OF THE UNIT - DG CONNECT

EUROPEAN COMMISSION




PROF. THOMAS WIEGAND

EXECUTIVE DIRECTOR

FRAUNHOFER HHI




AMANDEEP GILL

PROJECT LEAD, I-DAIR AND FORMER EXECUTIVE DIRECTOR, UNSG HIGH LEVEL PANEL ON
DIGITAL CORPORATION

UNITED NATIONS

UNITED NATIONS




DR. ANURAG AGRAWAL

DIRECTOR

INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY AT COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH




DR. ERIC OERMANN

DIRECTOR | AISINAI

INSTRUCTOR OF NEUROLOGICAL SURGERY, DEPARTMENT OF NEUROSURGERY | MOUNT SINAI
HEALTH SYSTEM




LETIZIA GIONFRIDA

CEO & MANAGING DIRECTOR

ARTHRONICA

 



DR. JAMES KINROSS

SENIOR LECTURER AND CONSULTANT IN COLORECTAL SURGERY

ST. MARY'S HOSPITAL, IMPERIAL COLLEGE LONDON

 



OLIVER SMITH

STRATEGY DIRECTOR & HEAD OF ETHICS

ALPHA HEALTH, TELEFÓNICA INNOVACIÓN ALPHA




DR. AMRITA KUMAR

CONSULTANT RADIOLOGIST & AI CLINICAL LEAD

FRIMLEY HEALTH NHS FOUNDATION TRUST




VICTORIA MACDONALD

HEALTH AND SOCIAL CARE EDITOR

CHANNEL 4 NEWS

         



 



NEIL SEBIRE

CHIEF RESEARCH INFORMATION OFFICER

GREAT ORMOND STREET HOSPITAL

         



 



SUE PAISH

CEO

CANADA’S DIGITAL TECHNOLOGY SUPERCLUSTER

         



 



DR. ALAIN DAGHER

NEUROLOGIST AND PROFESSOR

MONTREAL NEUROLOGICAL INSTITUTE, MCGILL UNIVERSITY




DR. INDRA JOSHI

DIRECTOR OF AI

NHSX




DR. ANDREA SUPERTI-FURGA

HEAD OF GENETIC MEDICINE

LAUSANNE UNIVERSITY HOSPITAL




DR. ROSHANA MEHDIAN

REGISTRAR TRAUMA AND ORHOPAEDIC SURGEON AND DIRECTOR

HARDIAN HEALTH

       


We're here to help, so if you have any questions or issues,
please email hello@intelligenthealth.ai

Produced by


 * 
 * 
 * 
 * 
 * 

© Copyright 2024 • All rights reserved  • Privacy policy •  Terms and conditions

Website crafted by Evermade.

INTELLIGENT HEALTH AI LTD

Registered address: c/o Solid Ltd, Eagle House, 163 City Road, London, EC1V 1NR

Company number: 11215348

 

Privacy policy

Cookie policy

Terms and conditions

 * 
 * 
 * 
 * 
 * 



PRATHIBHA VARKEY

PRESIDENT

MAYO CLINIC HEALTH SYSTEM



DR TAMARA SUNBUL

MEDICAL DIRECTOR OF CLINICAL INFORMATICS

JOHNS HOPKINS ARAMCO HEALTHCARE (JHAH)

 

Dr. Tamara Sunbul is a leading figure in healthcare innovation and digital
transformation, serving as the Medical Director of Clinical Informatics at Johns
Hopkins Aramco Healthcare and chairing the HIMSS Middle East Community Steering
Committee. With over 25 years of experience, she has been instrumental in
achieving prestigious recognitions for JHAH, including HIMSS Stage 7 EMRAM and
CHIME Most Wired Level 9, and has significantly contributed to the global
healthcare sector through her roles with the Global Digital Health Platform, the
International KLAS Advisory Board, and ZIMAM. Honored with awards and
recognitions such as HIMSS Future50 Class clinical leader, the ZIMAM/HIMSS
Digital Health Leader of the Year and the Arabian Business KSA Women In Business
award, Dr. Sunbul is also a renowned keynote speaker at numerous international
stages, advocating for the integration of healthcare and digital technology, and
driving forward the fields of healthcare informatics and digital health and
leveraging her expertise to redefine healthcare paradigm

SUNIL DADLANI

EVP, CHIEF INFORMATION & DIGITAL OFFICER & CHIEF CYBER SECURITY OFFICER

ATLANTIC HEALTH SYSTEM

Sunil Dadlani is an accomplished global business technology leader who has spent
his extensive career in this sector using his expertise to develop and implement
complex, global information technology strategies and processes. 

He joined Atlantic Health System in September 2020 and oversees Information
Technology systemwide. In this role, Mr. Dadlani continues to advance the
system’s use of information technology strategies and platforms to help support
the delivery of excellent patient care and team member experiences. One
particular focus is the management and continued growth and development of the
system’s electronic medical record, Epic.

Prior to joining Atlantic Health System, Mr. Dadlani was the Chief Information
Officer for the New York State Department of Health. He successfully led the
largest public-sector digital business technology transformation, delivering
digital health care services to 19 million New Yorkers.

Prior to this, Mr. Dadlani served as the Global Head of Enterprise Business
Applications & Digital Transformation at Sony.

Mr. Dadlani earned his MBA in Global Management and a Masters in Computer
Science and Information Systems. He is an advisory board member for the NY
Health Information Technology (HIT) and Health Information Exchange (HIE).

DR. NICOLAS LÖFFLER-PEREZ

DATA SCIENTIST

SWISSMEDIC 4.0

THE INNOVATION UNIT FROM

SWISSMEDIC 

 


RACHEL DUNSCOMBE

CEO

OPENEHR



PETER VAN OOIJEN

PROFESSOR OF AI IN RADIOTHERAPY, DEPARTMENT OF RADIOTHERAPY; MACHINE LEARNING
EXPERT & COORDINATOR MACHINE LEARNING LAB, DATA SCIENCE CENTER IN HEALTH (DASH)

UNIVERSITY MEDICAL CENTER GRONINGEN

Prof. Peter van Ooijen, MSc, PhD, CPHIMS is an informatician working in the
field of Artificial Intelligence in Healthcare. He is a full Professor in AI in
Radiotherapy and Machine Learning Expert & coordinator of the machine learning
lab of the Data Science Center in Health (DASH). Both positions are at the
University Medical Center Groningen in Groningen, the Netherlands. He
(co)authored over 190 PubMed enlisted papers and more than 25 book chapters. He
is the 2023-2024 president of the European Society of Medical Imaging
Informatics (EuSoMII).

 

PETER GROLIMUND

MANAGING DIRECTOR

SWISS HEALTH DATA SPACE



DR BERNARD GOUGET

PRESIDENT

NATIONAL COMMITTEE OF REFERENCE LABORATORIES, MINISTRY OF HEALTH AND PREVENTION,
FRANCE & IFCC - EMERGING TECHNOLOGIES DIVISION

Dr. Bernard GOUGET is currently serving as President of the National Committee
for the selection of Reference Laboratories (Ministry of Health, France) and
ex-President of the Healthcare Division Executive Committee (Comité Français
d’accréditation – Cofrac). He was formerly an Associate Professor in physiology
at Necker-sick children University Hospital, Paris-Cité (FR). With over three
decades of engagement with the International Federation of Clinical Chemistry
and Laboratory Medicine (IFCC), Dr. Gouget has occupied various key roles,
including Chair of committees, division, and Executive Board member and IFCC
Treasurer. He currently chairs the Task Force on IFCC History and has been
recently appointed to the IFCC Emerging Technology Division-Executive Committee,
spearheading initiatives to integrate disruptive innovations into laboratory
medicine practices.

NOAM SHOMRON

PROFESSOR OF GENOMICS

TEL AVIV UNIVERSITY

Professor Noam Shomron is passionate about using basic science to advance better
healthcare. Professor Shomron heads the Functional Genomic Team at the Faculty
of Medical and Health Sciences at Tel Aviv University after training at MIT. He
leads a multidisciplinary team of scientists that develops computational methods
for parsing big data in the bio-medical field using Artificial Intelligence
(AI). Shomron applied for over 30 patents and published over 200 peer-reviewed
publications on multiple genomic fields, including medicine, agriculture, and
business. Shomron also leads the Tel Aviv University Innovation Lab (TILabs)
Team on Digital Medicine. He is the Editor of ‘Deep Sequencing Data Analysis’
book (Springer, Edition I 2013, and II 2021); Director of ‘Rare-Genomics’ Israel
(NPO); Director of Djerassi Institute of Oncology; Academic Director of
‘ScienceAbroad’ (NPO); Co-founder of several Biotech and Digital Medicine
companies: Variantyx, GotSho, IdentifAI, Everly Bio, among
others. Website: https://nshomron.github.io/

DR MAGÍ LLUCH-ARIET

DATA MANAGER & ANALYST

EIT HEALTH

Data Manager at EIT Health, a prestigious Knowledge and Innovation Community of
the European Institute of Innovation and Technology (EIT) and coordinator of
SkillSync (a tool for upskilling and foster innovation) within the EIT AI
Community. Prior to this, professor at Universitat Politècnica de Catalunya
(UPC) and researcher on Personalized Computational Medicine. Additionally, I
founded and served as CEO of an SME headquartered at the Barcelona Science Park,
contributing to advancements in clinical decision support systems. My career has
been marked by a steadfast commitment to fostering innovation and collaboration
in the fields of healthcare, academia, and technology management. My areas of
expertise encompass personalized computational medicine, distributed systems,
and eHealth. I hold a Ph.D. in Network Engineering and BSC in Computer Science
at UPC. MSc in Information and Knowledge Society and Diploma of Advanced Studies
in Informatics Systems and Languages (DEA) at UOC.

BART SCHEERDER

BUSINESS DEVELOPER DATA SCIENCE & AI

UNIVERSITY MEDICAL CENTER GRONINGEN INNOVATION CENTER

Bart has over 20 years experience in clinical research and development in
several roles, always supporting the development of innovative products. He has
been actively focusing on developing innovative partnerships in data science
(artificial intelligence, machine learning, big data and e-health) and is
affiliated to the UMCG Innovation Center and the Data Science Center in Health
(DASH). He is also president of the Dutch Clinical Research Foundation and
president of the Dutch Association of Contract Research Organizations. His
activities focus on connecting excellent science to an extensive network in
private industry and develop innovative public private partnerships to achieve
UMCG’s strategic goals.

RAUL V. RODRIGUEZ

VICE PRESIDENT

WOXSEN UNIVERSITY

Dr. Raul Villamarin Rodriguez, Vice President of Woxsen University, is a
Cognitive Technologist and Adjunct Professor at Universidad del Externado,
Colombia. He serves as a member of the International Advisory Board at IBS
Ranepa, Russian Federation, and holds positions on the Advisory Boards of PUCPR,
Johannesburg Business School, SA, Milpark Business School, South Africa,
PetThinQ Inc, and SpaceBasic, Inc. Additionally, Dr. Rodriguez is a Visiting
Professor at Uni. del Rosario and an Expert at UNESCO.

DR ANN AERTS

HEAD OF NOVARTIS FOUNDATION

NOVARTIS FOUNDATION

 


ROLAND ROTT

PRESIDENT & CEO ULTRASOUND

 GE HEALTHCARE

Roland Rott is President & CEO of GE HealthCare Ultrasound & Cardiology, a
global leader that has defined ultrasound innovation for over 25 years. In this
role, Roland is responsible for driving the growth and innovation of the ~$3
billion business with more than 3000 employees worldwide. In his tenure leading
the Ultrasound & Cardiology segment he has presided over the acquisition of
surgical visualization & guidance pioneer BK Medical, the company’s largest
acquisition since 2017, the equity investment in at-home ultrasound start-up
Pulsenmore and the acquisition of AI healthcare leader Caption Health. Since
joining GE HealthCare, Roland has held senior roles Ultrasound IT and Women’s
Health, and prior to his appointment as President & CEO of Ultrasound, served as
General Manager of Women’s Health Ultrasound, where he grew the strategic
business unit to become the market leader in obstetrics/gynecology worldwide.
Before joining GE HealthCare, Roland was Managing Director, Europe, Middle East
& Africa (EMEA) and executive board member at Exact Software— a mid-cap public
company headquartered in the Netherlands— leading four R&D teams and
subsidiaries in 20 countries. Early in his career Roland was an entrepreneur who
founded two successful software companies in Austria that were later acquired by
strategic investors. Roland earned his post-secondary diploma (HTL) in
Engineering with specialization in Information Technology & Business
Administration from HTBLA Leonding in Austria, studied International Business
Administration at Leopold-Franzens Universität Innsbruck, and has completed
executive education programs at Stanford University, London Business School, and
the University of California at Berkley. He lives in Vienna, Austria with his
wife and three children.

MONA FLORES

GLOBAL HEAD OF MEDICAL AI

NVIDIA

Mona is the Global Head of Medical AI at NVIDIA. She brings a unique perspective
with her varied experience in clinical medicine, medical applications, and
business. She is a board-certified cardiac surgeon and the previous Chief
Medical Officer of a digital health company. She holds an MBA in Management
Information Systems, and has worked on Wall Street. Her ultimate goal is the
betterment of medicine through AI.

MARCO GIANNITRAPANI

VP GLOBAL DATA & ANALYTICS (COMMERCIAL)

ROCHE



ELENA BONFIGLIOLI

GLOBAL BUSINESS LEADER FOR HEALTHCARE, PHARMA AND LIFE SCIENCES

MICROSOFT

Elena Bonfiglioli is Microsoft’s Global Business Leader for Healthcare, Pharma
and Life Sciences. She is in the DIA Advisory Council and Vice Chair of the
DIGITALEUROPE Digital Health Executive Council. In this capacity she is
responsible for industry strategy and commercial go-to-market, enabling
co-innovation and strategic partnerships to accelerate transformation with cloud
and AI.

OZANAN MEIRELES 

SURGEON AT MASSACHUSETTS GENERAL HOSPITAL

DIRECTOR MGH SURGICAL ARTIFICIAL INTELLIGENCE AND INNOVATION LABORATORY (SAIIL)

ASSISTANT PROFESSOR OF SURGERY

HARVARD MEDICAL SCHOOL

 

Dr. Ozanan Meireles is an Assistant Professor of Surgery at Harvard Medical
School and a Bariatric, Foregut, and Advanced Endoluminal Surgeon at the
Massachusetts General Hospital in Boston. Dr. Meireles has been practicing
surgery at MGH for more than 10 years, where he has been responsible for the
introduction of new technologies and techniques. 

Dr Meireles graduated from the Sao Paulo State University School of Medicine in
Brazil. He completed his surgical training at Michigan State University and his
clinical fellowship in Minimally Invasive and Bariatric Surgery at the
University of California San Diego. He spent his research fellowship at the
Johns Hopkins Hospital investigating augmented reality in surgery, robotic
telemanipulation, and Natural Orifices Trans Endoluminal Surgery (NOTES).

He is the director of the Surgical Artificial Intelligence and Innovation
Laboratory (SAIIL) at the Massachusetts General Hospital. At SAIIL, his research
focus is on utilizing computer vision to investigate the intraoperative phase of
care through real-time, automated surgical analysis and provide surgeons with
additional data, with the goals of democratization of surgical knowledge,
lowering costs, improving patient outcomes, and reduction of morbidity and
mortality. 

He serves as the Chairman of the Society of American Gastrointestinal and
Endoscopic Surgeons (SAGES) Artificial Intelligence Task Force, where he has
been leading several projects to research and build the foundation for the
scalability and sustainability of Surgical AI.

DR AISHA RAHIM 

MEDICAL EXECUTIVE AND DIRECTOR

JOHNS HOPKINS HEALTHCARE

Meet Aisha Rahim, a seasoned healthcare executive with over a decade of
international leadership and board-level experience. A Harvard-educated
professional, Aisha is highly skilled in medical advisory, scientific strategy,
and patient safety. She has a strong track record of developing clinical quality
improvement processes, providing pharmaceutical solutions, and enhancing patient
outcomes. Aisha’s focus on Tech equity and healthcare equity has placed her
among the esteemed board members of the American Diabetes Association for the DC
MD VA chapters. Plus, she’s a tech-savvy individual who has completed education
in artificial intelligence at MIT and business process design improvement at
MIT. Aisha is an accomplished communicator, expert trainer, and skilled leader,
adept at building and strengthening relationships across functions to drive
cohesive, strategic operations.

AQUIL HARJIVAN

R&D HEAD - DIGITAL HEALTH

BAYER

Aquil Harjivan is the R&D Head of Digital Health at Bayer CH. Aquil is a
scientist by training and has been in the FMCG and the consumer healthcare
industries for all his career across P&G, Unilever, GSK and now Bayer.

Passionate about people and technology, he’s spent his career across innovation
and product roles understanding what drives human behaviour in healthcare and
how science and technology can be leveraged to solve it. Since joining Bayer in
2021, Aquil has led the digital health strategy and is now leading the Precision
Health business unit announced earlier this year to develop and deliver new
products and services that expand the role of the Bayer brands across the
healthcare journey.

NICHOLAS KELLEY

DATA SCIENCE & A.I. INNOVATION, CHIEF DIGITAL OFFICE

NOVARTIS

 

Nicholas Kelley is the Director Data Science & A.I. Portfolio Strategy and
Innovation in the central Novartis Data & AI organization, and has two main
priorities.  First, to identify, prioritise, and launch key use-cases with the
mission of delivering reusable AI capabilities for the scientific and medical
core of the business.  Second, to better define the AI opportunities landscape
and needed capabilities across the value chain.  Here the key focus is on
continued improvement of our Novartis data science foundation through innovative
partnerships and by leading the data science community and capability building
initiatives.

Recent initiatives include seeding and driving AI solutions such as Generative
Chemistry as part of the partnership with Microsoft Research, the first
cross-Novartis Data Science challenge in collaboration with MIT, and launching
the AI for Life Residency program.

Nick has a formal background in computational methodology with a Ph.D. in
Biophysics from Stanford University, with career experience in computational
biology, chem- and bioinformatics, and most recently in the application of A.I.
and machine learning in health.  

DR SUJOY KAR 

CHIEF MEDICAL INFORMATION OFFICER & VICE PRESIDENT

APOLLO HOSPITALS

Dr Sujoy Kar is the Chief Medical Information Officer and the Vice-President of
Apollo Hospitals, previously Medical Director of Apollo Gleneagles Hospitals,
Kolkata. He is a Clinical Microbiologist by background with subsequent post
graduations from Indian Statistical Institute and MIT Sloan School of
Management. He is an Adjunct Faculty for Healthcare Analytics and Management at
IIM Calcutta and IIT Kharagpur. His current and ongoing research interests are
in the development and adoption of Artificial Intelligence in Healthcare and
Digital Health Platforms.

ELIZABETH HAMPSON

PARTNER - LIFE SCIENCES AND HEALTH CARE STRATEGY AND ANALYTICS

DELOITTE



NICHOLAS ACCOMANDO

VP, CHIEF COMPLIANCE & PRIVACY OFFICER AT

FLATIRON HEALTH (AFFILIATE OF THE ROCHE GROUP)



KATIE BACA-MOTES

CO-FOUNDER

SCRIPPS DIGITAL TRIAL CENTER

SR. DIRECTOR, STRATEGIC INITIATIVES

SCRIPPS RESEARCH

 

Katie Baca Motes’ expertise includes digital health, strategic partnerships,
negotiation, clinical trial enrollment, decentralized clinical trial structure,
remote patient/participant monitoring, patient motivations, incentive structure,
and behavioral economics. She’s passionate about bringing communities together
to tackle health challenges, improving representation in research, and
decreasing health disparities.

She brings 14 years of experience running large-scale research programs. She’s
known for bringing innovation to the field of clinical research; for example,
bringing the practice of A/B testing to build the mSToPs study cohort, one of
the first remote site-less clinical trials. As the Co-Investigator and Director
(2016-2021) of The Participant Center component of the All of Us Research
Program (administered by the National Institutes of Health), she led the teams
who built out a national infrastructure that enables “anyone, anywhere” to
enroll in the program and she led innovations in digital and community-level
engagement and in participant retention practices. She’s partnered in pioneering
efforts such as working on some of the first studies to utilize patient-mediated
EHR capture via SMART on FHIR. In early 2020, she co-founded the Scripps Digital
Trials Center and launched DETECT, a COVID-19 research platform using wearable
data for early detection and understanding progression of disease, factors for
Long COVID, and vaccine response. In 2021, she launched the PowerMom Consortium,
focused on accelerating maternal health research and decreasing health
disparities.

 

PROFESSOR SHAFI AHMED

FUTURIST AND INNOVATOR

CONSULTANT SURGEON

BARTS HEALTH NHS TRUST

CEO

MEDICAL REALITIES

 

Professor Shafi Ahmed is a world renowned, multi award winning surgeon, teacher,
futurist, innovator and entrepreneur. He is a 3x TEDx speaker and has delivered
over 300 keynotes in 35 countries.

After studying  medicine at Kings College Hospital Medical School London, he
completed his surgical training in London. He is currently a Laparoscopic
Colorectal surgeon at The Royal London and St Bartholomew’s Hospitals.

He has received multiple Professorships and Honorary doctorates and was a Nobel
Peace prize nominee in 2020 for his humanitarian work in conflict zones. In 2018
he was awarded the Future NHS award for NHS70 by Members of Parliament. In 2017
he was the top British Asian star in Tech. He was also the British Bangladeshi
of the Year 2017

He is currently a member of the NHS Assembly advising on the NHS long term plan
and has previously been an advisor to the Abu Dhabi Ministry of Health.  He is
currently the Vodafone Connected Health 5G Ambassador for the UK and sits on the
board of The Centre for Health, a joint venture with Vodafone and Deloitte. He
sits on the board of advisors at Abilitii in Saudi Arabia building health for
Vision 2030 and is a Non Exec Director at the Considered, a global health
marketing agency.

He is the Co Founder of Medical Realities, an award winning XR medical education
company and was appointed as the Chief Medical Metaverse Officer at AIMEDIS who
are building the world’s first health metaverse. He also cofounded GIANT Health
the largest medtech conference in the UK. 

As a previous Associate Dean at Barts Medical School, Shafi disrupting the
traditional medical school curriculum by launching the Barts X Medicine
Programme in 2015. Shafi has embedded future technologies and entrepreneurship
into the medical school. 

As an advocate for equality and a passion for humanitarian projects, he recently
launched the Shafi Ahmed Foundation International. This foundation aims to
provide relief and aid to those in need whilst promoting access to medical
training.

 

DR DARREN GATES

CLINICAL INNOVATION CONSULTANT

ALDER HEY INNOVATION SERVICE

CONSULTANT PAEDIATRIC INTENSIVIST

ALDER HEY CHILDREN'S HOSPITAL

 

Dr. Darren Gates is a senior Registrar in Paediatric Intensive Care at Alder Hey
Children’s Hospital, Liverpool, UK. In addition to his clinical practice he
works as a Clinical Innovation Consultant in the Trust’s award winning
Innovation Hub where he is clinical lead for the artificial intelligence
workstream. This includes The Living Hospital project, a partnership with the
Science and Technology Foundation Council’s (STFC) Hartree Centre and IBM,
working to improve patient care and experience.

FRANCESCA CIPOLLI

ASSOCIATE DIRECTOR GLOBAL REGULATORY PRECISION MEDICINE

BRISTOL MYERS SQUIBB



SUSAN TILLMANN

HEAD DATA, ANALYTICS AND DIGITAL GLOBAL MANUFACTURING & SUPPLY

TAKEDA

Susan Tillmann leads Data, Analytics and Digital for Global Manufacturing &
Supply at Takeda Pharmaceuticals International AG. The digital and data
executive with over 16 years’ experience in pharma, successfully leads the
achievement of perceived previously unattainable goals leveraging Artificial
Intelligence, Data, XR and Hyperautomation.

ALBERTO TOZZI

HEAD OF PREDICTIVE AND PREVENTIVE MEDICINE RESEARCH UNIT,

BAMBINO GESÙ CHILDREN’S HOSPITAL, ROME

 

Alberto Tozzi is a distinguished pediatrician and epidemiologist renowned for
his expertise in vaccines and his contributions to the surveillance and
prevention of infectious diseases. With over 15 years of dedicated research at
the Italian National Public Health Institute, he has focused extensively on
developing effective vaccination strategies. Throughout his career, he has
collaborated closely with esteemed organizations such as the World Health
Organization and the European Centers for Disease Control in their joint efforts
to combat infectious diseases worldwide. In 2004, Dr. Tozzi transitioned to the
Bambino Gesù Children’s Hospital, assuming key roles in the prevention of
infectious diseases, telemedicine, and innovation in pediatrics. Currently, he
serves as the Head of the Predictive and Preventive Medicine Research Unit,
where his work revolves around pioneering projects that explore the integration
of artificial intelligence into pediatric medicine and the advancement of
related training initiatives. Notably, as a corresponding member of the
Pontifical Academy for Life, Dr. Tozzi actively addresses the ethical
implications of technological advancements in the field of pediatrics. His
involvement in this institution showcases his commitment to the responsible and
conscientious application of technology in healthcare. Additionally, Dr. Tozzi
currently holds the position of President of the International Society for
Pediatric Innovation, further demonstrating his leadership and dedication to
fostering innovation and progress in pediatric healthcare on a global scale.

DR ELISABETH ZEAITER

HEALTH DATA INSIGHTS DIRECTOR, GLOBAL CLINICAL OPERATIONS

NOVARTIS

Elisabeth obtained her PhD in Process Engineering, Bioprocesses and Applied
Mathematics from the University of Montpellier, France in 2004 with over six
publications, followed by several recognition awards in data and process
analytics used for process design, optimization, monitoring and control. 

Over 19 years of experience in Pharma Industry, the knowledge gained in various
roles across development, quality, regulatory and manufacturing, combined with
previous experience in academia , leading new technology design and
implementation, developing quantitative and predictive AI algorithms to optimize
processes and enable real-time analysis, evaluating new business development
opportunities (asset, digital therapies, technologies) across all development
stages, ensuring compliance using a quality by design, science and risk- based
approach considering patient safety, allowed to gain a deep understanding of
Pharmaceutical Industry with the ability to foster effective collaboration
across divisions, functions and countries.

CLARE BORNSTEIN

ADVANCED ANALYTICS PLATFORM LEAD, GLOBAL MANUFACTURING & SUPPLY

TAKEDA

Clare Bornstein acts as advanced analytics platform lead for Global
Manufacturing & Supply at Takeda Pharmaceuticals International AG. 

PETER SPEYER 

HEAD OF DATA, ANALYTICS & AI

NOVARTIS FOUNDATION

 

Peter is Head of Analytics, Data & AI at the Novartis Foundation, accelerating
the use of data and analytics as part of the Foundation’s mission to improve
population health and inequities. Before that, Peter co-founded Novartis AG’s
transformational data42 program which enables the use of the company’s deep
pre-clinical, clinical, and real world data to accelerate and improve drug R&D.
Prior to his work at Novartis, Peter was Chief Data & Technology Officer at the
Institute for Health Metrics and Evaluation (IHME) at the University of
Washington in Seattle. He managed the data for the Global Burden of Disease
(GBD) study and created IHME’s global public data catalog Global Health Data
Exchange (GHDx) and innovative interactive data visualizations.

ELIJAH APPIUS

MANAGER DIGITAL INNOVATION, DEPARTMENT OF ECONOMIC, SOCIAL AND ENVIRONMENTAL
AFFAIRES

CANTON OF BASEL-STADT



MATTHIAS PFISTER 

HEAD OF DEVELOPMENT TEAM, OPTICAL DATA SCIENCE

HELBLING TECHNIK

Matthias Pfister is Head of the Development Team at Helbling Technik, a
worldwide active, independent Swiss contract engineering company. He has 15
years of professional experience in the development of innovative technologies
and products for medical applications. Matthias Pfister has successfully managed
the development of several medical devices, from ideation until FDA approval. He
is currently heading a development team whose core competence is processing
complex signals acquired with optical sensors and systems. Past experiences
include various projects in ophthalmology, endoscopy, and dermatology.
Independent of the application, Matthias Pfister has a strong focus on a
holistic development approach along the signal chain, i.e., from photon
generation to digital signal processing. Furthermore, he considers strong
systems engineering and project management to be key success factors for
development.

JOHANNES BOCH

DIRECTOR OF POPULATION HEALTH

NOVARTIS FOUNDATION

 

Johannes Boch began his professional career as psychologist, working in
different research and mental health facilities across Europe. Subsequently he
expanded his experiences working with consulting, research and business
development for impact investors and entrepreneurs, with a focus on access to
healthcare in LATAM. He holds degrees in Psychology from the University of
Fribourg (CH), International Affairs and Finance.

At the moment, Johannes is serving his team as the Director of Population Health
at the Novartis Foundation. In this capacity he oversees global programs and
partnerships in cardiovascular population health and health equity which have
benefitted up to 17 million people over the last years and shaped health systems
to become more efficient and sustainable.

GAURICA CHACKO 

VICE PRESIDENT AND GLOBAL HEAD, LIFE SCIENCES CONSULTING

WIPRO

 

Gaurica Chacko is a proven industry leader with more than 20 years of experience
in management consulting and life sciences, primarily focusing on business and
digital transformation, cloud development, health equity, and clinical and
commercial strategy. Gaurica works at the intersection of business and
technology and specializes in connecting with clients and partners to find
innovative solutions to complex business problems.

Prior to joining Wipro, Gaurica was Managing Director at FTI Consulting focusing
on health solutions across the healthcare continuum. Previously she was the
Regional GM, Global Markets at Quest Diagnostics and prior to that she served as
a senior executive at Edwards Lifesciences leading several Global functions
including Compliance and Legal Operations, Business Excellence and Clinical
Affairs.

Gaurica spent more than a decade in management consulting working for Deloitte
and KPMG where she led highprofile strategic engagements in R&D optimization,
operational excellence, sales and marketing strategies and M&A due diligence for
life science clients.

Gaurica has a passion for bringing innovative therapies and diagnostics to
underserved patient populations. She is a champion for Health Equity and an
executive member of the WEF-Edison Alliance.

PROF. DR: MILAN PETKOVIC

HEAD OF AI & DATA SCIENCE R&D, CONNECTED CARE, 

PHILIPS





SOFIA MARTINEZ GOMEZ 

CYBER SECURITY EXPERT

ROCHE DIAGNOSTICS

 

Sofia Martinez is the ad-interim Director of Product Engineering Security at
Roche Diagnostics. Her team supports the implementation of cybersecurity and
privacy principles across all stages of the product life cycle to a variety of
medical devices and digital solutions used in the healthcare sector.

She has experience in developing and establishing product cybersecurity and
privacy strategies and she led the re-design of Roche Diagnostics operating
model to deliver product cybersecurity and privacy and allow for agility and
innovation.

In addition to that, she’s responsible for monitoring the ever-changing
regulatory landscape and consolidating new cybersecurity and privacy
requirements with the aim of ensuring compliance and continuously improving the
security maturity of the company by evolving cybersecurity strategies.

Sofia is currently an active member of the Geneva Dialogue representing the
medical device industry. She contributes with her expertise to address the cyber
norms and challenges related to reducing vulnerabilities in cyberspace.

JAN BEGER

SENIOR DIRECTOR DIGITAL ECOSYSTEM

GE HEALTHCARE

 

As Senior Director of the Digital Ecosystem, Jan’s role is to drive GE
HealthCare Digital EMEA’s Ecosystem Strategy and together with his team develop
cooperation with partner companies, indirect channels, start-up centers and
networks. Jan is the head of GE Healthcare’s Edison Accelerator. With over 15
years of experience in healthcare informatics, the medical imaging domain and
management, Jan is a seasoned leader with vast experience in leading strategic
initiatives and in fluencing strategic decisions that ultimately drive revenue
and contribute to enterprise value.

Prior to joining GE HealthCare, Jan has held consultancy roles in Digital Health
start-ups and radiology IT companies. Prior to his Digital Ecosystem
responsibility at GE HealthCare, he has been responsible for leading clinical
consultancy at GE HealthCare Digital in Europe, Middle East & Africa where he
and his team ensured and optimized the quality of clinical solution
architecture, clinical work flow consultancy, change management and user
adoption.

He brings a real passion for the digital transformation of healthcare,
understanding healthcare provider needs, improving healthcare work flows and
user experience.

Jan lives outside of Leipzig, Germany, with his wife and their two daughters and
founded www.gr4ai.academy, a non-profit to create awareness and educate children
around Artificial Intelligence.

FRANCINE DE STOPPELAAR

HEALTHCARE DIRECTOR, HOSPITAL OPERATIONS & ACTIVATION

CLEVELAND CLINIC LONDON

Francine has a 25+ year career in leadership roles within both the public and
private Healthcare sector, driving efficiencies across all operations and
spearheading innovation through new technology.  She is experienced working both
in house and as a consultant managing large cross functional teams, accomplished
at delivering hospital activation and green field capital projects, improving
clinical processes, patient outcomes, compliance, quality & safety, medicines
optimization and developing clinical services.  With an international
background, she has worked in British, American, Dutch and UAE health care
systems and is a Doctor of Pharmacy.

Francine is ambitious and entrepreneurial whilst remaining hands-on to drive
results through people.

Most recently, Francine has led on Cleveland Clinic London’s hospital wide
operational activation as well as the implementation of a revolutionary fully
automated Closed Loop Medicines Optimisation model, the first in the UK, now
fully operational within budget and timescale. She was awarded both the
Cleveland Clinic CEO team award and Team Innovation award for the successful
activation of Cleveland Clinic London. Additionally, her team was nominated for
the 2022 Laing Buisson Innovation award for the implementation of Cleveland
Clinic London’s unique closed loop medicines management system. She oversaw the
hospital’s Epic Medicines Management application, regarded the most successful
international implementation of its kind.

Prior to this, as an independent consultant, she led 5 independent hospitals to
achieve outstanding CQC ratings and transformed underperforming clinical and
operations teams. In this role, she worked with Executive Teams of around 20
hospitals on organizational analyses and improvement strategies to drive
inspection success.

She is a former Chief Pharmacist at HCA Healthcare’s Wellington Hospital, having
come from Lead Clinical Pharmacy roles at the Cromwell Hospital, leading NHS
Trusts and University Hospitals in The Netherlands. She has particular clinical
interest in Critical Care and Pediatrics. Francine has served on several boards
of Healthcare Organizations.

She holds an Honorary Associate Professorship at The University of Leicester and
completed her PharmD and MSc in Clinical Pharmacology at Utrecht & Maastricht
University in The Netherlands. In addition, she is an associate advisor at
Deloitte, completed a Certificate in Business Administration at Warwick Business
School and a Digital Transformation Leadership module at Harvard Medical School.

Francine is married with an 18 year old son and 12 year old daughter. She is a
keen traveler, played tennis in the Dutch National League and performs regularly
as a flute player.

Francine has a particular interest in voluntary work in Education and served as
a Chair of Governors at a school in Surrey. In addition, she was a volunteer
Covid vaccinator, having vaccinated 1,200 people at her local Primary Care
Network.

 

JIANGTAO WANG 

ASSOCIATE PROFESSOR OF HEALTH DATA SCIENCE, RESEARCH CENTRE FOR INTELLIGENT
HEALTHCARE

COVENTRY UNIVERSITY

Jiangtao Wang is an internationally recognized researcher of AI for Health at
Coventry University. His expertise lies in developing novel AI algorithms to
analyze complex healthcare data, aiming to improve the accuracy, efficiency, and
accessibility of healthcare delivery. Dr. Wang has made significant
contributions to the field, creating cutting-edge machine learning models that
tackle various health challenges. These include population health monitoring,
diagnosis prediction, drug-drug interaction analysis, and COVID severity
estimation. Notably, his models have consistently outperformed state-of-the-art
methods on real-world clinical datasets, such as the MIMIC-III Database and NHS
datasets. His research findings have been published in top AI and data science
venues like AAAI, IJCAI, KDD, and ICDM. Dr. Wang’s exceptional work has earned
him several prestigious awards and recognitions. In 2021, he was honored with
the Engineering and Physical Sciences Research Council’s (EPSRC) New
Investigator Award. Additionally, he was selected as a member of the UKRI Future
Leader Fellow development network in 2023, highlighting his talent and potential
as a leading researcher in his field.

SARAH DES ROSIERS 

DIRECTOR, HEALTH EQUITY

NOVARTIS FOUNDATION

 


DR. IR. HERMEN JAN VAN REE MBA

DIRECTOR DIGITAL HEALTH

UMC UTRECHT

Hermen Jan is a versatile bellwether in innovation, digitalisation and
transformation. As Director of Digital Health for UMC Utrecht he All supported
by a 24/7 operational and accessible Medical Service Centre providing
people-centric digital care services to support, monitor and treat patients in
their own living environment.

CAOIMHE VALLELY-GILROY

DIRECTOR OF HEALTHCARE INNOVATION

DAYONE

Caoimhe is an experienced pharmaceutical executive and clinical strategy
specialist with a focus on digital health. She provides strategic development
and go-to-market guidance to innovative digital health start-ups. Previously,
she held senior positions at Merck KGaA, Roche Pharmaceuticals, and others. A
trained geneticist and biomedical scientist, she holds an MSc in Translational
Medicine and is pursuing a PhD at University College London. She has previously
collaborated with the World Economic Forum on genomic testing and technology in
healthcare, and is currently working with DayOne to accelerate innovative
start-ups with a healthtech focus.

DR SAHAR HASHMI

FOUNDER AND CEO

MYRIAD CONSULTING LLC

Expert in Artificial Intelligence (AI), AI in Healthcare Transformation, Digital
Design, Digital Transformation, Digital Health, Data Science and Generative
AI-ChatGPT

 

Experience: Dr. Sahar Hashmi has consulted for over a 100 startups in the fields
of AI, design and digital transformation. Dr. Hashmi has consulted and advised
on a wide variety of projects that have included healthcare systems management
projects, digital transformation of EMR systems and automation and redesign of
processes in clinics and also for non-healthcare clients such as Citibank,
designing skincare products’ design chain, among others. Her work has also
included guiding VCs on investments into companies that design digital health
platforms for chronic diseases that carry a high economic burden. Her expertise
and consultancy has resulted in high profits for her clients and saving them
millions of dollars.

 

Dr. Hashmi has served as a Harvard faculty member where her course on AI
technology innovations and applications became famous amongst graduate students
at Harvard University. Dr.Hashmi was the recipient of numerous awards including
but not limited to the TITAN Gold Business Award for Creative Business
Consulting, Larry G. Benedict Institute Leadership Award, Graduate Women in
Excellence and the highly prestigious MIT Apple award for mentoring and advising
business executives and leaders. She also received the Bridge Builder award
honoring her civic leadership in forming partnerships across racial, social,
economic, and geographic barriers for the betterment of her community.

LINA ECHEVERRI

MEDICAL DOCTOR, MSC IN DISASTER MEDICINE, CONSULTANT, HEALTH EMERGENCIES

CRIMEDIM - CENTER FOR RESEARCH AND TRAINING IN DISASTER MEDICINE, HUMANITARIAN
AID AND GLOBAL HEALTH

Dr. Echeverri is a medical doctor with +18 years working experience, combined
clinical, disasters’

and public health expertise in complex humanitarian emergencies, protracted
crises, and outbreaks

of infectious diseases. She has a keen interest and experience in
migration/displaced population health- related operations, programs, and policy.

 

Dr. Echeverri has worked with various international, governmental, and
non-governmental organizations covering a variety of field and executive roles,
leading cross-functional teams, health strategy, negotiating access and
operational space for health programs, humanitarian responses, projects in
development, implementation, and evaluation, with a particular focus on
preparedness, readiness,and response. Equally, for the last 5 years she has
worked as a consultant for organizations and agencies such as DFID/FCDO,
WHO/PAHO, and Geneva Call, in activities related to strategy

and proposal development, monitoring and evaluation of projects, and fostering
relationships and

key partnerships.

 

Dr. Echeverri holds a Master in Disaster Medicine (EMDM) and is as faculty
member of the

European Master in Disaster Medicine (EMDM) where she has been supporting the
development,

design, and improvement of the complex humanitarian emergencies module of which
she is a

senior lecturer for Migration and Health, in addition to playing a role as
thesis supervisor. She is

currently a PhD candidate in Global Health, Humanitarian Aid and Disaster
Medicine at the

Università del Piemonte Orientale in Novara-Italy, and a Research fellow at
CRIMEDIM.

Dr. Echeverri is a member of the Health Care in Danger Initiative working group
led by ICRC.

 

KATRIN CRAMERI

DIRECTOR PERSONALIZED HEALTH INFORMATICS 

SIB SWISS INSTITUTE OF BIOINFORMATICS

Katrin Crameri is a group leader at SIB and heads the Data Coordination Centre
of the Swiss Personalized Health Network (SPHN) – a federal research
infrastructure initiative for the efficient and responsible use of health data.
She is also chair of the BioMedIT Board, which is responsible for the
development and operation of the Swiss Trusted Research Environment. Katrin is a
member of various national and international committees in the field of
data-driven medicine and is strongly committed to advance better research for
better health and to successfully maintaining Switzerland as a high-performing
biomedical research location.

DR. FRED MPALA

CHIEF SECURITY OFFICER

 EVIDATION



BRENNA LOUFEK

SAMD REGULATORY AFFAIRS LEAD, CENTER FOR DIGITAL HEALTH

MAYO CLINIC

 

Brenna Loufek is the SaMD Regulatory Affairs Manager in the Center for Digital
Health – Data & Analytics at Mayo Clinic. Brenna collaborates with
user-innovators to create regulatory strategies that offer the least burdensome
pathway to market for digital health technologies developed at Mayo Clinic. Her
subject matter expertise is in the nuanced application of US FDA regulatory
policies for AI/ML-enabled software functionalities.

Brenna brings extensive experience guiding teams through domestic and
international regulations and standards. With previous roles at Medtronic and
Philips, Brenna has managed complex regulatory submissions and advised on
studies for digital health products including AI/ML-based technologies,
telehealth platforms, and in-clinic management tools. In addition to program
support, Brenna has served as a cross-departmental liaison to provide training
for and interpretation of FDA’s current positioning on digital health products.

Brenna has a master’s degree in Patient Safety & Healthcare Quality from Johns
Hopkins. She is currently pursuing a PhD in Evidence-Based Healthcare from the
University of Oxford with a research focus on the efficacy of regulatory and
ethical frameworks within healthcare institutions to manage AI/ML-enabled
clinical decision support software.

 

FELICE BURN 

HEAD OF ARTIFICIAL INTELLIGENCE & DATA SCIENCE

KANTONSSPITAL AARAU AG

Felice Burn is a data science innovation expert in healthcare, medical doctor,
clinical researcher and leader of an AI and Data Science CoE at Cantonal
Hospital Aarau in Switzerland. With more than 20 years healthcare experience and
more than 12 years’ experience in development and integration of artificial
intelligence in healthcare. He designed and implemented new AI strategies and AI
Governances, has extensive experience in digitalization, big data projects and
AI driven solutions to support and optimize healthcare processes to gain
important business values for healthcare institutions

ADITYA KUDUMALA

PRINCIPAL (PARTNER)

DELOITTE

Aditya Kudumala is a Partner within Deloitte Consulting practice, leads Life
Sciences Strategy, AI, and innovation businesses to deliver insights and
innovative solutions to drive value for organizations. His primary focus has
been in leading and delivering strategy, AI, blockchain, products and
technology-enabled transformation initiatives to deliver strategic outcomes.

HELGE BUESS 

ASSOCIATE DIRECTOR POPULATION HEALTH

NOVARTIS FOUNDATION

 

Helge Buess joined the Novartis Foundation in September 2022 as Associate
Director Population Health. He coordinates urban population health initiatives
that leverage the power of data and advanced analytics to decipher the true
drivers of cardiovascular health and equity.

After roles in Sales and Marketing at Astellas Pharma AG, Helge joined the
Oncology Business Unit of Novartis Switzerland in 2018 as Disease Area Manager.
In this position, he was responsible for maximizing the commercial growth of
products in the local hematology portfolio.

In 2021, Helge was appointed Strategic Assistant to the Swiss Country Head,
supporting and driving strategic projects in Novartis’ Pharma Business Unit such
as the development of the Country Organisation’s strategic roadmap as well as
the design and implementation of transformation projects.

Helge graduated from the Swiss Federal Institute of Technology (ETHZ) with a PhD
in Molecular & Cellular Biology and from the University of St. Gallen (HSG) with
an Executive MBA in General Management. With his wide range of experience, Helge
refers to hands-on expertise in biomedical research, product marketing, matrix
leadership, multi-sectorial KOL- and stakeholder management, international
project management and strategy building.

PROF SOMAYA BEN ALLOUCH

HEAD OF DIGITAL LIFE RESEARCH GROUP, AMSTERDAM UNIVERSITY OF APPLIED SCIENCES

ENDOWED PROFESSOR OF HUMAN-SYSTEM INTERACTION FOR HEALTH & WELLBEING

UNIVERSITY OF AMSTERDAM

The main research interests of Professor Somaya Ben Allouch involve development,
use and evaluation of digital technologies, such as robotics and AI. She
obtained her PhD at the University of Twente (the Netherlands) and has been a
visiting researcher at the Ambient Intelligence Research Lab of Stanford
University. 

Since 2021, she has combined the endowed professorship of Human-System
Interaction for Health and Wellbeing at the University of Amsterdam, the
Netherlands, with heading the Digital Life research team at the Amsterdam
University of Applied Sciences. 

She has published several articles in scientific journals, including
International Journal of Mobile Human Computer Interaction, Journal of
Human-Computer Interaction and Journal of Medical Internet Research, and has
been guest editor of the scientific journals International Journal of
Distributed Sensor Networks and International Journal of Social Robotics. She is
a member of the editorial board of Journal of Ambient Intelligence and Smart
Environments. Furthermore, she is involved in several (inter)national third
party funded research projects and supervises several PhD projects.

VEYSEL KOCAMAN

HEAD OF DATA SCIENCE (HEALTHCARE)

JOHN SNOW LABS

     

Veysel is a Senior Data Scientist and Healthcare NLP Lead at John Snow Labs,
improving the Spark NLP for the Healthcare library and delivering hands-on
projects in Healthcare and Life Science. 

He is a seasoned data scientist with a strong background in every aspect of data
science including machine learning, artificial intelligence, and big data with
over ten years of experience. He’s also pursuing his Ph.D. in ML at Leiden
University, Netherlands, and delivers graduate-level lectures in ML and
Distributed Data Processing. He is also working towards his PhD in Computer
Science and is a Google Developer Expert in Machine Learning.

Veysel has broad consulting experience in Statistics, Data Science, Software
Architecture, DevOps, Machine Learning, and AI to several start-ups, boot camps,
and companies around the globe. He also speaks at Data Science & AI events,
conferences and workshops, and has delivered more than 20 talks at International
as well as national conferences and meetups.

MOSTAFA AJALLOOEIAN

ENGAGEMENT DIRECTOR, SENIOR DATA SCIENTIST

UNIT8 SA

Mostafa has been active in the field of AI for the last 18 years, working on a
wide range of topics namely NLP, computer vision, speech recognition,
automation, and robotics. He is a PhD graduate from EPFL and has been a Tech
Lead for conversational AI at Swisscom. He is an Engagement Director and Data
Scientist at Unit8 working actively on the topics around Azure and OpenAI
services.

ANTONIO RUSSO

PARTNER, INNOVATION LEADER AND PARTNER, HEAD OF ANALYTICS & COGNITIVE

DELOITTE SWITZERLAND

       

Antonio Russo leads Deloitte’s Analytics & Cognitive Advisory in Switzerland and
is responsible for Innovation within Deloitte Switzerland’s Executive team. His
team helps clients leverage the power of artificial intelligence and data to
deliver more customer-centric and innovative products and services that catalyse
growth and efficiencies.

He has over 20 years of experience in advising companies in large-scale global
transformations, leveraging new delivery models (GBS/SSC, outsourcing) and
innovative technologies (e.g. robotics, machine learning, natural language
processing/generation). He helps global organisations review and implement new
strategies for business support functions and deploy more effective and
efficient services and governance models. Prior to joining Deloitte in April
2013, he held various sales and consulting leadership positions across Europe
and was CEO of a start-up company developing brand protection technologies.

MAXINE MACKINTOSH

CO- FOUNDER

ONE HEALTHTECH

Maxine leads the Diverse Data initiative at Genomics England, which aims to
reduce health inequalities in genomic medicine by ensuring patients, regardless
of their background, receive the same quality of genomics-enabled personalised
medicine, supported by the latest research on people like them. Maxine is also
the co-founder of One HealthTech – a global, volunteer-led, grassroots community
that supports and promotes under-represented groups in health innovation. She
also set up Data Science for Health Equity, a community of practice that brings
together those with expertise in data science and health inequalities to connect
and collaborate on cutting-edge domains in health. She has been part of a number
of communities and committees including being a Non-Executive Director for the
Eastern Academic Health Science Network, a member of the World Economic Forum’s
Global Shapers, and the British Computer Society (Health Exec) and the DeepMind
Health Independent Review Board.

 

ALEXANDER FINLAYSON

CEO & FOUNDER

NYE HEALTH

NHS PRIMARY CARE DOCTORS & DOLL FELLOW

OXFORD UNIVERSITY



DR BETHEL DEREJE 

GYNECOLOGIC ONCOLOGIST

FOUNDER AND CEO

WECARE DIGITAL HEALTH

 

Bethel Dereje is a Gynecologic Oncologist and an assistant professor of
Obstetrics and Gynecology at St. Paul’s Hospital Millennium Medical College. Dr.
Bethel is also the Founder and CEO of Wecare Digital Health which managed to
take the largest market share of Digital Health service in Ethiopia. 

She has served as a lecturer, undergraduate program coordinator and as an
assistant Dean of St. Paul’s Hospital Millennium Medical College. She was one of
the female physicians to realize Ethiopian Medical Women Association (EMeWA) and
served as Executive board member for the first year. She is also an active
member of Ethiopian Society of Obstetrics and Gynecology (ESOG) and Ethiopian
Medical Association (EMA).

Apart from her professional activities she delivers her social responsibilities
in teaching high school students, leading outreach programs for orphanages and
as a board member of Addis Ababa city administration school feeding program. 

Dr. Bethel is a proud wife and a mother of four. She is passionate about
MENTORSHIP and gender EQUITY. As a hobby she enjoys gardening.

NICOLE SPIEKER

CHIEF EXECUTIVE OFFICER

PHARMACCESS 

Nicole Spieker is a healthcare professional with 17 years on the ground
experience in Africa. A scientist by training, she has focused her career on
developing and scaling innovative models for change that drive inclusive quality
healthcare, especially for vulnerable groups.

She is the CEO of PharmAccess, an international not-for-profit organization
dedicated to strengthening health systems in sub-Saharan Africa. PharmAccess’
mission is to create access to affordable, quality healthcare for low-income
groups. This is achieved through the introduction of standards, the creation of
health insurance systems, and provision of affordable loans to private clinics.
Mobile and digital technology are considered key transformational elements in
achieving UHC. At the core is the M-TIBA mobile health wallet, which connects
patients, payers and providers. M-TIBA creates new digital solidarity mechanisms
where people start paying for each other, and efficiently channels funding to
target groups at very low transaction costs.

Dr Spieker is also the founder of SafeCare, an internationally accredited
(ISQua) standards-based methodology that healthcare facilities use to improve
their quality-of-care. SafeCare has been adopted by public and private partners
in over 15 African countries.

Previously, Dr Spieker was Director of clinical support services at the Aga Khan
Health Services, Dar es Salaam, Tanzania and assistant professor at Aga Khan
University. She holds a PhD in Molecular Genetics of the University of
Amsterdam, The Netherlands.

PAU RUE, PHD

VP OF ARTIFICIAL INTELLIGENCE

INFERMEDICA

Pau Rue is an accomplished data and AI/maching learning leader with a
track-record of building impactful ML and Data Science and AI solutions in
different industries. He currently services as the VP of AI for Infermedica, a
Poland-based digital health company specializing in AI-powered solutions for
preliminary diagnosis and patient triage. After having earned a PhD in
Computational Physics and a short career in Academia (University of Cambridge),
Rue transitioned to the industry, first as a Staff Data Scientist
(Schibsted/Adevinta), then as a Data and ML team leader (Telefonica Alpha
Health) and executive (Typeform), before joining Infermedica.

HANNO RONTE

PARTNER

DELOITTE

Hanno Ronte is a Partner at Monitor Deloitte, in Deloitte UK’s strategy
consultancy business. He has more than 20 years of consulting experience
primarily in the Healthcare and Life Sciences sector. Hanno leads the Life
Sciences and Healthcare team in Monitor Deloitte and is responsible for building
the Real World Evidence Capability within that. His projects focus on corporate
and business unit strategy, competitive response, marketing strategy and
capability building

BERIT GERRITZEN, PH.D.

DIRECTOR, AI & DATA

DELOITTE CONSULTING AG

 

Berit is a Director in Deloitte’s AI & Data Consulting practice, based out of
Zurich, Switzerland. She focuses on enabling value from data for our Life
Sciences and Health Care clients and is the Program Manager of Deloitte
Switzerland’s Generative AI working group.

Berit’s sweet spot is where AI and strategy meet. A data scientist by training,
she started out in industry as a strategy manager at an international pharma
group before finding her passion for consulting.

Berit is a seasoned project manager, focusing on innovative, pragmatic solutions
using agile methodology: She has led data teams of up to 15 members, delivering
complex global projects on time and on budget. She is an engaging facilitator,
well-versed at running data and AI strategy workshops using methodologies such
as design thinking, lean start-up and Deloitte Insight Driven Organisation
framework. 

Berit holds a Ph.D. in Economics and Finance from University of St. Gallen
(HSG), focused on health econometric applications and which she finished during
a 1-year research fellowship at Harvard University.

MATTHEW ARENTZ MD MPH

LEAD – DIGITAL HEALTH VALIDATION PROGRAM; SENIOR TECHNICAL CONSULTANT

FIND

Matt Arentz is a pulmonary physician and data scientist with 15 years of
expertise in TB diagnosis and treatment, including 10 years of tuberculosis
research in East Africa and 5 years working on global disease burdens and health
technology. He spent 10 years in academic medicine at the University of
Washington and its affiliates while conducting clinical research on tuberculosis
in East Africa and mycobacterial research in the United States. Doctor Arentz
also has expertise in data science and has an MPH in global health metrics from
the University of Washington. While working with the Institute of Health Metrics
and Evaluation, he modelled the impact of the COVID-19 pandemic on TB global
case finding.  Additionally, Dr. Arentz worked as a visiting scientist at
Microsoft from 2020 to 2021 where he helped develop their global health access
program.  Beginning in 2021 Dr. Arentz joined FIND as a senior technical
consultant. Matt leads FIND’s validation platform, which focuses on evaluation
of AI based diagnostics.

 

RETO HAENI

PARTNER CYBER RISK SERVICES, DIGITALIZATION AND CLOUD TRANSFORMATION LEADER

DELOITTE

 

Reto Häni is a Cyber Risk Services Partner at Deloitte Switzerland. He leads the
Cloud Security and Risk practice for Risk Advisory across Europe, is member of
the European Cloud Transformation Leadership, acts as the global relationship
responsible for Saviynt and delivers innovative security solutions and performs
large-scale transformation programs across the whole Cybersecurity portfolio.
Amongst other roles, he previously worked as the Cybersecurity leader at another
Big 4, as the group CIO at the Swiss Department of Defense and Chief Security
Advisor at Microsoft responsible for Western Europe. 

Reto has over 20 years of experience in Information Security and Risk focused
ICT environments. He has deep experience in Information and Telecommunication
Security focusing on IT strategy and governance, Cloud Security, Cybersecurity,
Infrastructure Security, Risk Management, Business Continuity Management, Data
Protectio and Identity & Access Management. Reto proved his leadership
experience in commercial and public sector at local, regional and global level.

PAUL DE BLASI

HEAD DELOITTE LEGAL & PRIVATE, PARTNER

DELOITTE SWITZERLAND

 

Paul is a Swiss qualified attorney-at-law and Partner of Deloitte Legal
Switzerland. He has more than 15 years of experience as a business lawyer,
notably in M&A and Digital Law, and is very active in governance and Board of
Directors assistance. Prior to joining Deloitte in 2017, Paul worked for an
international and one of the largest law firms and a big 4 in Switzerland. Paul
is the Chairman of his own Family Business and member of the Family Business
Network Switzerland and International located in the IMD offices in Lausanne. 

 

PEACE NDOLI IRAGUHA

COO & CO-FOUNDER

LIFESTEN

 

Peace Ndoli Iraguha is a visionary healthcare provider and entrepreneur, holding
a bachelor’s degree in human nutrition and Dietetics, along with a master’s
degree in Global Health Delivery. With a passion for enhancing lives, Peace’s
journey began as a dedicated nutritionist in both public and private healthcare
sectors. These experiences paved the way for her transformative entrepreneurial
venture as a co-founder of Lifesten Health.

Her dynamic leadership steered Lifesten Health to a remarkable milestone,
clinching the prestigious 2022 Innovator of the Year award in Rwanda.
Additionally, her continuous contribution to Lifesten Health led the company to
secure victory at the Kigali Cardiovascular Challenge. Under Peace’s guidance,
Lifesten Health pioneered incentive-driven health and wellness programs,
contributing to transforming lifestyles.

Her exceptional ability to cultivate partnerships and networks, strategically
positioned Lifesten Health to address the escalating Non-Communicable Disease
challenge in sub-Saharan Africa. Peace Ndoli Iraguha embodies a relentless
pursuit of a healthier, more vibrant future for all.

DR. ANDREA BIASIUCCI

CEO

CONFINIS

 

Andrea is an electronic engineer (BSc) and biomedical engineer (MSc) with a PhD
from the École Polytechnique Fédérale de Lausanne (EPFL) for his research
activity in Neurotechnology for Brain-Repair and Brain-Computer Interfaces. He
is the CEO of confinis ag, a Swiss regulatory consulting firm specialized in
regulated innovation. In the past, he designed and managed randomized controlled
trials and authored several scientific publications and few patents related to
AI and machine learning in healthcare. Andrea has in-depth knowledge in
Biostatistics, Machine Learning, Signal Processing, and Data Analysis. He
created two neurotech companies, Intento SA and braincredible SA. Intento was
acquired in 2018 by mindmaze group; braincredible – a spinoff of ANT Neuro –
currently sells solutions to collect big EEG data. Andrea holds an honorary
appointment as President of the Basel Chapter of the Italian Chamber of Commerce
for Switzerland (CCIS).

KENN MILTON

CEO AND FOUNDER

MYBLUELABEL 

 

Over the past two decades, I have had the privilege to work with the largest
organizations in the life-science industry, including Novartis, Philips Medical,
Novo Nordisk, Leo Pharma, and some of the biggest consulting-firms in the world.

During this time, I noticed that most established organisations use large and
expensive solutions and consultants for operations and projects. And with
expensive solutions come, expensive consultants, including myself, to navigate
the complex regulatory landscape within life sciences — compliance could be an
actual show-stopper for small and mid-sized MedTech and Life Science companies.

To me a solution had to be found — I had to do something and change that. I
created MyBlueLabel to revolutionize compliance and with a keen focus to make
compliance a business advantage for all companies. 

With the knowledge of how to get regulatory approval, I designed a digital
platform with a work-break-down structure to help MedTech companies swiftly
incorporate a compliance framework into their company, allowing them to become
and stay compliant at a fraction of the expense and difficulty.

NISHANT SINHA

DIRECTOR, AI & AUTOMATION

DELOITTE SWITZERLAND

Nishant Sinha is a Director in AI and Data Strategy. He specializes in
Artificial Intelligence, Automation, Machine Learning and Analytics Strategy.
Nishant leverages his 20+ years of experience in Life Sciences consulting to
support his clients successfully embark on data driven transformations, bringing
a customer centric approach to the business process and model redesign enabled
by Artificial Intelligence

LISA FALCO 

LEAD CONSULTANT AI & DATA

ZÜHLKE GROUP

 

Lisa Falco, PhD, is Lead Consultant for AI & Data at Zühlke. She has 15+ years
of industry experience in in machine learning for healthcare and has led the
development of two AI based medical device products, that were brough to market
under regulatory requirements. She combines a solid know-how in machine learning
and AI with wearables, medical imaging and a passion for building user centric
products, especially within the domain of healthcare and MedTech. She is the
author of “Go Figure! The astonishing science of the female body”, a regular
Forbes contributor and an advocate for women’s health, active in the FemTech
community.

BENJAMIN VON DESCHWANDEN 

CO-FOUNDER AND CHIEF PRODUCT OFFICER (CPO)

ACODIS AG

Benjamin von Deschwanden is driven by the belief that cutting-edge Document AI
technologies have the potential to revolutionize how businesses handle
information, streamline workflows, and enhance decision-making processes. 

With a background in Computer Science and as a Teaching Assistant at ETH Zurich,
Benjamin co-founded Acodis back in 2016 with the mission to turn any document
into value.  

In his current role as Chief Product Officer, he is spearheading the development
of groundbreaking products that redefine the way we interact with documents,
transforming the future of document processing as we know it. As such, three out
of the top ten pharma and health companies worldwide are relying on the Acodis
platform to structure and extract data from documents.

NELSON IGBIRIKI

CEO & CO-FOUNDER 

MEDTECH AFRICA



WOLFRAM VON EHREN

SENIOR DIRECTOR

DELOITTE

 

Wolfram von Ehren leads the Business Operations Team for Life Science, a group
focused around creating efficiency and effectiveness of pharma and med-tech
organizations enabled by organizational, process-driven and digitalization
transformation.

His experience from 25+ years in Deloitte Consulting stretches from strategic
assessments all the way to running major international transformation
programmes. He is particularly strong in transforming strategy into executable
programmes, by building a business perspective on processes and technology
enablement. He has a solid background in major platforms such as SAP or
Salesforce, and enjoys exploring new possibilities alongside proven tools.

His ambition is it to leverage digitalization and AI in cross-functional
processes, connecting people and data for higher productivity.

STEFAN NAEFF

DIGITAL HEALTH CARE LEAD FOR SWITZERLAND

DELOITTE CONSULTING AG



GABRIEL KRUMMENACHER

HEAD OF DATA SCIENCE

ZÜHLKE GROUP

 


VINCENT DE CRAYENCOUR 

HEAD OF INTERNATIONAL DEVELOPMENT

CYBERPEACE INSTITUTE

 


WIM KEES JANSSEN

CO-FOUNDER & CEO

SYNTHO

 

Meet Wim Kees, Founder and CEO of Syntho, a startup that is disrupting the
healthcare sector with software for AI-generated synthetic data to unlock
privacy sensitive data and shorten the time-to-data. Why? The potential and
pressure to innovate with data in healthcare is enormous. However, healthcare
data is the most privacy sensitive data and is therefore locked. This privacy
sensitive data is time-consuming to access, requires extensive paperwork and
cannot simply be used. Hence, Syntho is on a mission to unlock this data to make
sure that data-driven innovation will be realized. Wim has proven with Syntho
that he can make (privacy-sensitive) data more accessible and quickly available
for leading healthcare organizations such as hospitals, pharmaceuticals,
healthtech and life science organizations, to make sure that those organizations
can realize data-driven innovation. Wim Kees and Syntho won the prestigious
Philips Innovation Award, won the Global SAS Hackathon in Healthcare & Life
Science, and were shortlisted as Generative AI startup “to watch” by NVIDIA. So,
why use real data when you could use synthetic data?

FRANK DANNACHER

DIRECTOR, LEAD AI & DATA FOR LIFE SCIENCE AND HEALTHCARE

DELOITTE SWITZERLAND

 

Frank is a Director in Deloitte’s AI & Data Consulting Practice in Switzerland. 
Frank’s focus and commitment is bridging his life sciences clients’ business
strategy needs to analytics & new technology to provide value/competitive
advantage.

Frank is innovative, and structured and speaks business and digital fluently – a
trusted advisor with significant management experience. High level of analytical
and leadership skills. Strong communicator and inspires teams and clients in
what he does. Global citizen and works well in all cultures at all levels.  

Frank is also an SME on Digital Health solutions and their development and
commercialization, engaged with key Life Science companies and consortia, while
also contributing to Intelligent Health conferences and lecturing on Digital
Health at Universities. 

His mother tongue is Danish and he is fluent in English and German.

SANATH KUMAR

CEO

SMITCH

In 2015, Sanath Kumar, a 19-year-old college dropout with a trove of patents and
the distinction of the National Innovator Award, initiated his venture into the
dynamic world of technology. His entrepreneurial drive was propelled by a
singular vision: to serve the Humans of Smitch. Starting with a simple light
bulb integrated with India’s first chip-to-cloud IoT stack, Smitch quickly
permeated 700,000 households.

Yet for Sanath, this was just the groundwork. The essence of Sanath’s leadership
lay not just in scaling but in recognising broader horizons. Delving deep into
the data lake formed by Smitch’s smart home products, Sanath deciphered the
shifting consumer behaviours. This data-driven insight prompted a pivotal shift:
transitioning from mere volume to creating profound value. This evolution
birthed the “Human Token,” a revolutionary concept bridging technology with
preventive healthcare, a significant departure from Smitch’s original offerings.

To manifest this vision, Sanath has meticulously built a team comprising some of
India’s best minds, ensuring Smitch is not only at the forefront of technology
but also embodies a collective drive for genuine healthcare evolution.

BABAJIDE OKE

CEO & FOUNDER

RENDER HEALTH

 

Founder & CEO of Render Health Technology, with many years of experience in the
biotech and healthcare industry. He has worked in several hospitals across the
United States of America supporting breakthrough clinical trials in oncology and
infectious diseases. He is committed to bringing simple Healthcare solutions to
the people and places that need it the most.

RODRIGO SAUCEDO-MARTINEZ 

HEAD OF DIGITAL HEALTH

CARLOS SLIM FOUNDATION





YURII KRYVOBORODOV

HEAD OF AI & DATA CONSULTING

UNICSOFT

 

Yurii Kryvoborodov is an experienced Product Manager with a remarkable
background in delivering and growing products through their entire life cycle.
With over 10 years of experience, Yurii is known for his result-oriented,
data-driven, and proactive approach to management. He is a SAFe certified
product manager, equipped with exceptional multi-cultural communication skills,
enabling him to effectively manage diverse projects with clients from the US,
EU, UK, Israel, China, and Latin America.

Currently serving as the Head of Technology Consulting at Unicsoft, a Global
Software Solutions Vendor, Yurii is playing a key role in defining the product
vision and strategy, developing the business model, and designing technical
architecture for businesses around the globe. In addition to AI for the
healthcare industry, his main areas of expertise are fintech and blockchain.

Yurii has an impressive track record of improving business profitability,
implementing modern delivery methodologies, ML models, and optimizing
operational pipelines. He has successfully launched high-load platforms in
various business domains, increased product conversions, and integrated
third-party systems to improve customer retention.

Yurii holds a Master’s degree in Finance and Banking and a Master’s degree in
Jurisprudence. He has a wide range of certifications, including Stanford Machine
Learning Certificate, SAFe Product Owner/Product Manager, QAI Certified Software
Business Analyst, and Agile Certified Professional, among others.”

DR ZAID AL-FAGIH

CO-FOUNDER & CEO

RHAZES AI



Dr Zaid Al-fagih is the Co-Founder and CEO of Rhazes AI. He is a medical doctor
who has worked in challenging healthcare environments, including warzones. He is
also a previous health tech founder and has worked in cross-disciplinary
research on applying technology to solve problems in healthcare. He also holds a
Master of Public Policy from the University of Oxford’s Blavatnik School of
Government and a BSc in Management from Imperial College Business School.

SHARON BATAMURIZA

PROGRAM DIRECTOR

BRIDGE FOR BILLIONS

 

 

 

Sharon Batamuriza works at Bridge for Billions as Senior Program Manager for
HealthTech Hub Africa. Sharon is an innovative technology solutions and
logistics leader, helping to bring market expansion to Africa and beyond. Her
investment, supply chain, and start-up development expertise has been proven in
her work with global enterprise platform Kountable and as a Consultant for the
FintechHub Rwanda and Euro Exim Bank. A Bennington College graduate with a
bachelor’s degree in Political Economy and Conflict Resolution, Sharon is fluent
in English, Swahili, and Kinyarwanda.

CHRIS MCKEE

MANAGING DIRECTOR

BETTER MEDICINE

Dr Chris McKee is Managing Director for Better Medicine. As Better Medicine
expands to international markets, his focus is to foster collaboration with a
diverse range of stakeholders, including startups, academic institutions and
healthcare providers.

Chris is passionate about driving transformative change in the field of health
and life sciences through innovation. With a deep understanding of the industry
and a keen eye for emerging trends, he specialises in business development for
innovations that revolutionise patient care and improve overall well-being. 

As a seasoned professional in health and life science innovation, he has
successfully led cross-functional teams to implement cutting-edge technologies,
digital solutions, and novel therapies. His expertise lies in leveraging
data-driven insights, artificial intelligence and a range of digital health
solutions to unlock new possibilities in healthcare delivery, precision
medicine, and biomedical research. 

Chris has collaborated with industry leaders, researchers, and clinicians over
the years to identify unmet needs and translate them into impactful strategies
and products, skills which he now gladly contributes to Better Medicine. 

By bridging the gap between scientific breakthroughs and practical
implementation, Chris strives to bring breakthrough technologies to market,
transforming healthcare systems and positively impacting lives on a global
scale.

DR WILLIAM MAPHAM

CEO

VULA MOBILE

Dr William Mapham founded Vula to connect health worker professionals. His
first-hand experience as the Vice-Chair of the Rural Doctors Association and as
a specialist ophthalmologist helped form the solution. He has published academic
articles on the role of innovation and technology in improving healthcare
delivery. To date, Vula has 32,776 registered health workers on the platform and
1,359,398 patients have benefitted to date. William believes that partnerships
are the key to delivering healthcare. Vula has partnerships with academic
institutions, public sector departments of health and pharmaceutical companies.

JENNIE NWOKOYE

FOUNDER CEO

CLAFIYA



SAMI CHAGAR

COO & CO-FOUNDER

DOCTHUS HEALTHTECH

Sami Chagar is a dedicated entrepreneur with a passion for transforming medical
education. As a co-founder of Docthus, he envisions a world where medical
professionals across Africa can access cutting-edge knowledge and techniques
effortlessly. With a background in IT, Sami recognized the pressing need for a
comprehensive platform that connects doctors, provides live surgeries, and
facilitates expert collaboration. Docthus, under Samil’s leadership, has emerged
as a pioneering solution that bridges the gap in medical learning by offering
real-time access to surgical procedures, interactive webinars, and expert
guidance. Sami’s unwavering commitment to enhancing medical knowledge and
patient care has positioned Docthus as a transformative force in healthcare
education, empowering doctors to excel in their practice and save lives.

DR ROB KOROM

CHIEF MEDICAL OFFICER

PENDA HEALTH

Dr. Robert Korom is a board-certified internal medicine physician. Dr. Korom
earned his medical degree from Weill Cornell Medical College in New York City,
USA, and completed his medical training at Massachusetts General Hospital in
Boston, where he was a clinical fellow at Harvard Medical School. Dr. Korom has
published several peer-reviewed studies of Penda’s work in clinical quality
improvement. He works closely with Penda’s digital health and technology teams
to improve clinical decision making and enhance patient experience.

CONRAD TANKOU

CEO

GIC SPACE

Conrad Tankou is a medical doctor from Cameroon, a technology enthusiast who
passionately believes that most of the health challenges in Africa can be solved
through technology solutions which are adapted to the African context. He
founded GIC Space, a health tech venture which designs and promotes cutting edge
and cost-effective solutions for health challenges in Sub-Saharan Africa. Its
flagship product is called GICMED, which targets breast and cervical cancers
through a panoply of proprietary health tech solutions, with several
recognitions received so far for its achievements. With his experience so far in
technology, medical practice, and entrepreneurship, he hopes to be a pillar in
ensuring that even the most remote communities in Africa enjoy standard and
affordable healthcare.

DR JOSEPH OLOWE

FOUNDER & CEO

DOKTORCONNECT

Dr. Joseph Olowe, CEO, has over 30 years in allied health and business. He has
built and sold many businesses and has been in the wellness industry for more
than 20 years. Joseph leads our product development and execution. He can
rightly be described as an epitome of virtue, with great accomplishment in
business. He’s a graduate of the University of Lagos (BSc) in Physical Therapy,
Rocky Mountain of Health Professional (MSc in Health Sciences and Doctorate in
Physical Therapy), and University of Phoenix (MBA), currently the CEO of Omega
Health Systems and sits on many boards. Joseph has exited two startups with
resounding successes and loves to do charity work (he is currently the Volunteer
CEO of His Dominion Christian Organization). He’s currently the only provider of
a hi-tech health and wellness platform driving preventive care in Nigeria and is
looking forward to growing into other Sub-Sahara African communities.

KIDIST TESFAYE

CHIEF EXECUTIVE OFFICER

YENEHEALTH

Kidist is a dynamic and accomplished strategic leader with over 12 years of
experience in top-tier management and administrative positions spanning diverse
sectors such as finance, education, business, and healthcare. She holds a
Master’s in Specialized Studies in Medical Education Curricula and
Entrepreneurship from Harvard University with a focus on Africa, and a
Bachelor’s of Individualized Studies from the University of Minnesota in Global
Studies, Strategic Communications, Public Health, and a Minor in Spanish.

Born in Ethiopia and returning after college, Kidist is dedicated to driving
Africa’s growth through her vision of establishing a leading women’s healthcare
brand. A visionary leader, she is passionate about leveraging her skills to
create a positive impact globally. Committed to empowering African women in
reproductive health, her revolutionary startup is reshaping women’s healthcare
across the continent. With a background in strategic operations, design
thinking, and venture building, Kidist excels in leading teams towards growth.

A former Director of Innovative Strategies and Operations at a prominent
government hospital and medical college, Kidist’s expertise extends to advising
the Minister of Health. She co-directed Harvard Innovation for Ventures in
Education, mentoring student entrepreneurs. An advocate for volunteerism, she
mentors young entrepreneurs and believes innovation, education, social impact,
and youth drive African economic development. Kidist’s groundbreaking women’s
health-tech startup, YeneHealth, embodies this commitment.

Beyond her professional achievements, Kidist enjoys travel and solving complex
problems. Her exceptional academic credentials, industry experience, and
relentless pursuit of her aspirations reflect her strong work ethic and
underscore her Ikigai.

NAOM MONARI

FOUNDER

BENA CARE

Naom Monari is a Visionary social entrepreneur and founder of Bena Care, a
social enterprise based in Kenya. Recognizing the profound economic and
emotional toll of long-term hospital stays, Naom established Bena Care with a
mission to revolutionize healthcare systems, particularly those that perpetuate
extreme poverty and enhance the well-being of chronically ill patients in Kenya.
By leveraging the extensive healthcare professionals’ network; she has developed
a unique healthcare model that addresses the multifaceted barriers to effective
healthcare delivery while spearheading a paradigm shift in healthcare
accessibility and ultimately improving healthcare outcomes for the communities.

JELLE SCHUITEMAKER

CMO & CO-FOUNDER

GOAL 3

Jelle Schuitemaker is one of the founders of GOAL 3 with the mission to make
quality healthcare fair and accessible for everyone, by focusing on smart, AI
and data-driven technologies suited for low resource settings. Through the GOAL
3 IMPALA system, GOAL 3 enabled and empowers healthworkers to save lives, time,
and costs in overburdened settings across Africa. 

Jelle is an out-of-the-box thinking, young and creative entrepreneur, marketeer,
innovation- and business manager, specialized in the combination of Technology,
Marketing, Innovation and Start-ups with a strong mission for a better world
through using innovation and technology as a force that can make a positive
change in the world.

ELIZABETH ADESHINA

FOUNDER

WAZIMA HEALTH

Elizabeth is an avid entrepreneur with a pharmacy and business education
background who has over 17 years’ experience building businesses in the UK and
Africa.  She successfully set up and grew her own brand pharmaceutical wholesale
business from one to seven Sub-Saharan African countries with several high
quality ethical and OTC products in various markets before exiting in 2016 to
launch Wazima Health.  She is passionate about health and improving the access
to and delivery of quality healthcare services. Her work in the healthcare space
includes various projects in the UK’s NHS and with the UN and WHO in Sub-Saharan
Africa. As a speaker, she regularly shares her expertise on various health and
technology related platforms globally including Europe, Africa and UAE.

DR. JEROME NSHIMIYIMANA

FOUNDER AND CEO

JO GRP LTD

Dr. Jerome Nshimiyimana is the Founder and CEO of Jo Grp Ltd, the driving force
behind the innovative healthtech platform JoCare. As a medical doctor working
under the Ministry of Health, his journey in healthcare has been fueled by a
deep commitment to improving lives.

During his time studying medicine at the University of Rwanda, Jerome realized
the urgent need for accessible and accurate health information across various
areas. This led him to create JoCare, a platform that provides evidence-based
information and services, not only in sexual and reproductive health but also in
telemedicine, non-communicable disease prevention, and inclusion of people with
disabilities.

From its inception, JoCare has grown beyond his expectations, impacting
thousands of lives and even conducting crucial research. Jerome’s commitment to
innovation, inclusivity, and community welfare has gained recognition and
support from organizations like Imbuto foundation, HealthTech Hub Africa, UNFPA,
Save the children Rwanda and Westerwelle Foundation.

Together with his dedicated team, Jerome is striving to create a world where
everyone has access to vital health information, services, and the opportunity
to lead healthier lives.

 

FABIAN SCHEUGENPFLUG

SENIOR ASSOCIATE VENTURE CAPITAL

PLUG AND PLAY TECH CENTER

Fabian Scheugenpflug is a trained medical physicist and leads the venture’s
activities for Plug and Play Health EMEA. He has been the first team member of
Plug and Play’s joint Venture with Roche Diagnostics – Startup Creasphere, a
digital health innovation framework.

As part of his role, Fabian works with a multitude of Fortune 500 companies on
specific projects ranging from enhanced POC capabilities to improving access to
healthcare in the global south. Since the inception of Startup Creasphere Fabian
has been leading more than 90 pilots. Additionally, he played a vital role in
the expansion of Startup Creasphere to Asia and America. Besides his corporate
engagement, Fabian has executed investments into 12 early-stage digital health
startups which truly transform the perception of future healthcare. Some of his
prominent portfolio firms include TestCard, Hyfe and Dyad.

LUCA EMILI

CEO & FOUNDER 

INSILICOTRIALS

   

Luca Emili is an entrepreneur and investor, Founder and current CEO
of InSilicoTrials Technologies, a pioneering platform that leverages modeling
and simulation to accelerate innovation in healthcare and life sciences.

From 2001 to 2010 he was CEO of Emaze, a cybersecurity company that became one
of the market leaders in Italy by automating security analysis for complex
networks and devices. He is member of the Cloud Security Consultative Group in
EMA and is responsible for the RCA Research Collaboration Agreement between
InSilicoTrials and the FDA. He also co-chairs the Good Simulation Practice Task
Force within the Avicenna Alliance’s Policy Development Working Group, with the
goal of driving a consensus approach toward standardization for reliable
development and use of in silico solutions.

VASILEIOS DIMAKOPOULOS

CO-FOUNDER & COO

AISTHESIS MEDICAL

Vasileios is Co-Founder and Chief Operating Officer of Aisthesis Medical. His
background is on Electrical and Computer Engineering with a major in Biomedical
Engineering. Currently he completes his PhD at ETH and University of Zurich
where he performs research on Computational Neuroscience. One of his biggest
achievements was that he was selected in the Forbes 30 under 30 in 2022 thanks
to the contributions of Aisthesis Medical in the healthcare sector. His
industrial experience involves working at big corporates and research institutes
including IBM and CERN. Driven by his passion for innovation he envisions
revolutionizing the healthcare sector by introducing Aisthesis Medical into the
wide market of predictive analytics for clinical decision support.

DR. JANIS REINELT

CHIEF MEDICAL OFFICER

AICURA MEDICAL

Janis is Chief Medical Officer at AICURA medical. Prior to joining AICURA, he
pursued his PhD at the Max Planck Institute for Human Cognitive and Brain
Sciences, where he specialized in brain imaging and examined the effects of
stress on brain plasticity. Simultaneously, he gained practical experience as a
part-time psychiatric physician. Recognizing the substantial gap between
cutting-edge, data-driven research and the outdated technology commonly found in
clinical settings, Janis was inspired to transition to AICURA to work on using
data science and AI to enhance clinical research and healthcare delivery.

VOLKER RUDOLPH

FOUNDER & DEVELOPER

MEDREPO

Electrical Engineer (Master Degree, Ruhr Universität Bochum) with programming
experience since 1987.

Project experience around Europe since 2000. Investor in Nextnetinc.com 075%

ANA BERNARDO GANCEDO

ASSOCIATE

AMADEUS CAPITAL PARTNERS



KATHRIN BIERNAT

CEO

123 SONOGRAPHY GMBH

Kathrin Biernat is CEO of 123 Sonography GmbH, a global leader in online medical
education in the field of ultrasound and echocardiography, with more than
400.000 customers and users worldwide.

She has a profound background in Digital transformation in Strategic Marketing,
Sales, and Business Development, with more than 13 years of international
experience. Kathrin started her career in Sales and Strategic Marketing in a
medium-sized lighting company, completing her first University degree in English
and combined European studies at the Karl-Franzen Universität in Graz in 2008.
After completing her MBA studies in 2012, she spent several years in the global
headquarters of a German enterprise in Munich in Strategic Planning and Digital
transformation in Business Development, Sales, and Marketing and returned to
Austria in 2020

SHUBHA KONERU 

SVP - HEALTHCARE STRATEGY & PARTNERSHIPS

MACHANI ROBOTICS

Shubha is a seasoned leader with over 24 years of experience in Healthcare
Strategy, Digital Transformation, and Clinical Data Operations. She possesses a
strong risk and quality mindset, leading with solutions that yield the best
value outcomes. Shubha is adept at cultivating cross-functional relationships to
drive strategic operations.

MAYORO DIAGNE

COO

BAAMTU

Mayoro Diagne is a 43-year-old accomplished Software Engineer living in Dakar,
with 17 years of experience in the tech industry. A proud graduate of Ecole
Superieure Polytechnique de Dakar (ESP), he has a passion for martial arts,
innovation, and AI. Throughout his career, Mayoro has held numerous responsible
positions in both public and private sectors, ranging from small to large
companies.

Currently serving as the COO of Baamtu Technologies, Mayoro brings his extensive
knowledge and skills in engineering and IT to every project he oversees. His
expertise in project management is further reinforced by his ITIL® v3 and COBIT®
5 certifications. Mayoro’s strong academic background in computer engineering
has enabled him to excel in various roles within the tech industry.

As the former Technical Director at Makeba, a fintech company, he designed and
implemented a mobile money platform. During his tenure at ADIE, the Senegalese
IT Agency, Mayoro held various positions and made significant contributions to
numerous e-government initiatives. In his current role at Baamtu, he has
successfully audited tech startups and led crucial projects for both private and
public sector clients.

Mayoro’s diverse experience highlights his ability to manage large-scale
projects, adapt to new technologies, and develop innovative solutions that
benefit organizations across industries.

MARK PINNES

DIRECTOR - STRATEGIC PARTNERSHIPS (EUROPE & MIDDLE EAST)

INDIVILLAGE PVT LTD



RASMUS STEN ANDERSEN

PRINCIPAL DATA SCIENTIST

AMSTERDAM DATA COLLECTIVE

 


CHRISTOFFER EKSTROM

CEO

AI MEDICAL TECHNOLOGY

Christoffer Ekström is one of the founders of AI Medical Technology and is the
company’s CEO and one of the board members. He is a serial entrepreneur and
holds a Master’s degree in immersive technologies (M.Sc.) from Stockholm
University and finalising a bachelor’s degree in business administration (BBA)
at Uppsala University. Christoffer is an experienced climber and adventurer.

DR DARIO MOTTI

HEAD OF DIGITAL HEALTH

CONFINIS

Dario has a PhD in Neuroscience from the International School of Advanced
Studies in Trieste, Italy.  He has over 15 years of experience in pre-clinical
and clinical research in academic and private organizations in Italy, France,
and the United States. He dedicated the last 7 years of his life to digital
health and digital medical devices, focusing on supporting product teams in
delivering effective, beneficial, and impactful digital solutions to patients
and care teams worldwide. First by leading a team of Software Developers and
Data Scientists at Vistronix (US) and for the past 5 years at Roche where he
focused on Clinical Evidence and Clinical/Performance Evaluation. His
experience, though, spans all aspects of digital health solutions: Over the
years, he participated in and led the development and validation of a diverse
range of regulated digital products including Digital Endpoints, Digital
Therapeutics (DTx), Remote Patients Monitoring solutions (RPMs), Clinical
Decision Support tools and algorithms.

DR CARL LEITNER

TECHNICAL OFFICER - DIGITAL HEALTH & INNOVATION

WORLD HEALTH ORGANISATION

   

Carl Leitner, Ph.D.  is a Technical Officer with the World Health Organization,
Geneva. He is the former Technical Director of Digital Square at PATH and
Associate Director of Health Workforce Informatics at IntraHealth. Carl Leitner
brings more than twenty years of experience in informatics, information
technology, software development, and education including more than fourteen
years of designing and adapting health information systems in low- and
middle-income countries.   Leitner has worked closely, in a variety of roles,
with many digital health global goods. Leitner also regularly engages with
health informatics standards development organization and has co-authored
several health informatics standards. Leitner has led numerous workshops working
with in-country teams to build their capacity to implement and manage
interoperable health information systems and to make use of data for effective
decisions and policymaking.

DR ANN AERTS

HEAD OF NOVARTIS FOUNDATION

NOVARTIS FOUNDATION

 


NICHOLAS KELLEY

DATA SCIENCE & A.I. INNOVATION, CHIEF DIGITAL OFFICE

NOVARTIS

 

Nicholas Kelley is the Director Data Science & A.I. Portfolio Strategy and
Innovation in the central Novartis Data & AI organization, and has two main
priorities.  First, to identify, prioritise, and launch key use-cases with the
mission of delivering reusable AI capabilities for the scientific and medical
core of the business.  Second, to better define the AI opportunities landscape
and needed capabilities across the value chain.  Here the key focus is on
continued improvement of our Novartis data science foundation through innovative
partnerships and by leading the data science community and capability building
initiatives.

Recent initiatives include seeding and driving AI solutions such as Generative
Chemistry as part of the partnership with Microsoft Research, the first
cross-Novartis Data Science challenge in collaboration with MIT, and launching
the AI for Life Residency program.

Nick has a formal background in computational methodology with a Ph.D. in
Biophysics from Stanford University, with career experience in computational
biology, chem- and bioinformatics, and most recently in the application of A.I.
and machine learning in health.  

DR LUKAS ENGELBERGER

MEMBER OF THE GOVERNMENT, CANTON BASEL-STADT

HEAD OF THE PUBLIC HEALTH DEPARTMENT

   

Since 2014, Dr. iur., LLM, Lukas Engelberger is a member of the Government of
the Canton Basel-Stadt and Head of the Public Health Department. 

He is also President of the Swiss Conference of the Cantonal Ministers of Public
Health (GDK) and Member of the Board of Swissmedic (Swiss Agency for Therapeutic
Products). He also is Member of the Board of Cantosana AG.

After his studies in law at the universities of Basel, Fribourg and Bern, he
obtained the bar examination (Canton of Basel-Stadt) in 2001. In 2003 he
doctorate in law at the university of Basel and holds a LLM (University College
London). 

From 2003-2005 he was practising as an atorney at Bär & Karrer in Zürich
(Practice areas: M&A, capital markets, general corporate and commercial
matters). From 2005- 2014 Mr. Engelberger was a legal counsel at F.Hoffmann-La
Roche Ltd. in Basel.

ELENA BONFIGLIOLI

GM, GLOBAL HEALTHCARE STRATEGY LEAD, PHARMA AND LIFE SCIENCES

MICROSOFT 

 

Elena Bonfiglioli is Microsoft’s Global Business Leader for Healthcare and
Strategy Lead for Pharma Life Sciences. 

 

In this capacity she is responsible for industry pharma strategy and commercial
go-to-market, enabling co-innovation and engagement with strategic customers and
partners to accelerate their transformation with cloud and AI.  

 

She was recently elected as Vice Chair of the DIGITALEUROPE Executive Council
for Healthcare. 

 

A signature outcome of her work – together with a core team across engineering
and research – was the design and launch of the AI partnership with Novartis in
2019 and the AI for Leprosy initiative with Novartis Foundation and Fiocruz,
recently published in The Lancet/Elsevier.  

Elena co-chaired the Health Cloud Council for Microsoft and partners from
2015-2019 where she led the development of a position on secondary use of health
data and championed the work on data collaboratives, leading to the creation of
the first global data collaborative in cardiovascular population health.

Elena has been working in the health sector for 18+ years, first in health
policy at EU level and then as regional business leader in public healthcare
across EMEA. In July 2017, Elena was elected to the HIMSS Europe Governing
Council.  In 2020 she was nominated one of the top 50 AI Innovators by
Intelligent Health.  Elena is one of the founding members of the Holomedicine
Association.

She is an active advocate and public speaker, invited to represent the approach
of Microsoft for Healthcare and AI and how Data save Lives.  She is also a
champion for the transformational impact of meditation in personal and
professional development, working with the Centre for Evolutionary Learning; and
the empowerment of women in leadership. 

Recent articles:

 * (99+) Empowering change: how mixed reality is driving the future of medicine
   | LinkedIn
 * Launching AI4BetterHearts, the First Global Data Collaborative for Improving
   Cardiovascular Health | Novartis Foundation
 * Harnessing health data for better outcomes: a call to action – Microsoft
   Industry Blogs
 * Improving the pace of vaccine distribution through technology – Microsoft
   Industry Blogs

DR. SUMEET S. CHUGH

MEDICAL DIRECTOR

HEART RHYTHM CENTER, SMIDT HEART INSTITUTE

DIRECTOR

DIVISION OF ARTIFICAL INTELLIGENCE IN MEDICINE; CEDARS-SINAI HEALTH SYSTEM, LOS
ANGELES, CA, USA



KELLY MCCAIN

HEAD OF HEALTH AND HEALTHCARE INITIATIVES

WORLD ECONOMIC FORUM



VICKY LEVY

DELOITTE GLOBAL LIFE SCIENCES SECTOR LEADER

DELOITTE

   

Vicky Levy is the Deloitte Global Life Sciences sector leader. In this role, she
ensures our leaders around the world are able to bring the best of Deloitte to
bear in the life sciences sector, helps to build the global capabilities of
Deloitte in the sector and guides and advises Deloitte Life Sciences leaders
across our global network as they serve global clients. Vicky brings more than
25 years of global life sciences professional services experience to our clients
around the globe. She advises executives across a range of topics, including
executive transitions, enterprise transformation, commercial performance,
culture and diversity, equity, and inclusion.

MARCO GIANNITRAPANI

HEAD OF GLOBAL GO TO MARKET DATA & ANALYTICS

ROCHE

   


BRUNO VILLETELLE

HEAD OF DATA AND DIGITAL

NOVARTIS GLOBAL DRUG DEVELOPMENT

   


DR. JOHN HALAMKA

PRESIDENT

MAYO CLINIC PLATFORM

   


MENI STYLIADOU

VP DISTINGUISHED FELLOW, DATA SCIENCE INSTITUTE

TAKEDA R&D

FOUNDER & CO-LEAD

H2O ENTERPRISE

     


YARON ILAN

DIRECTOR OF THE DEPARTMENT OF MEDICINE

HEBREW UNIVERSITY-HADASSAH MEDICAL CENTER

Dr. Yaron Ilan is the Director of the Department of Medicine at the Hebrew
University-Hadassah Medical Center. Dr. Ilan served as the Vice Dean of the
Hebrew University-Hadassah Medical School. Dr. Ilan was a Visiting Professor at
Harvard University, working on novel immunotherapies. Dr. Ilan’s main areas of
research are developing artificial intelligence-based algorithms for improving
care, developing immunomodulatory therapies for fatty liver disease, diabetes,
and inflammatory bowel diseases, and developing drugs for primary liver cancer.
Dr. Ilan holds over 50 patents for discoveries based on his innovative research
and has authored more than 300 articles. He is the inventor of several drugs and
medical devices developed by several pharmaceutical companies. Several of his
innovations have already reached the clinical market. Dr. Ilan is the founder of
several companies and is a medical director and advisor for several biotech
companies.

 

CAOIMHE VALLELY-GILROY

FORMER GLOBAL HEAD OF DIGITAL HEALTH & THERAPEUTICS

 HEALTHCARE BUSINESS OF MERCK



PROF. S. YUNKAP KWANKAM, PH.D.

EXECUTIVE DIRECTOR

INTERNATIONAL SOCIETY FOR TELEMEDICINE AND EHEALTH (ISFTEH)

     


DR DANIEL KNECHT

VP, CHIEF CLINICAL INNOVATION OFFICER 

CVS CAREMARK

   

A board-certified internist, Daniel Knecht, M.D., currently serves as Vice
President, Chief Clinical Innovation Officer, CVS Caremark. Dr. Knecht’s focus
is on helping clients better understand the evolving clinical landscape of
specialty medications, develop strategies for better patient care and outcomes,
and manage costs. 

Prior to this role, as Vice President, Clinical Product, Dr. Knecht was
responsible for clinical product ideation, concept development and testing,
optimization, launch, performance, and measurement in collaboration with key
stakeholders across the enterprise.

Dr. Knecht is a Fulbright scholar and graduated with honors from Dartmouth
College. He also has a joint M.D., M.B.A., from Weill Cornell Medical College
and Johnson Graduate School of Management where he was a recipient of the Lee
Family Scholarship. He is an associate clinical professor at Mount Sinai West in
New York City where he still sees patients, and a member of the Board of the
Foundation of CUNY School of Public Health.

ACHIM PLUECKEBAUM

HEAD DATA42

NOVARTIS

   


STEFAN GERMANN

CEO

FONDATION BOTNAR

Dr Stefan Germann is the CEO of Fondation Botnar, a Swiss-based foundation which
champions the use of AI and digital technology to improve the wellbeing of young
people in urban environments. To achieve this, the foundation supports research,
catalyses diverse partners, and invests in scalable solutions around the world.

Dr Germann has spent over 25 years working in various leadership roles in Africa
and Asia, focusing on health-related development for children, relief and
advocacy work. He was previously the Senior Director of World Vision’s
International Sustainable Health Partnership, Innovation and Accountability unit
based in Malaysia. His work focused on a complex relief and reconstruction
program in response to the Asian Tsunami. 

He has previously held several board and advisory board memberships. These
include for the Partnership for Maternal, Newborn and Child Health (PMNCH), UBS
Optimus Foundation, REPSSI in Africa, the Global Health Program and The Graduate
Institute in Geneva, where he focused on the role of NGOs in global health
diplomacy.

DR IMRAN SIDDIQUI

UK/I RADIOLOGY MEDICAL ADVISOR

BAYER PLC

Dr Imran Siddiqui studied in London and trained in clinical radiology in the
NHS, prior to joining Bayer, where he now leads the Radiology Medical Affairs
team for the UK. He focuses on growing value and expertise for both
pharmaceutical and medical device products, advising on medical and commercial
strategy and driving regulatory excellence and innovation. Imran is passionate
about medical education as well as the safe and sustainable adoption of AI
technologies. He was a core team member for the global launch of an AI platform
technology for medical imaging, was recently awarded a scholarship to complete
the renowned UCL ‘Artificial Intelligence in Business’ executive course on AI
implementation and strategic business models and sits on the British Institute
of Radiology’s AI & Innovation specialist interest group.

LUCIEN ENGELEN

EDGE FELLOW, DELOITTE CENTER FOR THE EDGEX

DELOITTE 

     


DR. JIM RITCHIE

CONSULTANT RENAL PHYSICIAN; CHIEF CLINICAL INFORMATION OFFICER; DEPUTY DIRECTOR
FOR RESEARCH AND INNOVATION

NORTHERN CARE ALLIANCE NHS FOUNDATION TRUST

   

Dr. Jim Ritchie is the Chief Clinical Information Officer and Deputy Director
for Research and Innovation (Digital Health and Artificial Intelligence) at the
Northern Care Alliance and an Honorary Clinical Lecturer at the University of
Manchester. He continues to practice clinical medicine as nephrologist Salford
Royal, one of the most digitally mature trusts in the NHS.

Jim supported delivery of the Salford Global Digital Exemplar programme,
provides clinical leadership to the digital ‘Living Lab’, and has skills and
knowledge in design thinking, system evaluation and developing collaborative
partnerships with industry. In 2018, he graduated as part of Cohort 1 of the NHS
Digital Academy

Over recent years, Jim has led the design and development of the NCA Digital
Control Centre Programme; a transformational partnership that will embed
advanced technologies and behaviours to optimise operational efficiency and
improve care delivery. In addition, he has worked with colleagues to develop
partnerships that can deliver new models of care for chronic disease into the
NHS. This work includes development of the RevOCE programme which has delivered
tools for population risk segmentation, targeted care and holistic
multimorbidity clinics.

NATASHA SUNDERJI

GLOBAL HEALTH LEAD, ACCENTURE DEVELOPMENT PARTNERSHIPS 

ACCENTURE

   

Natasha Sunderji is the Global Health Lead of Accenture’s social impact
business, and also co-leads Accenture’s Health Equity Center of Excellence. She
has 18+ years of experience advising companies, NGOs, donors, and multilaterals
on social business model design, digital health, and cross-sectoral
partnerships. She has designed patient centric solutions with leading health
actors, developed 30+ inclusive businesses, and advised policy makers on the
investments needed to create robust digital health ecosystems. She was named a
World Summit AI Top 50 Innovator in 2020. Natasha holds a Bachelor’s in
Biomedical Engineering from University of Toronto, and a Master’s in Public
Policy from Harvard Kennedy School.

ARNAUD RUNGE

MEDICAL ENGINEER

EUROPEAN SPACE AGENCY

   


ELIF OZKIRIMLI

HEAD OF DATA SCIENCE AND ADVANCED ANALYTICS - PHARMA INTERNATIONAL DATA AND
ANALYTICS CHAPTER

ROCHE AG

 

Elif is the Head of Computational Biology and Exploratory Analytics Products at
Roche. She leads a global team of product managers that focus on building
bioinformatics, omics and predictive analytics products that enable new
hypothesis creation using state-of-the-art, interpretable and robust machine
learning and advanced mathematical modeling approaches. 

 

Elif holds a BS and MS in Chemical Engineering from Bogazici University and a
PhD in Structural Biology from Purdue University, where she used molecular
dynamics simulations to study the Src kinase activation mechanism. She then
joined the Chemical Engineering Department at Bogazici University as a faculty
member. Her research spanned both experimental and computational studies on
elucidating protein – compound interaction mechanisms and structure based drug
design for proteins related to antimicrobial resistance and sphingolipid
binding. She moved from >15 years in academia to industry when she joined Roche
as the Head of Data Science in Go-to-market Data and Analytics in 2020. 

 

CAROLINE PERRIN, PH.D.

EXECUTIVE DIRECTOR 

GENEVA DIGITAL HEALTH HUB (GDHUB)

   


VALENTINA SARTORI

PARTNER, LEADER OF QUANTUMBLACK IN SWITZERLAND

QUANTUMBLACK, AI BY MCKINSEY

Valentina is a Partner in McKinsey’s Zurich office. Since joining in 2006, she
has worked with multiple Healthcare and Life Sciences stakeholders, including
Pharma companies, Health Tech start-ups, Hospitals and NGOs on a range of
including how they can leverage advanced analytics to step-change their
performance and operating model.

Valentina has been co-leading the QuantumBlack hub in Zurich since 2020, and
it’s Digital and Analytics effort in Global Public Health. Valentina is
passionate about the topic of diversity and leads Women Recruiting for the Swiss
office as well as D&I for the Life Sciences Practice.

PETER HACKEL

HEAD OF DATA PRODUCTS

TAKEDA PHARMA

   

Peter Hackel leads the Data Products Team for Takeda’s Global Manufacturing
Supply and Global Quality Organization. With his team he builds an environment
where data analytics is possible and scalable across the organizational levels
and pillars.

 

He brings more than 14 years of experience in the pharmaceutical industry
working in areas such as process development, process optimization, technology
deployment and data strategy. He believes the harnessing of technologies such as
natural language processing or machine learning built on a sustainable data
infrastructure is a differentiating factor in how companies can run operation
and serve patients around the world.

JUAN GUTIERREZ ALLIENDE

MEDICAL LEAD EMEA DIGITAL SOLUTION BUSINESS, RADIOLOGY

BAYER AG

   

Medical radiologist, enthusiast of health innovation with clinical experience in
public and private health systems in Latin America and Europe. Since 2020 he has
been working at Bayer Radiology.

VICTOR SAVEVSKI

CHIEF INNOVATION OFFICER AND AI CENTER DIRECTOR

HUMANITAS RESEARCH HOSPITAL



MARCO OBISO

CHIEF AI OF THE DIGITAL NETWORKS & SOCIETY DEPARTMENT, TELECOMMUNICATION
DEVELOPMENT BUREAU

INTERNATIONAL TELECOMMUNICATION UNION (ITU)

 

Mr. Marco Obiso is the Head of the Cybersecurity division and currently acting
as Chief of the Digital Network Society Department in the Telecommunication
Development Bureau of the International Telecommunication Union (ITU), the lead
UN-specialized agency for Information and Communication Technologies (ICT).

He has been working in the ICT field for the past two decades, operating in
several ICT-related domains such as network infrastructure development, system
integration, application cooperation, IT Service Management, Internet governance
and information security.

As Head of the Cybersecurity division, he is currently facilitating the work of
ITU in elaborating Cybersecurity strategies and implementing programmes and
initiatives as well as leading the ITU’s efforts on enabling the use of ICT
applications, for the benefit of ITU Member States, including providing
technical assistance in establishing capabilities and working to strengthen
coordination and cooperation within the UN system.

DR AENGUS TRAN

CO-FOUNDER AND CLINICAL AI DIRECTOR

ANNALISE.AI 

   


GIUSEPPE MARCO RANDAZZO

HEAD OF AI AND CHEMINFORMATICS

ENDOGENA THERAPEUTICS, INC

   

Giuseppe Marco Randazzo is a cheminformatic data scientist with more than 10+
experience in drug discovery. After completing his Ph.D. in chemical science at
the laboratory of chemometrics and cheminformatic University of Perugia, in 2013
moved to the pharmaceutical sciences department of the University of Geneva for
a post-doc position in the analytical chemistry group. He worked on
machine-learning (ML)/cheminformatics tools for automatic compound annotation in
metabolomics approaches. He also worked in a joint venture between the
University of Geneva and a private industrial partner, Firmenich, delivering new
active nature-identical compounds using ML and cheminformatics approaches. In
2017 he joined the Dalle Molle Institute for Artificial Intelligence in Lugano,
developing new AI tools for drug discovery. In 2019 he joined F. Hoffmann-La
Roche as a post-doc scientist to implement new machine-learning and AI methods
for polypharmacology. In 2021 he joined Endogena Therapeutics in the role of
Head of AI and Cheminformatics. He is an enthusiast and active open-source
supporter, contributing to several scientific projects.

PATRICIA GEE

PARTNER IN LIFE SCIENCES AND LEADER FUTURE OF HEALTH INITIATIVES

DELOITTE SWITZERLAND

   

Patricia Gee leads Deloitte’s Future of Health initiative in Switzerland. She
has spent over20 years in the life science and health industry, bringing
together cross-sector experience in biopharma, payer, provider and capital
markets. She focuses on driving sustainable value, growth and innovation for
leading life science clients in the areas of commercial transformation, digital
innovation, product launch, marketing, sales and market access.

DR ANDREW SOLTAN

NIHR ACADEMIC CLINICAL FELLOW

UNIVERSITY OF OXFORD & OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

 

Dr Andrew Soltan is an NIHR-funded practicing Clinician at Oxford University
Hospitals NHS Trust, and Clinical Machine Learning Researcher at the University
of Oxford. His research applies machine learning methods to Electronic Health
Record data for rapid diagnosis and prognostication in acute and emergency care
settings. During the COVID-19 pandemic, Dr Soltan led the CURIAL programme which
developed and deployed an AI test to screen patients for infection in Emergency
Departments, using clinical data routinely available within 1h. The CURIAL
evidence base has achieved two publications in The Lancet Digital Health,
showing a 26% reduction in time-to-result when piloted at the John Radcliffe
Hospital and reduction in missed COVID-19 cases compared to Lateral Flow Testing
alone.
Previously Dr Soltan has worked in industry as Medical Officer at Visulytix,
which partnered with Orbis International to make its AI tool for detecting
treatable eye disease accessible to doctors in low-resource countries.
Since graduating with Distinction in Medicine from the University of Cambridge,
Dr Soltan has received awards including an NIHR Academic Clinical Fellowship and
a Translational Research award funded by the Wellcome Trust.

DR. SABINA MAGALINI

PANACEA COORDINATOR; SENIOR SURGEON OF EMERGENCY TRAUMA

GEMELLI UNIVERSITY HOSPITAL

Sabina Magalini is a Surgeon of the Emergency and Trauma Surgery Department of
the Policlinico Gemelli of Rome Italy (World’s Best Hospitals 2022, Newsweek)
and an aggregate Professor of the Catholic University School of Medicine. 

Aside from clinical work she is interested in the organization of emergency
medicine and surgery procedures in situations of disaster medicine. Together
with her team she has participated in many EU projects dealing with CBRNe
response (EDEN, ENCIRCLE, SMARTSTADIUM), decision support systems for first
responders (FR) (PULSE, IMPRESS), development of new technologies for FR
(NIGHTINGALE), security problems for communication during the pandemic (REACT2,
COVINFORM), data sharing for research in medicine (TRUSTEE). 

The increasing importance of cybersecurity for hospital resilience has pushed
her interests in the direction of identifying response and responsibilities of
hospital personnel. She has coordinated the PANACEA project on people-centric
hospital cyber resilience and will be part of the DYNAMO project on business
continuity during cyberattacks. 

Partner in the EU Coordination Supporting Action Networks NO-FEAR, INCLUDING,
EU-HYBNET, her main effort is in participation of medical personnel as end-users
in technological projects in the medical security setting, because this
interaction will guarantee the development of the best technology in an EU
perspective.

JACQUES GILBERT

SENIOR DIRECTOR STRATEGY – HEALTHCARE 

NUANCE COMMUNICATIONS

   

Jacques Gilbert is the Senior Director of Healthcare Strategy at Nuance
Communications. Jacques leads business development, strategic partnerships and
M&A activities for Nuance’s Diagnostics business unit which includes a large
portfolio of AI applications integrated into both clinical and administrative
workflows for healthcare providers, pharmaceutical, payors and self-insurance
employers and medTech customers. Prior to joining Nuance in 2017, Jacques
cofounded start-ups in AI/ML and strategy consulting in financial services
sector and more recently held multiple leadership roles in strategic marketing
for GE Healthcare. He received Bachelor of Commerce degrees from University of
the Witwatersrand in Johannesburg, South Africa

DR EWELINA TURK

SVP MEDICAL PRODUCTS

ADA HEALTH

   


BABITA SHARMA

BROADCASTER AND AUTHOR

Babita Sharma is a BBC News presenter, regularly seen on the BBC News Channel,
BBC World News, and presenting the show Newsday.

 

Babita has presented the finance programme Your Money, and fronts business
reports for BBC News. She has also covered economic and political stories from
around the world.

NISHANT SINHA

DIRECTOR, AI & AUTOMATION

DELOITTE SWITZERLAND

Nishant Sinha is a Director in AI and Data Strategy. He specializes in
Artificial Intelligence, Automation, Machine Learning and Analytics Strategy.
Nishant leverages his 20+ years of experience in Life Sciences consulting to
support his clients successfully embark on data driven transformations, bringing
a customer centric approach to the business process and model redesign enabled
by Artificial Intelligence

RICHARD PLUMB

CYBER THREAT INTELLIGENCE LEAD

NHS DIGITAL

     

Richard Plumb is a seasoned cyber and physical security speaker. After spending
15 years in the Police, he transitioned to cybersecurity consulting and threat
intelligence. He now works as the Cyber Threat Intelligence Lead for NHS
Digital, whose team provide cutting edge threat intelligence to the whole of the
NHS, from senior leadership teams to the technical teams on the ground. Richard
has extensive experience of communicating complex cybersecurity concepts to a
wide range of audiences and enjoys making presentations both thought-inspiring
and enjoyable.

LOUBNA BOUARFA

CEO & FOUNDER

OKRA TECHNOLOGIES

Dr Loubna Bouarfa is a machine learning scientist turned entrepreneur. She is
the founder and CEO of OKRA Technologies – an artificial intelligence data
analytics company for healthcare. OKRA allows healthcare professionals to
combine all their data in one place and generate actionable, evidence-based
insights in real time, to save and improve human lives. Loubna is currently a
member of the European Union High-Level Expert Group on Artificial Intelligence,
where she is particularly focused on healthcare and achieving competitive
business impact with AI. She was named an MIT Technology Review Top Innovator
Under 35, a Forbes 50 Top Women In Tech, and won several prizes, including CEO
of Year 2019 at the Cambridge Independent Science and Technology Awards and Best
Female-Led Startup at the StartUp Europe Awards. On a personal level, she is a
strong

advocate for diversity, women and challenging the status quo.

ALEX ZHAVORONKOV

FOUNDER AND CEO 

INSILICO MEDICINE

   

Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine
(insilico.com), a leader in next-generation artificial intelligence technologies
for drug discovery and biomarker development. Under his leadership Insilico
raised over $380 million in multiple rounds from expert investors, opened R&D
centers in six countries or regions, and partnered with multiple pharmaceutical,
biotechnology, and academic institutions, nominated 8 preclinical candidates,
and entered human clinical trials with AI-discovered novel target and
AI-designed novel molecule. Since 2015 he invented critical technologies in the
field of generative adversarial networks (GANs) and reinforcement learning (RL)
for generation of the novel molecular structures with the desired properties and
generation of synthetic biological and patient data. Since 2012 he published
over 160 peer-reviewed research papers, and 2 books.

 

He founded and co-chairs the Annual Aging Research, Drug Discovery and AI Forum
(9th annual in 2022), the world’s largest event on aging in the pharmaceutical
industry. He is the adjunct professor of artificial intelligence at the Buck
Institute for Research on Aging.

THOMAS LINDAHL

CHIEF MEDICAL OFFICER

UNILABS SWEDEN

   

Thomas Lindahl is the Chief Medical Officer for Unilabs Sweden, a country leader
in medical diagnostics. He did his training as a radiologist, as well as a PhD
in oncology, at the Karolinska University hospital in Stockholm. After leaving
academic medicine Thomas has held many leadership roles within the medical
diagnostics business, including the Unilabs TMC on call teleradiology service in
Sydney, Australia. His present role includes responsibility for AI and
innovation strategy. Being an early AI adopter he has overseen the validation
and clinical implementation of several AI tools for radiology and digital
pathology.  Thomas is part of the steering comity for the Unilabs Group AI
center of excellence.

DR ARNAUD WILMET

MD, CHIEF MEDICAL INFORMATION OFFICER

NUANCE

   

Arnaud Wilmet, MD is Chief Medical Information Officer at Nuance where he is in
charge of the France Medical Accounts. Prior joining the team, he managed a
Pediatrics center in Paris for five years and implemented a full patient
integrated EHR with success. He joined Cerner France where he applies clinical
knowledge to facilitate development, marketing, sales and integration of
solutions to improve patient outcomes and raise physician satisfaction in French
Hospitals. He relocated 3 years in the USA as a Senior Physician Executive for
Cerner Corp. working with major clients. His last role was Chief Medical Officer
of H4D, a telehealth provider where he manages the virtual clinics and medical
affairs. Dr Wilmet finished medical school at University of Angers as a family
practice physician. The breadth of his background has given him a holistic
perspective which encompasses both the patient and provider experience.

ARDY ARIANPOUR

CEO & CO-FOUNDER

SEQSTER

 

Ardy Arianpour is CEO & Co-Founder of Seqster the leading healthcare technology
company that puts the patient at the center of all their health data. He is a
visionary health tech executive with 20+ years driving innovation in biotech and
digital health. 

Prior to starting Seqster, Ardy launched several clinical and consumer-based
genetic tests as CCO of Pathway Genomics, and served as SVP of Ambry Genetics,
which sold to Konica in 2017 for $1 Billion.

 

As a key player in the 2013 landmark SCOTUS decision scrapping gene patents,
Ardy played an instrumental role in expanding genetic testing access with the
launch of BRCA testing benefiting patients and family members across the
country.

 

Ardy received his BS in Biological Sciences from UC Irvine and an MBA from
Marshall Goldsmith School of Management. He was a Medical, Marketing, and
Media’s (MM&M) Top 40 Healthcare Transformer and San Diego Business Journal 40
under 40.

 

OMAR KHAWAJA

CHIEF INFORMATION SECURITY OFFICER

HIGHMARK HEALTH

   

Omar Khawaja is passionate about people, community, frameworks, communication
and measurement. Omar is currently Chief Information Security Officer (CISO) at
Highmark Health, a blended health care delivery and financing system, employing
more than 45,000 people and serving 50 million Americans. Prior to Highmark
Health, Omar was at Verizon Enterprise Solutions, where he had product
management and marketing responsibilities for their security solutions portfolio
with customers in 72 countries.

In order to sustain the effective delivery of security controls at scale, Omar
led the development of 14 frameworks and 8 measurement programs. For this focus
on sustainability, Highmark’s Information Security & Risk Mgmt program has been
profiled by: Wall Street Journal, SANS, Forrester, Gartner, NACD, Reuters,
HIMSS, CSO Magazine and others.

Omar’s certifications include SAFe Agilist, human centered design practitioner,
CPHIMS (Certified Professional in Healthcare Information and Management
Systems), CISSP (Certified Information Systems Security Professional), CCSK
(Certificate of Cloud Security Knowledge) and FAIR Risk. Omar has a BS in
Electrical Engineering from Georgia Tech and an MBA from University of
Virginia’s Darden School of Business.

Omar currently serves on the boards of HITRUST, the FAIR Institute and
Leadership Pittsburgh; on the CISO Workgroup of the Blue Cross Blue Shield
Association, as an advisor to a half dozen tech firms and as adjunct faculty for
the Chief Information Security Officer (CISO) program at Carnegie Mellon
University.

 

DR JACOB J VISSER

RADIOLOGIST & CMIO, ASSISTANT PROFESSOR VALUE-BASED IMAGING

ERASMUS MEDICAL CENTER

   

Dr Jacob J Visser is an experienced radiologist and proclaimed academician at
the Erasmus Medical Center. He is also the Chief Medical Information Officer at
the hospital and the Head of Imaging IT and Value-based imaging at the
department of Radiology & Nuclear Medicine.  

Dr Visser has been working closely with the hospital & health care industry
focused on Radiology since 2006 and has been associated with the legacy
institution – Erasmus MC for the past decade. Dr Visser focuses on the
intersection of health economics, technology with radiology and focuses on
Telehealth, Clinical Informatics, Integrated Diagnostics, and Artificial
Intelligence. He is a keen scholar and an illustrious member of many prestigious
industry bodies for Radiology and Medical Imaging across the globe. He has
written more than 20 critically acclaimed clinical research papers on radiology
and nuclear medicine. 

LinkedIn: https://www.linkedin.com/in/jacob-j-visser-7455426/  

PRATEEK BHARADWAJ

GLOBAL MARKET ACCESS MANAGER, RADIOLOGY

BAYER AG

 

A bio-medical engineer and digital health enthusiast with a decade of experience
in diagnostic imaging, radiology and Hospital AI. Having extensively worked with
radiologists, clinicians, hospital administrations and health tech companies
understands and contributes towards effective implementation of AI in healthcare
services.

PROF DR STANISA RASPOPOVIC

PROFESSOR, DEP. OF HEALTH SCIENCES AND TECHNOLOGY

ETH ZÜRICH

   

Stanisa Raspopovic is an Assistant Professor of Neuroengineering at the
Department of Health Sciences and Technology of the Swiss Federal Institute of
Technology, Zurich, Switzerland. He worked as a PostDoc at EPFL, Lausanne,
Switzerland 2013-17. He received the MS in Biomedical Engineering with full
marks from the University of Pisa, Italy, in 2007 and the Ph.D. cum laude in
Biorobotics, from Scuola Superiore Sant’Anna, Pisa in 2011. His research
interest is focused on the development of innovative medical devices for
treatment of neurologically disabled persons. In particular, he develops
mechatronic systems directly interfacing the environment with the residual
nervous system. Stanisa achieved the groundbreaking translational research
results in the field of sensory restoration in amputee patients. Driven by the
desire to share these inventions with the wider population, in 2014 he
co-founded SensArs Neuroprosthetics, a spin-off that develops neuroprosthetic
systems, which won many international recognitions, and raised several millions
of non-dilutive funding. He won several grants from EU and Switzerland in the
role of a project leader and is presently the PI of the prestigious ERC starting
grant FeelAgain.  

ERIC DURAND

SVP DATA SCIENCE

OWKIN

   


RIGVEDA KADAM

HEAD OF DIGITAL HEALTH

FIND, THE ALLIANCE FOR DIAGNOSTICS

   


REUVEN ARONASHVILI

FOUNDER & CHIEF EXECUTIVE OFFICER

CYE

   


DR ANITA PRINZIE

PRODUCT MANAGER

OMINA TECHNOLOGIES

   

Anita is Product Manager at Omina Technologies. She is responsible for the
product management of Justifai. Justifai is an AI as a Service platform that
empowers business domain experts to co-create scalable, trustworthy and
regulatory compliant AI innovations and bring them to value faster and more
efficiently. 

Anita is passionate about AI, product management, innovation management and
marketing. Before joining Omina Technologies, she worked as a product manager
for NGDATA and Showpad. She also worked as an innovation manager for Boobook
consulting. She holds a PhD in Business Administration and Management. She had
an academic career in the field of AI and marketing at Ghent University,
Manchester Business School and Monash University.

LUKE MARKHAM

ML ENGINEER 

GRAPHCORE

 


SAMUEL DEMHARTER

PHD, HEAD OF BIOINFORMATICS, TARGET & BIOMARKER DISCOVERY

ABZU

Sam was awarded his PhD in Systems Biology from the Department of Computer
Science at the University of Oxford. He conducted research at the Biotech
Information & Research Center in Copenhagen and Harvard Medical School on
single-cell transcription data sets, and has over 5 years’ experience working in
the pharmaceutical industry.

Sam has an extensive problem-solving and explorative toolkit, and he enjoys
applying his knowledge in machine learning, R, Python, and drug R&D to
challenging projects.

Sam is Head of Bioinformatics, Target & Biomarker Discovery at Abzu, the deep
tech startup whose proprietary AI accelerates exploration with simple and
explainable models, enabling scientists to bring drugs to market faster.

At home, Sam is an avid runner and is learning Danish by reading Rasmus Klump to
his two kids.

DR. SURAJ KAPA

SVP HEALTHCARE

TRIPLEBLIND

   

Dr Suraj Kapa is the SVP of healthcare at TripleBlind. He practiced as a cardiac
electrophysiologist at Mayo Clinic and over the course of his career he has
published more than 200 peer-reviewed articles and book chapters, given 100s of
invited lectures, and has filed over 30 patents resulting in startups and FDA
approved technologies.

He is highly sought after for his views on the future of digital health and
healthcare delivery, having advised multiple public companies and startups in
digital strategy. Additionally, his work on digital tools to address the
pandemic in 2020 and developing algorithms to enable early prediction of disease
has been featured in major news outlets.

ANTONIO RUSSO

PARTNER, INNOVATION LEADER AND PARTNER, HEAD OF ANALYTICS & COGNITIVE

DELOITTE SWITZERLAND

       

Antonio Russo leads Deloitte’s Analytics & Cognitive Advisory in Switzerland and
is responsible for Innovation within Deloitte Switzerland’s Executive team. His
team helps clients leverage the power of artificial intelligence and data to
deliver more customer-centric and innovative products and services that catalyse
growth and efficiencies.

He has over 20 years of experience in advising companies in large-scale global
transformations, leveraging new delivery models (GBS/SSC, outsourcing) and
innovative technologies (e.g. robotics, machine learning, natural language
processing/generation). He helps global organisations review and implement new
strategies for business support functions and deploy more effective and
efficient services and governance models. Prior to joining Deloitte in April
2013, he held various sales and consulting leadership positions across Europe
and was CEO of a start-up company developing brand protection technologies.

SOFIAT AKINOLA

HEALTH POLICY LEADER

ROCHE

Sofiat Akinola is currently a Director of Health Policy and External Affairs at
Roche Diagnostics. In this capacity, she works with decision-makers to advocate
for access to timely screening and diagnostic tools to improve patient outcomes.
Her portfolio includes cervical cancer, women’s health, health system
strengthening and resilience, and universal health coverage.

Before joining Roche Diagnostics, Sofiat was a Global Health Lead at the World
Economic Forum. Her portfolio focused on keeping populations healthy and health
systems transformation – Value-Based Healthcare, Universal Health Coverage, and
Healthy Ageing and Longevity. She led the Global Future Council on Healthy
Ageing and Longevity at the World Economic Forum, a dynamic platform for leading
businesses, governments, civil society organizations, and world-class experts to
shape the global healthy aging and longevity agenda. In this capacity, she
worked with the community to generate and disseminate new content and insights
and engaged with multiple actors to co-create solutions to boost the impact of
healthy life expectancy.

Sofiat also has extensive experience in the NGO and Government sectors. She used
her monitoring and evaluation skills to support strategies ranging from Fetal
Alcohol Spectrum Disorder Initiative to Ending Homeless in Alberta, Canada.

Sofiat has two Masters, one from the University of Oxford on Evidence-Based
Social Intervention and Policy Evaluation with a focus on Impact Evaluation, and
from Tulane University School of Public Health and Tropical Medicine, where she
received her MPH. Sofiat received her Bachelor’s degree from McGill University
in Sociology, focusing on Gender, Health, and International Development.

CECILE TARDY-SRINIVASAN

DAYONE HEALTH 4.0 ACCELERATOR MANAGER

DAYONE - HEALTHCARE INNOVATION

   

Cécile Tardy-Srinivasan leads the DayOne Health 4.0 Accelerator. In this role,
she supports international digital health startups to scale up at the interface
with biopharma companies. Passionate about advancing healthcare, her focus is on
building bridges between the patients, clinicians, startups, and Pharma worlds
to enable collaborations.

Previously, Cécile worked at major pharma companies, like Novartis, where she
held various roles at country, regional and global levels. She brings a
background in finance from working at EY. Striving to improve patients
experience and outcomes, she specialized in co-creating solutions for patients
and healthcare professionals, working with different stakeholders in the
healthcare ecosystem.

Cécile studied Design Thinking at the MIT Sloan School of Management and holds a
Master’s in Management from the EDHEC Business School France.

Curious to know more about DayOne Health 4.0 accelerator? More information
available on https://www.dayone.swiss/dayone-accelerator/health-4-0/

 

EDWIN GELEIJN

PHYSIOTHERAPIST / HEALTHCARE INNOVATOR

AMSTERDAM UMC

     

Edwin has been working as a physiotherapist / healthcare innovator in the
Amsterdam UMC university hospital since 1991. As a healthcare innovator he has
initiated innovations that have led both to research projects and, when
positively evaluated, have been implemented in daily practice; some local, some
regional and some national. These innovations encompass projects based on
changes in ‘regular’ healthcare as well as eHealth and recently also concern
datascience related projects. Our pilot study to detect in hospital fall
incidents is currently being implemented in the electronic health record of our
hospital. Pubmed: https://pubmed.ncbi.nlm.nih.gov/?term=geleijn&sort=date

MICHAEL BLANKENBURG

MARKET ACCESS MANAGER, RADIOLOGY

BAYER AG

   

A biochemist and health economist with 30+ years in pharmaceutical research and
development and experience in various health areas including cardio-vascular
therapies and diagnostic imaging.

VALERY LASRY

DIRECTOR, EUROPE, MIDDLE EAST, AFRICA AND LATIN AMERICA

NURALOGIX CORPORATION

     

Valerie heads the business expansion and sales activities for Nuralogix
Corporation across the EMEA and LATAM markets. Multi-disciplinary,
multi-cultural and multi-lingual, she uses her vast and extensive experience in
the various tech sectors over the years to provide a holistic approach when
dealing with customers. An “out of the box” thinker and executor, she is a real
believer that great professional and personal interactions is the key to long
lasting successful business relationships which is reflected in her unique
approach. The last few years within the Digital health space, she has been
involved in numerous projects for the private and public health sector and has
contributed significantly to the dynamic expansion and growth of Nuralogix.

MATHIEU MORAND

SENIOR MANAGER, DIGITAL & HEALTH FINANCING

CITY CANCER CHALLENGES

   


DR NOA HURVITZ

RESIDENT, DEPARTMENT OF MEDICINE

HEBREW UNIVERSITY-HADASSAH MEDICAL CENTER

 

Dr. Noa Hurvitz is a resident in the Department of Medicine at the Hebrew
University-Hadassah Medical Center. She was educated in the Hebrew
University-Hadassah medical school. Dr. Hurvitz has authored and participated in
several clinical trials comprising second-generation artificial intelligence
systems for improving the response to chronic medications and the development of
digital twins.

JÜRG HUTTER

SENIOR PRODUCT MANAGER DIGITAL HEALTH

SWISS POST COMMUNICATION SERVICES LTD

   

Jürg Hutter works as Senior Product Manager in the Digital Health Business Unit
at Swiss Post.

He has more than 20 years of experience in working with national and
multinational companies in the field of digital health, healthcare, corporate
social responsibility and climate change. Together with clients, he is on the
road to establish healthcare eco-systems and bring digital health solutions to
life. Jürg holds a Master in Environmental Sciences at the Swiss Federal
Institute of Technology as well as a Master in Information- and Technology
Management at University of St. Gallen.

Find more information about Swiss Post and Digital Health
at https://www.post.ch/en/business-solutions/digital-health

VEYSEL KOCAMAN

HEAD OF DATA SCIENCE (HEALTHCARE)

JOHN SNOW LABS

     

Veysel is a Senior Data Scientist and Healthcare NLP Lead at John Snow Labs,
improving the Spark NLP for the Healthcare library and delivering hands-on
projects in Healthcare and Life Science. 

He is a seasoned data scientist with a strong background in every aspect of data
science including machine learning, artificial intelligence, and big data with
over ten years of experience. He’s also pursuing his Ph.D. in ML at Leiden
University, Netherlands, and delivers graduate-level lectures in ML and
Distributed Data Processing. He is also working towards his PhD in Computer
Science and is a Google Developer Expert in Machine Learning.

Veysel has broad consulting experience in Statistics, Data Science, Software
Architecture, DevOps, Machine Learning, and AI to several start-ups, boot camps,
and companies around the globe. He also speaks at Data Science & AI events,
conferences and workshops, and has delivered more than 20 talks at International
as well as national conferences and meetups.

DR SANDEEP REDDY

DIRECTOR, HEALTHCARE MANAGEMENT PROGRAM 

DEAKIN UNIVERSITY

   

Associate Professor Sandeep Reddy is an Artificial Intelligence (AI) in
Healthcare researcher based at the Deakin School of Medicine besides being the
founder/chairman of Medi-AI, a globally focused AI company. He also functions as
a certified health informatician and is a World Health Organisation recognised
digital health expert. Further, he is a Fellow of the Australasian Institute of
Digital Health and a certified health executive with the Australasian College of
Health Service Management. He has a medical and healthcare management background
and has completed machine learning/ health informatics training from various
sources. He is currently engaged in research about the safety, quality and
explainability of the application of AI in healthcare delivery in addition to
developing AI models to treat and manage chronic diseases. Also, he has authored
several articles and books about the use of AI in Medicine. Further, he has set
up local and international forums to promote the use of AI in Healthcare in
addition to sitting on various international committees focusing on AI in
Healthcare.

MICHAEL ZAIAC

ORE MEDICAL AFFAIRS HEAD

NOVARTIS

   

Since joining the pharmaceutical Industry 25 years ago, Michael has covered
roles of increasing responsibility in clinical research, medical affairs and
strategic marketing and participated in new medicines launches, large
development programs for small molecules and monoclonal antibodies and the
day-to-day management of medical affairs, research and commercialisation at
Country, Regional and Global level.

Michael pursued a postgraduate career in Surgery and Surgical Oncology in the UK
and in Germany gaining an MD in myocardial preservation in 1989 and became a
Fellow of the Royal College of Physicians and Surgeons in 1992. He also gained
an MBA in 1999, a specialist registration in pharmaceutical medicine in 2005 and
is a fellow of the Faculty of Pharmaceutical Medicine at the Royal College of
Physicians and was awarded an honorable Global Fellowship in Medicine
Development title in 2020

Michael has published scientific papers on the use of artificial intelligence in
medicine, various hematology indications, surgery, breast cancer, sarcoma
targeted small molecules, mToR and general aspects of pharmaceutical medicine

MUKESH BANSAL

CHIEF OPERATING OFFICER & CO-FOUNDER

PHABLE

   

Mukesh co-founded Phable in 2018, along with his partner Sumit Sinha. Before
founding Phable, Mukesh had extensive experience in market research and
analytics having worked with Borderless Access and Kantar. During his career,
Mukesh has pioneered new research methods and technologies for consumer
behaviour tracking basis which he built a new multi-million-dollar revenue line
that was eventually acquired by AC Nielsen for an undisclosed sum. Mukesh holds
an engineering degree and masters from Birla Institute of Technology and
Science, Pilani and is a part of the country’s young founders’ league. 

 

ANURAAG DUBEY

CHIEF PRODUCT OFFICER

PHABLE

Anuraag has extensive experience in building technology products for Healthcare
providers, payers, and beneficiaries. His work on reducing Health Insurance
Fraud gave him a unique view into challenges of standardising healthcare data
and later, at Practo, he worked extensively on simplifying EMR creation for
practitioners at Hospitals and Private Practice. He has over 24 years of
experience in building technology products for B2C & B2B applications in
Education and Healthcare domains.  He is an alum of IIT-BHU Varanasi, India.

BLAISE THOMSON

CEO & FOUNDER

BITFOUNT

   


MAME DABA DIOUF

BUSINESS UNIT & PROJECT MANAGER

IT4LIFE

     

Mame Daba DIOUF, Business Unit and Project Manager

Engineer in computer networks and multimedia communication, Mame Daba Diouf has
8 years of experience in the field of ICT.

She has led around twenty “digital for impact” projects applied to solar energy,
NGO and association management, banking, microfinance, trade, and mobile
applications for social and behavior change.

Since 2018 at IT4LIFE she puts her skills to the service of this social
enterprise : 28 programming languages and frameworks; Databases; Agile project
management methods (SCRUM certified); and Project Management.

She is interested in applying innovative technologies to meet the needs of
underserved populations, with a focus on women’s health and hygiene issues.

As Associate Director of the Changeons Les Règles programme, Daba has played a
major role in resource management, strategic oversight, user testing of WeerWi
mobile application, scope management, testing and feedback, personal data
collection declarations follow-up. She looks forward to being part of future
high-impact ICT projects that change the lives of millions of girls and women,
particularly in Africa.

HANNAN HASHMI

C0-CEO

KAPSULE 

   

Kapsule co-founder with an eclectic background spanning medicine, law and
machine learning. While working in an East African hospital, he identified many
challenges in African healthcare. He then tried to understand the root causes
and noticed a huge lack of data. Hannan then decided to find ways to capture and
structure healthcare data to enable evidence-based decision making and drive
patient outcomes.

FEMI AMOO

CTO & HEAD OF ENGINEERING

KAPSULE 



GINYU INNOCENTIA KWALARTOH

CEO & FOUNDER 

KLARAH



 

A seasoned nurse practitioner with over 20 years experience who has dedicated
her life to the improvement of healthcare for patients across the continent. She
has also taught at many universities in Cameroon and Innocentia holds a Masters
Degree in Internal Medicine and a Ph.D in Public Health.

NIELS VAN ESPEN

HEALTH INNOVATION & DESIGN DIRECTOR

MADE

 



Niels is Partner and Health Innovation Director in a global award-winning
innovation studio. He has extensive experience in working in and with health
start-ups through a wide-array of incubation trajectories. Associated to the
Novartis Foundation’s HealthTech Hub in Kigali, he is currently serving as a
Strategic Advisor for the African HealthTech Start-up “Klarah – The Uber for
home care in Sub-Saharan Africa”. The Klarah solution guarantees peace-of-mind
to Africans residing outside the continent, by allowing them to deliver quality
home nursing care to their loved ones back at home.

JOHN SHOBOIKI

CMO 

RENDER HEALTH 

   


THEOPHILA HURIRO UWACU

DIRECTOR 

E-HEZA DATA SOLUTIONS

   

Theophila oversees the design and development of E-Heza Data Solutions software
and leads the scale up of E-Heza across health facilities and villages in
Rwanda. She uses her exceptional leadership skills to bring together software
designers, developers, implementation experts, and frontline health workers to
successfully expand E-Heza. Since 2020, Despite the challenges associated with
the covid-19 pandemic, her leadership led to a four-fold increase in the number
of women and children served on E-Heza. She utilizes her expertise in
stakeholder engagement to support the organization in external relations with
new and existing partners, as well as the Rwandan government. She was chosen as
a finalist for the Commonwealth Digital Health Awards 2020 and 2022. Theophila
has a passion to build digital solutions that contribute to the improvement of
health outcomes and community engagement through health systems digitalization.

ALOYS RUKUNDO

FOUNDER & CEO

HELLOMED

   

Aloys Rukundo is the Founder & CEO at Hellomed a virtual medical Consultation
Platform based in Kigali, Rwanda. Prior to this, Aloys Co-Founded Watotosmile
Ltd a social enterprise improving literacy to children (girls) from low-income
households. He holds a Bachelors’ Degree in Banking and Finance,  and is very
passionate about improving Public Health in Africa using Technology. Aloys,
loves travelling, spending time with family and watching basketball.

CHRIS MULLHALL

CEO & FOUNDER 

REMOTE DOCTORS FOR ALL

   

Over 30 years of executive experience with major listed corporation in the IT
Industry.

PETER HURST

BDM

REMOTE DOCTORS FOR ALL

   

Conducted business in almost 40 international markets within many business
sectors (including over 20 sub-Sahara Africa markets and other developing
economies).

MOSES MUKUNDI

CEO 

EDEN CARE

   


CLIVATE MAIBA

CEO 

DENGA LOGISTICS LTD

   

Mr Clivate Maiba is a 23-year old Award-winning innovator and experienced
clinician who is passionate about health promotion, disease prevention,
entrepreneurship, and digital healthcare, he believes that preventive measures
are always better to approach than curative care. He is currently pursuing a
BSc. In public health and holds a diploma in clinical sciences.

He is a Co-founder and chief operations officer of Health Literacy Zambia, a
non-profit organization that aims to promote health education and practices in
vulnerable communities. Over 18,000 Zambians have so far benefited.

Mr. Maiba serves as an executive director at Denga Logistics limited, a digital
health start-up optimizing and automating lab reports, a network of motorbikes,
and drones connecting hard-to-reach health facilities with medical supplies,
state-of-the-art laboratories, and state-of-the-art blood banks. Denga is on a
mission of taking essential health services to hard-to-reach remote communities

Clive’s passion for innovations had led him to participate in two hackathons
organized by the Massachusetts Institute of technology and a good number of
hackathons.

He worked on a digital health project that would monitor chronic patients living
with hypertension and diabetes in real time, he received business and technical
support from ZICTA but along the way, he resorted to putting the project on
hold.

Clivate has so far volunteered in numerous organizations both locally and
internationally, in the year 2019, he was awarded an ambassadorship of
hypertension. He volunteered as a student against COVID, he also volunteered at
copper rose Zambia as a sexual and reproductive health rights advocate. He is a
2022 ambassador at Bukovinian International Medical Congress and a former
hypertension ambassador at the international society of hypertension.

He has undergone leadership, business, and entrepreneurship training. He is a
2021 semi-finalist at Harvard Cross Roads Emerging leaders’ program, He is one
of the 34 African fellows at the African Oxford Initiative-Health innovation
program, a Young African Leadership initiative (YALI-RSA) Alumni, and an
Award-winning innovator at the 2021 National Innovation Initiative (supported
by; UNDP, UNFPA, ZICTA, PACRA, Finish Government). He is among the top 30 in the
next Gen incubation program by the jacaranda hub from over 2000 participants.”

AFFIONG OSUCHUKWU

CO-FOUNDER 

DIGI-DIBIA HEALTH-TECH LTD

   


AUDACE NAKESHIMANA

FOUNDER 

INSIGHTIV

 

Founder of Insightiv, a Rwandan medical imaging diagnostics startup.  MIT
Computer Science and Economics graduate, with years of experience as engineer
and Researcher in areas of Artificial Intelligence and Machine Learning, and
their applications in Health and Speech Recognition. Published author in
world-class journals such as Frontiers of Artificial Intelligence.

LUCAS SCHERDEL

DIRECTOR 

DAYONE - HEALTHCARE INNOVATION

   


AMOS ANKRAH

BOSTON SOLUTION SPECIALIST

BOSTON LIMITED 

   

Amos Ankrah MSC is Boston’s Solution Specialist focusing on Product Management
within Boston Medical Systems (BMS). Amos has 25 plus years of experience
working in IT, however, before commencing his career in IT he gained a degree in
Biochemistry and Pharmacology at Kings College London.

Amos and his team are driving the evolution of Boston Medical Systems with the
delivery of a novel approach to drive the detection of anomalies in large
organs. This role enables Amos to work on two career passions, the evolution of
IT technology and the application of AI in Pharmacology.

JENNIFER GOODALL

CEO 

MINDAFFECT 

   


LUCA JAHREISS

CO-FOUNDER & CHIEF MARKETING OFFICER

ANCORA.AI 

   


ANTON BALAKIREV

CTO

ACRUX CYBER SERVICES

   

About Acrux Cyber Services

Mechanical ventilation saves lives but causes lung injury and pneumonia.

Solving these problems requires highly qualified specialists and constant
monitoring of the patient, which is impossible.

For years our company developed AI solutions for businesses, but after meeting a
Professor who worked 30 years in respirology, we learned how complicated the
mechanical ventilation was, so we decided to combine our knowledge in AI with
the professor’s experience in ICU to develop a solution that improves patient
care.

We have made an AI-based solution that helps improve the quality of ventilation
and patient comfort, which significantly reduces the risk of complications.

YANA KOZIS

CEO & FOUNDER 

DEBABY 

   

Yana Kozis is the CEO & Founder of Debaby, a startup from Ukraine aimed to help
women struggling with infertility by providing mental health support. 

Before starting her venture, she was a part of a start-up team in the childcare
field. In addition to 5+years of Operations and Customer Support experience with
SaaS products and the commerce field, she has 4 years of content creation
experience and an MBA degree. 

She’s passionate about technological innovations in the reproductive health area
and focused on creating a meaningful product that has an impact on one of the
sustainable development goals.

RISHI DAS-GUPTA

CO-FOUNDER 

NODENS 

   


RENE GILVERT

FOUNDER AND CEO

OPTICHRONIX



ANCA DEL RIO

LEAD HEALTH TECH COMMUNITY & STAKEHOLDER RELATIONS

DAYONE - HEALTHCARE INNOVATION



JISKIA REIS

CORPORATE INNOVATION LEAD, HEALTH

PLUG AND PLAY GMBH



FABIAN SCHEUGENPFLUG

INVESTOR & SENIOR VENTURES ASSOCIATE

PLUG AND PLAY HEALTH EMEA



KARTHIK KANNAN

CO-FOUNDER & CTO

ENVISION



JULIE AGEZ

PROJECT MANAGER ANTOINE LACASSAGNE CENTRE FOR THE FIGHT AGAINST CANCER

UNICANCER NETWORK



MICHAL DUBNO

HEAD OF OUTPATIENT SCHEDULING

LUX MED



ROHIT GHOSH

CHIEF STRATEGY OFFICER, FOUNDING MEMBER

QURE.AI



STEVEN TRUONG

FOUNDER & CEO 

VINBRAIN

   

Steven Truong is the Founder and CEO of VinBrain, a subsidiary of Vingroup, the
largest conglomerate in Vietnam. He has been in the AI and software industry for
more than 26 years and has held senior leadership positions in top technology
companies in the USA and Canada, including Microsoft, Honeywell, and
IntelliCommunities. Before he formed VinBrain, he was the Director of AI
Incubation and Engineering at Microsoft in the USA, reporting directly to the VP
of MSAI. Steven has led multi-development center teams at Microsoft. He has been
a key innovation initiator for AI products that have been used by millions of
users worldwide, such as Email Smart Reply and iRanker. Steven established
VinBrain with the mission to infuse AI and IoT to improve human lives and
productivity. He has led his team to deploy DrAid – the 1st AI-powered doctor
assistant in Vietnam – to more than 100 hospitals across Vietnam and the USA.
VinBrain also served thousands of Vietnamese COVID-19 patients through
VinBrain’s second flagship product, AIviCare, for telehealth. VinBrain won ACM
SIGAI Industry Award in 2021 – previously, Microsoft was the only winner.

LUCA EMILI

CEO & FOUNDER 

INSILICOTRIALS

   

Luca Emili is an entrepreneur and investor, Founder and current CEO
of InSilicoTrials Technologies, a pioneering platform that leverages modeling
and simulation to accelerate innovation in healthcare and life sciences.

From 2001 to 2010 he was CEO of Emaze, a cybersecurity company that became one
of the market leaders in Italy by automating security analysis for complex
networks and devices. He is member of the Cloud Security Consultative Group in
EMA and is responsible for the RCA Research Collaboration Agreement between
InSilicoTrials and the FDA. He also co-chairs the Good Simulation Practice Task
Force within the Avicenna Alliance’s Policy Development Working Group, with the
goal of driving a consensus approach toward standardization for reliable
development and use of in silico solutions.

DR GEORGE CHATZIPIRPIRIDIS

COO & CO-FOUNDER 

MAGNES AG

   


SEVERIN KAPPELER

PRODUCT MANAGER 

ACODIS 

   


DYLAN JOHNSTON

CHIEF EXECUTIVE OFFICER

MOD1 AG

   

Dylan Johnston is the founder and CEO of MOD1 AG and one of Switzerland’s
leading cybersecurity experts. His organisation provides strategic, tactical and
operational consulting services in cybersecurity, privacy, risk management and
regulatory compliance to organisations in the digital healthcare, MedTech,
BioTech and pharmaceutical space.

Dylan has over 20 years of experience designing, executing and overseeing
security and privacy programs for organisations in highly regulated business
sectors, where a comprehensive, risk-based approach to protecting critical
information assets is central to corporate missions and business success.

Dylan holds a B.Sc. in Business Information Technology from the University of
Bedfordshire, an M.Sc. in Information Security at Royal Holloway, University of
London, and is currently a doctoral candidate (Information Security) at the
University of East London.

ANDRÉ DIAS

CHIEF COMMERCIAL OFFICER

GIOTTO.AI

   

André has twenty years of cumulative professional experience, mainly in roles
related to Marketing&Sales in the tech industry. As Chief Commercial Officer of
Giotto.ai, he is part of a top-notch team on a mission to redefine how Humans
and Artificial Intelligence should work together on healthcare regulatory
activities.

DR MATTEO TOGNINALLI

CHIEF OPERATIONAL OFFICER

VISIUM

After a Ph.D. in Machine Learning applied to healthcare and life sciences at ETH
Zurich, Matteo Togninalli is now the Chief Operating Officer at Visium. He
provides applied ML expertise to Visium’s clients and gives technical and
strategic guidance to the delivery teams at Visium. With his academic experience
from EPFL, Stanford, and ETH in combination with his professional track record,
Matteo has helped many of Visium’s clients to translate business needs into
technical solutions leading to various breakthroughs for Roche, Novartis,
Incyte, and many more.

MARK CHALMERS

LIFE SCIENCES CONSULTING, PARTNER

EY



MAURICE PERRINJAQUET

LIFE SCIENCES CONSULTING, PARTNER

EY



SEAN O'PRAY

HEALTH OUTCOMES PLATFORM DIRECTOR

EY



BINARA RUPASINGHE

LIFE SCIENCES CONSULTING, DIRECTOR

EY



THERESA REIKER

ASSOCIATE DIRECTOR OF POPULATION HEALTH

NOVARTIS FOUNDATION

Theresa Reiker is Associate Director of Population Health at the Novartis
Foundation. In her role, Theresa supports health systems across the globe in
harnessing the power of data to improve the health of their populations.

As a former biologist, turned machine learning enthusiast, turned public health
professional, Theresa is excited to build bridges between fields. The global
quest to improve population health requires intersectoral collaborations between
diverse partners. Theresa sees herself as a connecting node in this network.
Through her academic training at the Universities of Oxford and Cambridge and
her PhD at Swiss TPH, she attained broad expertise in using real-world data and
computational techniques for health, but also in health systems and policy
planning. Her expertise spans the applications in health planning of classical
data science, genomics, simulations and AI methods. Publications: click here

ANDREW ADDISON

SENIOR TECHNOLOGIST

BOSTON

Andrew Addison is a senior software engineer with nearly 30 years of experience
in the financial services industry.  He graduated in Computational Science at
St. Andrews University in 1990 and spent several years working in core
development for a 4GL company specialising in compiler writing. With a deep
understanding of technology, Andrew has developed and deployed high-volume
distributed computational solutions for major investment banks such as Salomon
Brothers, JP Morgan, Merrill Lynch, SwissRe, Bank of America, Deutsche Bank as
well as several well-known hedge funds. Andrew is very well versed in the
security risks that business face today and is in regular dialogue with
like-minded individuals through his vast network.

RACHEL DUNSCOMBE

CEO

OPENEHR



DR. ERIC TOPOL

EXECUTIVE VICE-PRESIDENT | SCRIPPS RESEARCH INSTITUTE

DIRECTOR & FOUNDER | SCRIPPS RESEARCH TRANSLATIONAL INSTITUTE

Eric Topol is the Founder and Director of the Scripps Research Translational
Institute, Professor, Molecular Medicine, and Executive Vice-President of
Scripps Research. As a researcher, he has published over 1,200 peer-reviewed
articles, with more than 310,000 citations, elected to the National Academy of
Medicine, and is one of the top 10 most cited researchers in medicine. His
principal scientific focus has been on the genomic and digital tools to
individualize medicine.

In 2016, Topol was awarded a $207 million grant from the NIH to lead a
significant part of the Precision Medicine (All of Us) Initiative, a prospective
research program enrolling 1 million participants in the US. This is in addition
to his role as principal investigator for a flagship $35M NIH grant to promote
innovation in medicine. He was the founder of a new medical school at Cleveland
Clinic, Lerner College of Medicine, with Case Western University. He has over
440,000 followers on Twitter (@EricTopol) where recently he has been reporting
insights and research findings for COVID-19. Besides editing several textbooks,
he has published 3 bestseller books on the future of medicine: The Creative
Destruction of Medicine, The Patient Will See You Now, and Deep Medicine: How
Artificial Intelligence Can Make Healthcare Human Again. Lastly, Topol was
commissioned by the UK 2018-2019 to lead planning for the National Health
Service’s integration of AI and new technologies.

LAURA MATZ

CHIEF SCIENCE & TECHNOLOGY OFFICE

MERCK KGAA

Dr. Laura Matz is the Chief Science and Technology for Merck, driving innovation
and digitalization in Merck across the 3 business sectors, Life Sciences,
Healthcare and Electronics.    Serving as an executive vice-president within
Merck, she is responsible for the corporate innovation teams including the
digital office and new digital business models.  She possesses 20 years of
experience in semiconductor manufacturing and a decade of experience running
semiconductor materials businesses. 

Prior to becoming the CSTO, she was a senior vice-president within EMD
Electronics (previously Versum Materials and Air Products Electronics division).
She has always been a key contributor to the growth in semiconductor materials,
driving for a strong R&D presence to enable business growth.  

Laura is a strong advocate for science and engineering in young talent.  She has
collaborated with ASU over the past 5 years to build a strong pipeline of
interns.  In 2020, Laura joined the AICHE (American Institute of Chemical
Engineers) ILI board (Institute for Learning and Innovation) which serves as a
conduit for advancing chemical engineering talent for the U.S.    Given that
artificial intelligence and machine learning are enablers for the continued
growth in the semiconductor industry, she is a member of the SEMI Smart
Manufacturing board as well as the local AZ SEMI board. 

Laura has a PhD in analytical chemistry from Washington State University and
undergraduate degree from Indiana University of Pennsylvania.  When she is not
working, Laura enjoys watching soccer games and running in the beautiful Arizona
weather.

DR. GREG MOORE

CVP

MICROSOFT HEALTH & LIFE SCIENCES

             

Dr. Moore leads Microsoft’s Health efforts globally and is responsible for
product strategy, product development, and research including AI and machine
learning technology for healthcare and life sciences. He is also Microsoft’s
senior executive leading dedicated research and development collaborations with
Microsoft’s strategic alliance partners in this domain with the goal of enabling
a more open, interoperable, and AI-infused foundation for healthcare delivery
that aspires to enable access to healthcare for all globally.

Greg is an engineer (MIT PhD), practicing neuroradiologist, clinical
informaticist, neuroscientist, and innovator experienced in assembling and
inspiring highly talented teams to positively transform healthcare for the
benefit of humankind. Prior to joining Microsoft, Greg was Vice President Google
Inc, Google Cloud Healthcare & Life Sciences and founder of the healthcare
vertical for Google Cloud. Prior to his leadership appointment at Google, he was
Chief Emerging Technology and Informatics Officer at Geisinger Health System
where he also was Director of the Institute for Advanced Application and served
as Interim Chair of System Radiology. His prior appointments include Los Alamos
National Laboratory (University of California), Wayne State University School of
Medicine, Children’s Hospital of Michigan and Penn State University Hershey
Medical Center where he was a tenured Professor in the College of Medicine. Greg
currently serves on the board Hillrom Inc, and is an Adjunct Clinical Professor
of Radiology at Stanford University School of Medicine.

Moore is board certified in Diagnostic Radiology, Neuroradiology and Clinical
Informatics and holds degrees from North Park College-Chicago (BS),
Massachusetts Institute of Technology (SM-Nuclear Engineering and
PhD-Radiological Sciences), and Wayne State University School of Medicine
(MD-Doctor of Medicine) and completed residency in Diagnostic Radiology and a
fellowship in Neuroradiology, both at Penn State University Hershey Medical
Center.

CAROLYN STARRETT

CEO

FLATIRON HEALTH

Carolyn Starrett is CEO of Flatiron Health®, a world leader in transforming
patients’ real-life experiences into knowledge to help accelerate improvements
in cancer care and treatments.

Almost everything known today about what works for patients with cancer comes
from the relative few who enroll in randomized controlled trials. Flatiron uses
clinical and data science to improve lives by learning from the experience of
every cancer patient. Insights from Flatiron’s U.S-derived real-world data and
analyses support meaningful learnings relevant to a global cancer population,
and have helped expand treatment alternatives for people with gastric,
colorectal, esophageal, breast, and head and neck cancer. Through three
international subsidiaries, Flatiron now also works to improve treatments and
outcomes for cancer patients in Japan, Germany and the United Kingdom.

Carolyn became Flatiron CEO in April, succeeding the company’s co-founders and
bringing a deep understanding of the challenges facing those on the cancer
frontlines from her years leading the company’s community oncology business.
Prior to joining Flatiron in 2016, Carolyn held senior strategy, product and
operations roles at data and technology companies, and worked with healthcare
and technology companies as a principal with Boston Consulting Group. Carolyn
holds an MBA from the Kellogg School of Management at Northwestern University
and a Bachelor’s degree from Brown University.

DR. LE LU (TIGER)

SENIOR DIRECTOR

ALIBABA DAMO ACADEMY PHD



Le Lu received a Computer Science PhD in 2007 from Johns Hopkins University.
During his first six years at Siemens, he made significant contributions to the
company’s CT colonography and Lung CAD product lines. 

From 2013 to 2017, Dr. Lu served as a staff scientist in the Radiology and
Imaging Sciences Department of the National Institutes of Health Clinical
Center. He then went on to found Nvidia’s medical image analysis group and he
held the position of senior research manager until June 2018. From 2018 to 2021,
he was the Executive Director at PAII Inc., Bethesda Research lab, Maryland, USA
which has become one of the leading industrial research labs in medical
imaging. 

He is currently the global head of Medical AI R&D for Alibaba group. He was the
main technical leader for two of the most-impactful public radiology image
dataset releases (NIH ChestXray14, NIH DeepLesion 2018). 

He won NIH Clinical Center Director Award in 2017, NIH Mentor of the year award
in 2015, and won numerous best paper awards in recent MICCAI and RSNA technical
and clinical conferences from 2016 to 2021 (over 11600 citations). In 2021, He
was elected into IEEE Fellow class cited for his contribution to machine
learning for cancer detection and diagnosis, and MICCAI society board member
(MICCAI-Industry Workgroup Chair). He is currently an Associate Editor for IEEE
Trans. Pattern Analysis and Machine Intelligence and IEEE Signal Processing
Letters. He has published more than 200 peer-reviewed articles and leading
conference papers in Nature Communications, Clinical Cancer Research, IEEE TMI,
MedIA, etc. He is the (co-)inventor of 69 USPTO/PCT patents (granted or
pending).

JEROEN TAS

STRATEGIC BUSINESS DEVELOPMENT

PHILIPS

Jeroen Tas is responsible for Strategic Business Development at Philips and
former Chief Innovation & Strategy Officer at Philips. He has more than 35 years
of global experience as an entrepreneur and executive in the healthcare,
information technology and financial services industries.

Jeroen is closely involved with the company’s strategy, platforms, ventures and
emerging businesses. In his current position in Strategic Business Development,
he plays a central role in coaching digital business ventures and leadership and
is involved in strategic projects to create new models of people-centric
healthcare. He leverages emerging technologies such as artificial intelligence,
robotics and the Internet of Things to reinforce the company’s health
propositions aimed at supporting consumers, care professionals and health
systems with personalized, connected health solutions. 

Jeroen’s stance is echoed in Philips’ commitment to touch the lives of billions
and improve better health outcomes at lower cost: from healthy living and
prevention to diagnosis, treatment and home care. 

A respected thought leader, Jeroen was responsible for turning around Philips’
healthcare IT business and has been instrumental in establishing HealthSuite as
the new open industry standard for the ‘Healthcare Internet of Things’ Cloud
platform.

Jeroen joined Philips in 2011, leading IT worldwide as Group Chief Information
Officer (CIO). In 2014 he became CEO of Philips Healthcare, Informatics
Solutions & Services, overseeing digital health and clinical informatics. From
2016, Jeroen led the company’s Connected Care and Informatics businesses,
demonstrating a passion to create new models of people-centric healthcare, based
on the power of information technology.

Before joining Philips, Jeroen co-founded and served as President, COO and
Vice-Chairman of the board for MphasiS, an IT and Business Process Outsourcing
company, which was acquired by HP in 2006. Prior to MphasiS, he was the head of
Transaction Technology, Inc., Citigroup’s tech lab, responsible for the
innovation and development of the bank’s customer-facing systems, including
Internet banking and self-service devices. From 2007-8, he was Vice President
and General Manager at EDS, responsible for the company’s global competency
centers.

PROFESSOR SIR NIGEL SHADBOLT

PROFESSOR OF COMPUTING SCIENCE | UNIVERSITY OF OXFORD

CHAIRMAN AND CO-FOUNDER | OPEN DATA INSTITUTE

Sir Nigel Shadbolt is Principal of Jesus College and Professor of Computing
Science at the University of Oxford, where he has centred his research in human
centred AI in a wide range of applications.  Most recently he was asked to lead
the setting up of the Oxford Institute of Ethics in AI.  He is also the Chairman
and Co-Founder of the Open Data Institute (ODI).  Since 2009, Sir Nigel has
helped transform public access to Government information.

In 2010, he joined the UK government’s Public Sector Transparency Board –
overseeing Open Data releases across the public sector.  He was knighted in 2013
for ‘services to science and engineering’. 

With over 500 publications, he has researched and published on topics ranging
from cognitive psychology to computational neuroscience, Artificial Intelligence
to the Semantic Web.  In 2018 he published The Digital Ape: how to live (in
peace) with smart machines, described as a ‘landmark book’.

He is a Fellow of The Royal Society, the Royal Academy of Engineering and the
British Computer Society.

DR. JUNAID BAJWA

CHIEF MEDICAL SCIENTIST

MICROSOFT

Dr. Junaid is a practicing physician in the NHS and is also the Chief Medical
Scientist at Microsoft Research. He also serves as a Non-Executive Director at
University College London Hospitals NHS Foundation Trust. He was previously the
Global Lead for Strategic Alliances and Solutions for the Global Digital Centre
of Excellence at Merck Sharp & Dohme (Merck & Co), where he helped shape their
global digital strategy. Junaid also has experience in the academic world where
he is a Clinical Associate Professor at University College London (UCL), and a
Visiting Scientist at the Harvard School of Public Health. Over the past 15
years, Junaid has worked across primary care, secondary care, and public health
settings in addition to acting as a payer,and policy maker within the UK, where
he specialised in informatics, digital transformation, and leadership. He has
also acted as a consultant for health care systems across the US, Australia, New
Zealand, Singapore, the Middle East, and Europe.

DR MATTHEW LUNGREN

CO-DIRECTOR | STANFORD CENTER FOR ARTIFICIAL INTELLIGENCE IN MEDICINE AND
IMAGING 

ASSOCIATE PROFESSOR | STANFORD UNIVERSITY

Dr. Lungren is the Co-Director of the Stanford Center for Artificial
Intelligence in Medicine and Imaging and Medical School Faculty in the
Department of Radiology at Stanford University Medical Center. Dr. Lungren’s NIH
and NSF funded research is in the field of AI and deep learning in medical
imaging, precision medicine, and predictive health outcomes. His work has been
featured in national news outlets such as NPR, Vice News, Scientific American
and he regularly speaks at national and international scientific meetings on the
topic of AI in healthcare.

 

PROFESSOR DR EFFY VAYENA

DEPUTY HEAD OF INSTITUTE OF TRANSLATIONAL MEDICINE

ETH ZURICH

Effy Vayena is a Professor of Bioethics at the Swiss Federal Institute of
Technology (ETHZ) and renowned expert at the intersection of medicine, data, and
ethics. Her work focuses on how emerging technologies in biomedicine and data
analytics affect our society and what ethical safeguards we should put in place
to avoid negative consequences. To address these questions, she uses different
research methodologies. She founded and directs the Health Ethics and policy
Lab, an interdisciplinary research lab including philosophers, social
scientists, lawyers, biologists and engineers.

Vayena has been appointed Faculty Associate at the Berkman Klein Center for
Internet & Society at Harvard University, where she was previously a Fellow. She
has published over a hundred peer-reviewed articles and book chapters and
co-edited several books. Vayena is also an elected member of the Swiss Academy
of Medical Sciences. She chairs the Ethical, Legal and Societal Implications
advisory group for the Swiss Personalized Health Network, a national
infrastructure and research program which aims to advance personalized
healthcare in Switzerland. She currently co-chairs the WHO’s expert advisory
group on Artificial Intelligence health ethics and governance. She is also a
member of the Swiss COVID19 Science Task. Vayena frequently advises governments
and public policy organizations on matters of digitization and ethics.

DR OLIVER MORGAN

DIRECTOR OF HEALTH EMERGENCY AND RISK ASSESSMENT - WHO HEALTH EMERGENCIES
PROGRAM

WORLD HEALTH ORGANIZATION

Dr. Oliver Morgan is the Director of the Health Emergency Information and Risk
Assessment Department in the WHO Health Emergencies Program.  From 2007 through
2016, Dr. Morgan worked for the US Centers for Disease Control and Prevention
during which time he held critical leadership positions in the Ebola response
between November 2014 and February 2016 (CDC Atlanta Ebola Response Incident
Manger and CDC Country Director in Sierra Leone). From March 2010 to October
2014, Dr. Morgan was the CDC Country Director in the Dominican Republic.  Dr.
Morgan was an Epidemic Intelligence Service Officer at CDC from 2007 to 2009
with the International Emerging Infections Program, during which time he
conducted projects in Thailand, Bangladesh, Kenya, Uganda, and Guatemala.  

Before joining CDC, Dr. Morgan worked for the UK Health Protection Agency,
leading epidemiological investigations of outbreaks (enteric, vaccine
preventable, hospital acquired, zoonotic, respiratory, and sexually acquired
infections), chemical and radiation exposure incidents, terrorist bombings in
London, natural disasters, and humanitarian civil conflicts.  Dr. Morgan has
also worked as a consultant to WHO/PAHO in several countries.  Dr. Morgan’s
academic achievements include a doctorate in epidemiology from Imperial College
London and extensive publication in peer reviewed journals and reference books.

PIETER JEEKEL

CHAIRMAN

NETHERLANDS AI COALITION FOR WELL-BEING & HEALTHCARE

Pieter Jeekel is chairman of the Netherlands AI Coalition for Well-being &
Healthcare and director and founder of Evodoc and The Social Health Company.
Pieter has a background as an eHealth entrepreneur and leader of nationwide
healthcare reform programs.

ELEONORA HARWICH

HEAD OF COLLABORATIONS 

NHS AI LAB AT NHSX

Eleonora is Head of Collaborations of NHSX’s AI Lab. Her work focuses on
communicating and engaging with health and care professionals, the public and
industry to support and share the work of the NHS AI Lab and the potential of
AI. She has co-authored papers on AI in the NHS, the value of healthcare data,
commercial models in healthcare and the regulation of data-driven technologies.
She is a member of the British Standards Institution’s Committee on Artificial
Intelligence and the London Hub Lead of One HealthTech, a grassroots community
which seeks to promote diversity in healthtech.

PROFESSOR DR MAX WELLING

DISTINGUISHED SCIENTIST | MICROSOFT RESEARCH

RESEARCH CHAIR IN MACHINE LEARNING | UNIVERSITY OF AMSTERDAM

Prof. Dr. Max Welling is a research chair in Machine Learning at the University
of Amsterdam and a VP Technologies at Qualcomm. He has a secondary appointment
as a fellow at the Canadian Institute for Advanced Research (CIFAR). Max Welling
has served as associate editor in chief of IEEE TPAMI from 2011-2015. He serves
on the board of the Neurips foundation since 2015 and has been program chair and
general chair of Neurips in 2013 and 2014 respectively. He was also program
chair of AISTATS in 2009 and ECCV in 2016 and general chair of MIDL 2018. He is
a founding board member of ELLIS. Max Welling is recipient of the ECCV
Koenderink Prize in 2010. He directs the Amsterdam Machine Learning Lab (AMLAB)
and co-directs the Qualcomm-UvA deep learning lab (QUVA) and the Bosch-UvA Deep
Learning lab (DELTA). He is a fellow and founding board member of the European
Lab for learning and Intelligent systems (ELLIS).

NAOMI LEE

SENIOR EXECUTIVE EDITOR

THE LANCET

Naomi Lee is a Senior Executive Editor at The Lancet. She heads the research
section of the journal, and handles peer review and commissioning across a broad
range of subjects including her specialist areas of surgery, oncology, digital
medicine/AI, and medical technology.  She is also a vice chair for the ITU/WHO
Focus Group on Artificial Intelligence for Health. Naomi joined The Lancet in
2014. Previously she studied medicine at Cambridge University and King’s College
London, before training in surgery, specialising in urology and working for
almost 10 years in the UK. She has completed fellowships in Argentina and
Mexico. She has also studied data science at University College London.

STEFAN GERMANN

CEO

FONDATION BOTNAR

Dr Stefan Germann is the CEO of Fondation Botnar, a Swiss-based foundation which
champions the use of AI and digital technology to improve the wellbeing of young
people in urban environments. To achieve this, the foundation supports research,
catalyses diverse partners, and invests in scalable solutions around the world.

Dr Germann has spent over 25 years working in various leadership roles in Africa
and Asia, focusing on health-related development for children, relief and
advocacy work. He was previously the Senior Director of World Vision’s
International Sustainable Health Partnership, Innovation and Accountability unit
based in Malaysia. His work focused on a complex relief and reconstruction
program in response to the Asian Tsunami. 

He has previously held several board and advisory board memberships. These
include for the Partnership for Maternal, Newborn and Child Health (PMNCH), UBS
Optimus Foundation, REPSSI in Africa, the Global Health Program and The Graduate
Institute in Geneva, where he focused on the role of NGOs in global health
diplomacy.

EMMANUEL AKPAKWU

CHIEF COMMERCIAL OFFICER

NOVARTIS SSA

Emmanuel Akpakwu has been the Chief Commercial Officer for Novartis’s SubSaharan
Africa region since April 1st 2020. Reporting to the Regional Head, he and his
team are responsible for driving the Commercial Strategy and execution of
Novartis’s Sub-Saharan Africa mandate to expand patient reach across the full
income pyramid and reach the full billion.

Emmanuel joined Novartis in January 2019 as Director of Corporate Strategy,
reporting to the Head of Corporate Strategy. Prior to that, he led the
Value-Based Healthcare Practice of the World Economic Forum in Geneva and was
Associate Director of Corporate Strategy at Merck. His career started at JP
Morgan Investment Bank in London.

Emmanuel holds a Bachelor of Science in Computer Science from the University of
Hertfordshire, England and an M.Phil./MBA from the University of Cambridge,
England. He also completed an Advanced Executive Education Certificate in Value
Measurement for Healthcare from Harvard Business School.

SEBASTIEN BURNETT

GENERAL MANAGER OF CONVERGEHEALTH

DELOITTE EUROPE



BABITA SHARMA

BROADCASTER AND AUTHOR

Babita Sharma is a BBC News presenter, regularly seen on the BBC News Channel,
BBC World News, and presenting the show Newsday.

 

Babita has presented the finance programme Your Money, and fronts business
reports for BBC News. She has also covered economic and political stories from
around the world.

DR. CHRIS BATES

DIRECTOR OF RESEARCH & ANALYTICS

TPP

Chris is a data scientist and developer at TPP and holds a PhD in Mathematics
from the University of Manchester. Chris leads TPP’s work in the use of EHR data
to support analytics, research, and surveillance. He has previously been
recognised by the Health Service Journal (HSJ) as one of the top 50 innovators
in UK healthcare.

In recent years, Chris led the TPP team which contributed to the development of
the national Electronic Frailty Index (eFI). He is involved in a number of
national research programmes, including in cancer survivorship and antimicrobial
resistance. He works closely with the UK Biobank team, helping to combine EHR
data with genomic information to support their vital research.

Chris also has a strong interest in clinical terminologies and open standards
for interoperability. He has spoken on many digital health topics at large
conferences, including at both SNOMED CT Expos and at Health Datapalooza in the
US. He is an active researcher and has co-authored a number of academic papers
in prominent journals, such as Science.

As part of TPP’s response to the Covid-19 pandemic, Chris has been a key member
of the OpenSAFELY collaborative and has helped build a large, secure platform
for national Covid-19 research. He is also leading TPP’s support of the
PRINCIPLE trial at the University of Oxford, aiming to discover whether selected
treatments can improve Covid-19 outcomes.

PROF DR. MAURICE VAN DEN BOSCH

CEO

OLVG

Maurice van den Bosch (1974) studied Biomedical Health Sciences (MSc) and
Medicine (MD) at the Radboud University Nijmegen, the Netherlands. He finished
his PhD-thesis in the field of Epidemiology at the University of Utrecht in
2001, and became a resident in Radiology at University Medical Center (UMC)
Utrecht (2002 – 2007). 

He did a postdoctoral fellowship Interventional Radiology at Stanford Medical
Center (2007-2008) USA. In 2009 he obtained a faculty position as Interventional
Radiologist in UMC Utrecht. He was appointed Professor of Interventional
Radiology in 2011. 

Maurice van den Bosch has published more than 200 peer reviewed manuscripts in
the field of cancer imaging and interventions. He is member of several
international advisory boards, including CIRSE Foundation Advisory Coucil and
European School of Radiology (ESR) Leadership Institute.

In 2014 he became Chairman of the department of Radiology and Nuclear Medicine
in UMC Utrecht and was appointed Medical Director of the Center for Image
Sciences, UMC Utrecht. In 2017 he became member of the Executive Board OLVG
hospital Amsterdam and per April 2018 he was appointed Chairman of the Board of
Directors.

MERI PETROVSKA

KNOWLEDGE MANAGEMENT (KM) DIRECTOR

ASTRAZENECA

Meri Petrovska is a Knowledge Management Director at AstraZeneca. She is a
product owner of the Real World Knowledge Management platform and the
Publications Systems at AZ.  Meri’s background is in software development and
data analytics. 

Prior to joining AstraZeneca, Meri was Head of Business Intelligence for
Specialised Commissioning at NHS England (Midlands and East), with
responsibility for the Informatics Contracts with the hospitals, data collection
and analysis, and where she developed a special interest in drugs data and
patient pathways.

DR EMMA LAWRANCE

MENTAL HEALTH INNOVATIONS FELLOW, INSTITUTE OF GLOBAL HEALTH INNOVATION

IMPERIAL COLLEGE LONDON



PROF. DR. AMEEN ABU-HANNA

DEPARTMENT OF MEDICAL INFORMATICS

AMSTERDAM UNIVERSITY MEDICAL CENTERS - UNIVERSITY OF AMSTERDAM

Ameen Abu-Hanna is full professor at the department of Medical Informatics at
the University Medical Centers and the University of Amsterdam. He is Principal
Investigator in the research area of Methodology in Medical Informatics with
interest in statistical machine learning (including development and validation
of models for risk prediction, pattern recognition, and sub-group discovery),
NLP, causal inference, decision support systems, and impact studies of IT
systems. He was a former head of department; president of the European Society
of Artificial Intelligence in Medicine; and associate editor of Journal of
Biomedical Informatics. In 2017 he has been elected a founding member of the
International Academy of Health Sciences Informatics. Ameen has a BSc (Cum
Laude) in computer engineering, MSc in computer science, and a PhD in Artificial
Intelligence.

PROF. ANDRÉ DEKKER

PROFESSOR OF CLINICAL DATA SCIENCE

MAASTRICHT UNIVERSITY MEDICAL CENTER

Prof. Andre Dekker, PhD (1974) is a medical physicist and professor of Clinical
Data Science at Maastricht University Medical Center and Maastro Clinic in The
Netherlands. His Clinical Data Science research group (40 staff) focuses on 1)
federated FAIR data infrastructures, 2) AI for health outcome prediction models
and 3) applying AI to improve lives of patients and citizens. Prof. Dekker has
authored over 200 publications, mentored more than 30 PhD students, and holds
multiple awards and patents on the topic of federated data and AI. He has held
visiting scientist appointments at universities and companies in the UK,
Australia, Italy, USA and Canada.

MARLOES POMP

INTERNATIONAL PARTNERSHIPS

NETHERLANDS AI COALITION & STEERING COMMITTEE EUROPEAN AI FORUM

Marloes Pomp is the Initiator and Program Officer for the blockchain and AI
projects within the Dutch Government, including projects in the field of digital
identities, logistics, healthcare, finance and food. She is also responsible for
the international strategy and partnerships of the Dutch Blockchain Coalition 
and the National AI Coalition. Both coalitions are a jointly developed
partnership by government, industry and knowledge institutions. Together they
have a leading role and joint responsibility for the success of the solving
societal challenges and making a major contribution to new economic activities.

 

She is also a member of the Steering Committee of the European AI Forum, a

platform where entrepreneurs and policymakers get together to jointly determine
the path forward for European AI innovation. 

 

Marloes her professional interests focus on tech-innovation within governments.
Prior to the blockchain and AI activities, Marloes Pomp worked in several roles
like projectleader and researcher at governmental organizations, including the
ministry of Interior and Kingdom Relations and the city of Amsterdam. In
addition, she serves as an advisory member for the SIDN Fund, the Dutch Court,
The Blockchain and the Society Board of the University of Amsterdam (VU).

REZA KHORSHIDI

CHIEF SCIENTIST

AIG

Reza is currently the chief scientist at AIG, and a principal investigator (in
machine learning and medicine) at Deep Medicine program of The University of
Oxford. His current research at Oxford is focused on probabilistic machine
learning, and neural sequence models, for biomedical informatics, population
health, and precision medicine; more specifically, he is interested in using
machine learning for the development of personalized health predictions and
recommendations, as well as an improved understanding of multimorbidity. Reza’s
team at AIG (i.e., Investments AI) is a group of scientists, engineers,
designers, and product managers, focused on the development of AI-first products
in the investments and FinTech space.

BART-JAN VERHOEFF

DIRECTOR (CEO)

EXPERTISECENTRUM ZORGALGORITMEN

Bart-Jan Verhoeff studied medicine at the University of Amsterdam and
specialized in nephrology at the Academic Medical Center in Amsterdam. Since
2012 he works as an internist-nephrologist in St Jansdal Hospital in Harderwijk.
Since 2016 he has been involved as CMIO in innovation and optimization of
digital care processes at St Jansdal. Shortly after, he became enthusiastic
about the possibilities of artificial intelligence and started the blog
dokter.ai to write about opportunities and pitfalls of AI for healthcare. At the
same time, he started developing machine learning algorithms driven by the
vision that healthcare should be the owner of algorithms for healthcare. This
year, Bart-Jan and ‘Samenwerkende Algemene Ziekenhuizen’, the umbrella
organization of 28 general hospitals in the Netherlands, founded the company
‘Expertisecentrum Zorgalgoritmen’ (Expertise Center for Healthcare Algorithms)
to develop AI for healthcare and to help healthcare organizations with
implementation of AI in clinical practice.

DR JILDAU BOUWMAN

SENIOR SCIENTIST AND PROGRAMME LEADER DIGITAL HEALTH TECHNOLOGIES

TNO

Jildau Bouwman works as senior scientist at TNO, the Netherlands. She leads the
“digital health technology” roadmap of TNO, that is focusing on health data and
development of non-invasive sensors. Her work focusses on omics data
interpretation (transcriptomics and metabolomics), data analysis and data
management. The goal of her work is to reuse data to improve public health. This
requires data from the whole system (omics data) and from multiple sources
(wearables, human (intervention) studies and hospital data).

She leads the Public-Private-Partnership projects C4yourself and
Connect2HealthConsumer, both projects aiming toward privacy-by-design reuse of
health data. She is one of the driving forces behind the development of the
Phenotype database, as system developed to store and reuse nutritional
(meta)data. Her vision is that for the reuse of data a rich set of meta data is
crucial. She is coordinator of the Food&Nutrition ELIXIR community and the JPI
HDHL INTIMIC knowledge platform that brings together data on microbiome-diet and
health.

DR ALEX ZHAVORONKOV

CHIEF LONGEVITY OFFICER | DEEP LONGEVITY

FOUNDER & CEO | INSILICO MEDICINE

 

Alex Zhavoronkov, PhD, is the founder and Chief Longevity Officer of Deep
Longevity, Inc, a global company developing a broad range of artificial
intelligence-based biomarkers of aging and longevity. He is also the founder and
CEO of Insilico Medicine (insilico.com), a leader in next-generation artificial
intelligence technologies for drug discovery, and biomarker development. Since
2015 he invented critical technologies in the field of generative adversarial
networks (GANs) and reinforcement learning (RL) for generation of the novel
molecular structures with the desired properties and generation of synthetic
biological and patient data. He also pioneered the applications of deep learning
technologies for prediction of human biological age using multiple data types,
transfer learning from aging into disease, target identification, and signaling
pathway modeling. Under his leadership Insilico raised over $50 million in
multiple rounds from expert investors, opened R&D centers in 6 countries and
regions, and partnered with multiple pharmaceutical, biotechnology, and academic
institutions. Prior to founding Insilico, he worked in senior roles at ATI
Technologies (acquired by AMD in 2006), NeuroG Neuroinformatics, Biogerontology
Research Foundation. Since 2012 he published over 130 peer-reviewed research
papers, and 2 books including “The Ageless Generation: How Biomedical Advances
Will Transform the Global Economy” (Palgrave Macmillan, 2013). He serves on the
editorial boards of Aging Research Reviews, Aging, Trends in Molecular Medicine,
Frontiers in Genetics, and co-chairs the Annual Aging Research, Drug Discovery
and AI Forum (7th annual in 2020) at Basel Life, one of Europe’s largest
industry events in drug discovery. He is the adjunct professor of artificial
intelligence at the Buck Institute for Research on Ageing. Website:
www.Longevity.ai

DR. ALLISON GARDNER

LECTURER IN DATA SCIENCE, SCHOOL OF MATHS AND COMPUTING | KEELE UNIVERSITY

CO-FOUNDER | WOMEN LEADING IN AI

Allison lectures at Keele University in Data Science and is a co-founder of
Women Leading in AI, CEO of AI Aware and ForHumanity Fellow. Her research is
focused on algorithmic bias; gender and computing; AI Ethics and Governance of
AI and health tech. She works on the IEEE P7003 Considerations of Algorithmic
Systems and with the ISO and BSI on AI linked standards, sitting on the UK
national committee for ART/01 Artificial Intelligence standards and on
CEN-CENELEC JTC21. She speaks internationally on AI Ethics, the need for
diversity in tech and the potential regulation and governance of AI. Allison
acts as a consultant on the ethical design of autonomous and intelligent systems
offering training and AI bias audits/AIAs.

DR BART GEERTS

ADVISOR AI / DIGITAL HEALTH | NLC - THE EUROPEAN HEALTHTECH VENTURE BUILDER

FOUNDER | HEALTHPLUS.AI

Bart Geerts is the founder of Healthplus.ai, an Amsterdam-based startup that
focuses on making surgery more proactive by reusing existing data to predict
infections and other complications. He is an advisor to NLC which is the largest
European Healthtech and Biotech venture builder, and he has worked as an ICU
physician at Spaarne Gasthuis throughout the covid pandemic. He is a
cardiac-anaesthetist, intensivist and clinical pharmacologist, and has over a
decade of clinical research under his belt with papers about machine learning in
health care in journals like JAMA and Nature. Bart works also with Edwards
Lifesciences and Philips to bring computational intelligence and support to the
ED, ICU and OR. His interests are to connect people and creating solutions in
teams and consortiums.

FARINA SCHURZFELD

CO-FOUNDER | SELFAPY

SOCIAL ENTREPRENEUR & GROWTH EXPERT

Farina is a social entrepreneur, advisor and speaker. In 2016 she founded
Selfapy – Germany’s leading therapy platform for people suffering from mental
health disorders. As a “growth expert”, she lived in Sydney where she became
part of the founding team of the discount portal Groupon. Later she started
Airtasker, a platform for mini jobs, which is now listed on the ASX where she
led the (international) expansion. During that time, she also founded Sydney’s
largest Co-Working Space TSL, which counts more than 400 members today. In 2017,
Farina has been awarded as “Top 30 under 30” of Forbes Magazine as well as one
of the “25 women, that make the world more sustainable”.

JEN HORONJEFF

PATIENT ADVOCATE AND FOUNDER

SAVVY

Jen Horonjeff, PhD, is a patient advocate and the founder & CEO of Savvy
Cooperative, the first and only patient-owned co-op that helps innovators
connect directly with diverse patients in order to get the insights they need to
build better and more inclusive healthcare solutions. Jen was named one of the
50 Most Daring Entrepreneurs of 2018 by Entrepreneur Magazine for her work at
Savvy. She grew up with multiple autoimmune conditions and survived a brain
tumor as an adult, and is also a patient-centered outcomes researcher, a human
factors engineer, and formerly an FDA advisor. Jen strives to give patients a
platform to have their experiences be heard, included, and equitably valued.

DR BAHER AL HAKIM

CEO

MEDICUS AI

Baher Al Hakim is the CEO of Medicus AI, an AI-based platform that explains and
interprets medical reports and health data, turning numbers into meaningful
insights with a global presence.

Baher is a dentist by study and a serial entrepreneur by practice, with 17
years’ experience in a broad spectrum of disciplines including product &
technology, business, sales and marketing.

 

PETRA HOOGENDOORN

LEAD EXPERT ISO 82304-2; PATIENT ADVOCATE; FOUNDER

GOINGS-ON AND REMIND APP

Petra Hoogendoorn is an industrial engineer, change manager and lead expert for
ISO 82304-2 health and wellness apps – quality and reliability. This assignment
from the European Commission went global in its cooperation with ISO and was
published in July 2021. As part of the Commission’s Digital Single Market
transformation of health and care strategy ISO 82304-2’s health app quality
label and health app quality assessment aim to have digital tools and data
contribute to patient-centred healthcare and citizen empowerment. Petra has been
a patient advocate since her late husband was diagnosed with a brain tumor at
age 38. She founded the ReMind cognitive rehabilitation app and the Goings-On
what matters monitor app. ReMind is based on the award-winning
neuropsychological research by Dr Karin Gehring and provides psycho education,
alternative strategies, and an attention game. Goings-On enables cancer patients
to monitor, within a minute a day, their individual life goal attainment and
symptom burden. Goings-On further enhances decision making that not only matches
tumor biology, but also addresses what matters most in the personal and working
life of the person that carries the oppressive tumor. Petra does research at the
National eHealth Living Lab, Leiden University Medical Center, The Netherlands.

GEORGE AFFUL

MANAGER OF MED4ALL

PHARMACCESS GROUP GHANA

George Afful serves as the Manager of ‘Med4All’ for the PharmAccess Group,
Ghana. PharmAccess is a dynamic international non-profit organization with a
digital agenda, dedicated to connecting more people to better healthcare in
sub-Saharan Africa.  Med4All is one of PharmAccess’ newer and most promising
initiatives, which leverages digital technology to strengthen the supply chain
of medicines, with the aim of making quality medicines available to everyone in
Ghana. In his role, George works closely with the Christian Health Association
of Ghana (CHAG) to oversee the expansion of the digital supply chain platform.

George has over fifteen years of senior level experience in both public and
private sectors in areas of Clinical Pharmacy and Public Health practice,
Essential Medicines Management as well as Managerial Leadership.

He holds a Bachelor of Pharmacy and a Master of Clinical Pharmacy from Kwame
Nkrumah University of Science and Technology in Ghana. He also holds a Master of
Public Health from the Royal Tropical Institute in Amsterdam, the Netherlands.
Among other qualifications, George has a certificate in Leadership Management in
Health from the University of Washington (USA) and a certificate of Health
Administration and Management, from the Ghana Institute of Management and Public
Administration. 

LOUBNA BOUARFA

CEO & FOUNDER

OKRA TECHNOLOGIES

Dr Loubna Bouarfa is a machine learning scientist turned entrepreneur. She is
the founder and CEO of OKRA Technologies – an artificial intelligence data
analytics company for healthcare. OKRA allows healthcare professionals to
combine all their data in one place and generate actionable, evidence-based
insights in real time, to save and improve human lives. Loubna is currently a
member of the European Union High-Level Expert Group on Artificial Intelligence,
where she is particularly focused on healthcare and achieving competitive
business impact with AI. She was named an MIT Technology Review Top Innovator
Under 35, a Forbes 50 Top Women In Tech, and won several prizes, including CEO
of Year 2019 at the Cambridge Independent Science and Technology Awards and Best
Female-Led Startup at the StartUp Europe Awards. On a personal level, she is a
strong

advocate for diversity, women and challenging the status quo.

MICHAEL MITTLEMAN

AMBASSADOR

PATIENT-CENTRED OUTCOMES RESEARCH INSTITUTE



KUMARA PALANIVEL

CO-FOUNDER AND CBDO

PATCHAI



CHAITH KONDRAGUNTA

CEO

AIRA MATRIX

Chaith Kondragunta is the CEO of AIRAMatrix Pvt. Ltd based in Mumbai, India.
AIRAMatrix develops and provides AI-powered solutions to the Life Sciences
industry. The company’s solutions help improve workflow efficiency and increase
accuracy in research labs, drug discovery studies and clinical diagnostics.

Chaith previously founded, grew and publicly listed AnalytixInsight Inc.
AnalytixInsight is a Toronto based Big Data Analytics company that produces
algorithmic driven analytics and informative content for leading financial
institutions globally.

Prior to AnalytixInsight, he worked in corporate strategy and management
consulting, including serving as the CEO of Stern Stewart Europe Ltd, a
Corporate Finance and Strategy Consulting firm.

He has frequently written and spoken on corporate performance and analysis for
several business media outlets including The Economist Group, CNBC and Bloomberg
TV. He is also frequently contacted by media for topics related to AI and Data
Analytics. He has a Bachelors in Electrical Engineering from NIT Warangal,
Masters in Computer Engineering from the University of California, San Diego and
an MBA from Carnegie Mellon University.

VALERIE LASRY

DIRECTOR, EUROPE, MIDDLE EAST, AFRICA AND LATIN AMERICA

NURALOGIX CORPORATION

Multi-cultural, multi-disciplinary and multi-lingual is how Valerie can best be
described. A real believer that great professional and personal interactions is
the key to successful business relationships.

Prior to working in the Health Tech sector, Valerie was a senior banker for many
years with BNP Paribas and very successfully led its business development
efforts in parts of the Middle East.  She then carried on to work in the
Start-up Nation with various entities in the different sectors, including
Fintech, Cybertech, B2B platforms and digital health-tech.    

Her vast and broad experience as well as unique approach, has allowed her to
contribute significantly to the dynamic expansion and profitability enhancement
of the entities she has worked with.

RITSAART VAN MONTFRANS

CEO

INCISION

Ritsaart is CEO at Incision and joined the company in 2017.

Ritsaart is a serial entrepreneur. He enjoys leading ventures where commercial
success and positive impact go together. He founded the company NewMotion in
2009 and grew the company to be the largest network of charge points in Europe.
Following this, Ritsaart co-founded ScaleUpNation, a growth accelerator for
impact ventures with large scale-up potential. Earlier in his career, Ritsaart
was partner at the hands-on investment firm H2 Equity Partners, worked as a
strategy consultant at McKinsey & Company and worked at the M&A department of JP
Morgan.

As a CEO, Ritsaart likes to use some of the ‘Rockefeller Habits’. So, he is very
fond of Big Hairy Audacious Goals, morning huddles, quarterly rocks, core
values, etcetera.

FLORIAN ROESSLER

LEAD DATA SCIENTIST

UNIT8

Florian is a Lead Data Scientist at Unit8 where he helps clients across various
industries adopt and excel with data driven decision making. Before joining
Unit8 he worked as a Data Science Consultant in Germany and London. He completed
his PhD (Computational Chemistry) at the University of Cambridge in
collaboration with the Cambridge Crystallographic Data Centre. As part of his
research he also collaborated several pharmaceutical companies.

He is a strong believer in the open source community and has contributed to
several projects as well as helping organize conferences and Meetups in
Cambridge, London and Bonn.

OLIVIANA BAILEY

HEAD OF BRAND & COMMUNITY | ESCHERCLOUD

NL AMBASSADOR | WOMEN IN AI

Oliviana leads the development of EscherCloud’s community and ecosystem,
including the launch of the AI Lab. Formerly Head of Community at Rockstart and
ING’s open innovation district Cumulus Park, Oliviana has built and scaled
communities across sectors successfully bringing startups, corporates,
governments and talent together to collaboratively innovate.

MOSES BRAIMAH

NASOPHARYNGEAL CANCER SURVIVOR; EXECUTIVE PROJECT DIRECTOR | PACIFIC MESSAGES

CEO | COMPUTICS

Moses is the CEO of Computics Limited, who has combined his technology and
communications expertise to manage and deliver a wide range of projects in
healthcare, climate change and core technology.

Moses is currently consulting for the Africa Development Bank (AfDB) in a
climate action project. He has spent the last 20 years professionally and as
community service in communicating, promoting and advocating technology and
healthcare.

Moses also acts as the Director, Marketing, Communication & Strategy of the
Nigerian Healthcare Excellence Award (NHEA). Some of the healthcare projects he
has been involved in includes, but is not limited to, data governance; privacy;
PPP; CMEs; conferences & exhibitions; awards; and medical outreaches.

Moses is a cancer survivor who had Naso-Pharyngeal Carcinoma (NPC).
Interestingly, his chemotherapy & radiotherapy were both done in Nigeria.

MACIEJ MALENDA

CO-FOUNDER AND CEO | K.I.D.S

HEAD OF PARTNERSHIPS | INFERMEDICA



JAN BOT

HEAD OF ENGINEERING

OKRA TECHNOLOGIES

Jan has a rich experience in scientific computing. Prior to OKRA, he worked as a
senior consultant at SURFsara, the Dutch supercomputer centre. He also held
research positions at various universities specialising in high throughput
networking and computing. Jan holds an MSc in Bioinformatics from Delft
University of Technology

YAHYA ANVAR

HEAD OF DATA SCIENCE

OKRA TECHNOLOGIES

Yahya was a senior scientist before joining OKRA, serving as the principal
investigator of preclinical personalised medicine. He has over 12 years of
experience in the healthcare sector and is the author of over 30 peer-reviewed
scientific articles. Yahya holds a PhD in Medicine from Leiden University, and
an MSc in Bioinformatics and Artificial Intelligence from Brunel University.

MILOSZ WICIŃSKI

BUSINESS DEVELOPMENT EXECUTIVE

INFERMEDICA



Milosz Wiciński is a Business Development Executive at Infermedica, a leading
Artificial Intelligence health company that provides preliminary diagnosis and
triage solutions. Milosz is passionate about technology, digital health,
clinical decision support, and startups. In his work, Milosz works closely with
health organizations, helping them create digital front door strategies in line
with their product and financial objectives.

BAS JANSEN

HEAD OF AI IN LIFE SCIENCES

OMNIA TECHNOLOGIES

Bas has a multidisciplinary background combining clinical biochemistry and
computer sciences. He has degrees in computer sciences, biology and life
sciences and a PhD in glyco-bioinformatics. He is the head of life sciences at
Omina Technologies. He is responsible for providing explainable, transparent and
trustworthy AI to life sciences, pharma and healthcare.

In the past, he worked at contract research organizations in Oxford and Zagreb
where he focussed on method development using laboratory automation and
artificial intelligence. Additionally, he led various biomarker discovery
projects.

ELYES BEN MANSOUR

FOUNDER & CEO

EPINEST

Elyes Ben Mansour is founder & CEO of Epinest, eHealth IT solutions editor. He
holds a Masters’ degree in Computer Sciences applied to companies Management. An
IT Entrepreneur and now a Med Tech actor, since 2015 he has brough medical
professionals and scientists around the start-up table to work on providing
effective IT solutions to the eHealth market for the next generations.

PROF. ABDERRAHIM EL MOATAZ BILLA

PROFESSOR OF APPLIED MATH-COMPUTER SCIENCE

UNIVERSITY OF CAEN BASSE NORMANDIE

Prof. Abderrahim El Moataz is a full-time Professor of computer science in the
Computer Science Department of the University of Caen, in Normandy. His research
concerns Partial differential Equations variational methods on graphs with
applications in machine learning and Data Sciences.

JUSTIN ANDERSON

CEO | XPERT AI

MANAGING PARTNER | ANDERSON STRATEGY

Xpert AI (a spin-out start-up from Anderson Strategy) has developed a digital
diagnostics platform which is able to model the human brain in order to diagnose
neurological disorders. 

Justin also leads a team of digital strategy consultants at Anderson Strategy, a
boutique strategy firm helping leaders realise value from digital innovation. He
has developed digital strategies for 10 cities across the world looking at the
social, health and economic benefits that can be realised by emerging
technologies including 5G, AI & IOT. Justin has advised KPMG International on
its global digital strategy and transformation and the digital programmes they
deliver to their clients. He set-up the All Party Parliamentary Group on
Artificial Intelligence to encourage debate on the impact of AI. He also sits on
the BSI Innovation Committee developing standards for innovation.

YONI SCHIRRIS

PHD CANDIDATE AI FOR COMPUTATIONAL PATHOLOGY

NETHERLANDS CANCER INSTITUTE & UNIVERSITY OF AMSTERDAM

Yoni has an interdisciplinary background with a formal education in
neuroscience, biomedical science, economics, and artificial intelligence. With
years of experience in operational and technical roles, he now wishes to bridge
the gap between artificial intelligence, medical science, and clinical
implementation of AI models. He obtained his master’s degree in AI at the
University of Amsterdam in 2020. His thesis titled “Predicting DNA Damage Repair
Deficiencies directly from H&E Whole-Slide Images using Deep Learning” was
supervised by dr Jonas Teuwen, dr Hugo Horlings and dr Efstratios Gavves.

He is now a PhD candidate under the HISTO-AI project (2020-2024), with the aim
to develop deep learning methods to predict genomic and transcriptomic
information directly from H&E WSIs. The larger goal of this project is to
predict which patient can benefit from immune therapy or targeted therapy,
directly from commonly available H&E WSIs.

Yoni pitched the topic of his PhD for the 3MT (three minute thesis) competition,
and won the UvA-wide finals. You can see the winning pitch here.

DERICK MONTAQUE

CO-FOUNDER & CEO

WSK MEDICAL B.V.

Senior director with over 20 years’ experience in building and implementing IT
systems. A passionate believer that the time has come for AI to move from the
research world and into the clinical working environment, thus assisting doctors
and clinicians to transform the diagnosis and treatment of diseases through
machine learning systems.

YOSEF SAFI HARB

FOUNDER & CEO

HAPPITECH

Yosef Safi Harb is the Founder and CEO at Happitech. With an Aerospace
engineering background, he has 10 years of mechatronic / sensor design
experience and holds 2 patents.  Happitech provides telehealth companies medical
grade technology for monitoring heart rate and rhythm on a smartphone without
additional devices. Happitech is helping to provide telehealth important vitals
to the tele-health and medical professionals to help support those patients.

The technology has been validated and CE Certified & TGA Approved after
undergoing clinical trials for the past three years at the largest Cardiology
Hospital OLVG (Amsterdam).

MIGUEL MASCARENHAS SARAIVA, MD. MSC.

GASTROENTEROLOGY; CEO

DIGESTAID

Dedicated field: Research and Development; Capsule endoscopy patent main
inventor; Capsule endoscopy experienced reader.
Detail dedicated field: AI applications in GI endoscopy
Domains of expertise: Gastroenterology; Capsule endoscopy; Coloproctology
High capability of bridging the gap between clinical needs and technological
solutions. Capsule Endoscopy expertise in its main submodalities.
Entrepreneurial soft skills and creative mindset.

DR. SURAJ KAPA

SVP HEALTHCARE

TRIPLEBLIND

   

Dr Suraj Kapa is the SVP of healthcare at TripleBlind. He practiced as a cardiac
electrophysiologist at Mayo Clinic and over the course of his career he has
published more than 200 peer-reviewed articles and book chapters, given 100s of
invited lectures, and has filed over 30 patents resulting in startups and FDA
approved technologies.

He is highly sought after for his views on the future of digital health and
healthcare delivery, having advised multiple public companies and startups in
digital strategy. Additionally, his work on digital tools to address the
pandemic in 2020 and developing algorithms to enable early prediction of disease
has been featured in major news outlets.

ANTONIO RUSSO

PARTNER, INNOVATION LEADER AND PARTNER, HEAD OF ANALYTICS & COGNITIVE

DELOITTE SWITZERLAND

       

Antonio Russo leads Deloitte’s Analytics & Cognitive Advisory in Switzerland and
is responsible for Innovation within Deloitte Switzerland’s Executive team. His
team helps clients leverage the power of artificial intelligence and data to
deliver more customer-centric and innovative products and services that catalyse
growth and efficiencies.

He has over 20 years of experience in advising companies in large-scale global
transformations, leveraging new delivery models (GBS/SSC, outsourcing) and
innovative technologies (e.g. robotics, machine learning, natural language
processing/generation). He helps global organisations review and implement new
strategies for business support functions and deploy more effective and
efficient services and governance models. Prior to joining Deloitte in April
2013, he held various sales and consulting leadership positions across Europe
and was CEO of a start-up company developing brand protection technologies.

YAN HUANG

GENERAL MANAGER - INTELLIGENT HEALTHCARE

BAIDU

                     

Yan has nearly 20 years of experience in the field of machine learning and
artificial intelligence, with a focus on R&D, application, management and
innovation. She has been the General Manager of Baidu Intelligent Healthcare
since 2018. During her role, she has launched the brand “Ling Yi Zhi Hui
(Chinese name:灵医智惠) “ with the vision of “Evidence-based AI empowers primary
healthcare”.

 

Prior to joining Baidu, she was the Staff R&D engineer at Google in the U.S.,
where she started her career in 2005.

 

Yan graduated from Georgia Institute of Technology. Yan serves as the Vice
Chairman of Intelligent Hospital and Artificial Intelligence Application Working
Committee of Chinese Medical Information and big data Association (CHMIA). She
also serves as a leading advisory expert of Peking University Medical Science
and Technology Innovation Project.

DR. ROBERT CALIFF

FORMER COMMISSIONER FDA & HEAD OF HEALTH AND POLICY 

ALPHABET (GOOGLE HEALTH AND VERILY LIFE SCIENCES)

     


DR. JOHN HALAMKA

PRESIDENT

MAYO CLINIC PLATFORM

   


WENJUN XIE

HEAD OF AI HEALTHCARE STRATEGY

TENCENT

       


DR. PETER LEE

CORPORATE VICE PRESIDENT, HEALTHCARE

MICROSOFT

Dr. Peter Lee is Corporate Vice President, Microsoft Healthcare. He leads an
organization that works on technologies for better and more efficient
healthcare, with a special focus on artificial intelligence and cloud computing.
Dr. Lee has extensive experience in managing the process of going from basic
research to commercial impact. Past illustrative examples include the deep
neural networks for simultaneous language translation in Skype, next-generation
IoT technologies, and innovative silicon and post-silicon computer architectures
for Microsoft’s cloud. He also has a history of advancing more “out of the box”
technical efforts, such as experimental under-sea datacenters, augmented-reality
experiences for HoloLens and VR devices, digital storage in DNA, and social
chatbots such as XiaoIce and Tay. Previously, as an Office Director at DARPA, he
led efforts that created operational capabilities in advanced machine learning,
crowdsourcing, and big-data analytics, such as the DARPA Network Challenge and
Nexus 7. He was formerly the Head of Carnegie Mellon University’s computer
science department. As a thought leader, he has spoken and written widely on
technology trends and policies, spanning the fields of computing technology,
healthcare, and innovation ecosystem. He is a member of the Boards of Directors
of the Allen Institute for Artificial Intelligence and the Kaiser Permanente
School of Medicine. He served on President’s Commission on Enhancing National
Cybersecurity. He has led studies for the National Academies on the impact of
federal research investments on economic growth and testified before the US
House Science and Technology Committee and the US Senate Commerce Committee.

DR. TOBY COSGROVE

EXECUTIVE ADVISOR AND FORMER PRESIDENT & CEO

GOOGLE & CLEVELAND CLINIC

Toby Cosgrove, MD, is former CEO and president of Cleveland Clinic. Serving from
2004 through 2017, he led the $8 billion organization to new heights of
achievement and efficiency, seeing it ranked the #2 hospital in America (U.S.
News). He currently serves as Executive Advisor, working with Cleveland Clinic
leadership on strategies for national and international growth.

 

Dr. Cosgrove graduated from Williams College and the University of Virginia
School of Medicine. He trained at Massachusetts General Hospital and Brook
General Hospital in London. In 1967, he was a surgeon in the U.S. Air Force,
earning a Bronze Star.

 

Dr. Cosgrove joined Cleveland Clinic in 1975, and chaired the Department of
Thoracic and Cardiovascular surgery from 1989 to 2004. He performed over 22,000
operations and earned an international reputation in valve repair He holds 30
patents for medical innovations. As CEO from 2004 to 2017, he reorganized
services, improved outcomes and patient experience, and strengthened the
organization’s finances.

 

He is a member of the National Academy of Medicine, and a Fellow of the National
Academy of Inventors. In 2016, he was a Fortune Businessperson of the Year (No.
14). Three successive presidents of the United States have consulted him on
healthcare issues.

BERNARDO MARIANO JUNIOR

DIRECTOR, DIGITAL HEALTH & INNOVATION, CHIEF INFORMATION OFFICER

WORLD HEALTH ORGANIZATION

   

Bernardo Mariano Junior is the Director of the Digital Health Department and the
Chief Information Officer of WHO. He is responsible for setting and maintaining
the vision and direction of WHO’s strategy of health in the digital age. As CIO,
he ensures that the digital transformation of WHO enhances the organization’s
collective performance and efficiency to deliver the ‘Health for all’ global
development agenda.

Prior to joining WHO, Mr. Mariano held senior managerial positions in the
International Organization for Migration as Senior Regional Adviser for
Sub-Saharan Africa in the office of the Director-General, Chief Information
Officer/Director, Information & Communications Technology, and Regional Director
for East and Southern Africa.

VANESSA CANDEIAS

FORMER HEAD, GLOBAL HEALTH AND HEALTHCARE; MEMBER OF THE EXECUTIVE COMMITTEE

WORLD ECONOMIC FORUM

Trained as a nutritionist, Faculty of Nutrition and Food Sciences, Porto
University; Master’s in Public Health, London School of Hygiene and Tropical
Medicine. Formerly: worked at national level on developing and implementing
health promotion policies with the Ministry of Health in Portugal and the
Institute of Preventive Medicine of the University of Lisbon; worked with the
World Health Organization Headquarters on global guidelines and policy
development for noncommunicable diseases.

 

Currently, Head of System Initiative on Shaping the Future of Health and
Healthcare and Member of the Executive Committee, World Economic Forum. The
System Initiative on Shaping the Future of Health and Healthcare provides a
dynamic platform for leading businesses, governments, civil society
organizations and world-class experts to shape the global health agenda;
co-design and accelerate the implementation of collaborative approaches that
transform the health ecosystem – across prevention, diagnosis, treatment, cure
and maintenance of health; and ultimately enables populations to live healthier
lives and have access to the care they need when they need it.

DR. FREDDY ABNOUSI

INTERVENTIONAL CARDIOLOGIST AND HEAD OF HEALTH TECHNOLOGY

FACEBOOK

                 

Dr. Abnousi is the Head of Health Technology at Facebook and a practicing
Interventional Cardiologist. He also serves as Innovation Advisor to the
American College of Cardiology, Professor Adjunct at Stanford University School
of Medicine, and Assistant Professor Adjunct at Yale University School of
Medicine. He has previously led innovative healthcare efforts at companies such
as McKinsey and Google, and has served as Founder and CMO of CorDynamix Inc., an
interventional heart failure company. He completed Fellowships in Cardiovascular
Medicine and Interventional Cardiology, as well as Residency in Internal
Medicine at Stanford University Medical Center. He was previously a resident
surgeon at the University of California, San Francisco. He completed his MD at
Stanford University School of Medicine, MBA from Oxford University, and MSc in
Health Policy, Planning, & Financing from the London School of Economics. 

KIMBERLY POWELL

VICE PRESIDENT HEALTHCARE

NVIDIA

Kimberly Powell is vice president of healthcare at NVIDIA, where she leads the
company’s efforts to build healthcare computing platforms that address grand
challenges like early detection, diagnoses and personalized treatment.

Partnering with healthcare researchers, startups and industry leaders, her
mission is to accelerate the adoption of advanced computing technologies like
GPU computing and artificial intelligence.

Powell joined NVIDIA in 2008 as the global business development manager for
healthcare. She also served as senior director of AI business development. Prior
to joining NVIDIA, she was a product manager for diagnostic imaging at Planar
Systems and a hardware engineer at DOME Imaging Systems doing FPGA design.

Powell has a Bachelor of Science from Northeastern University in electrical
engineering with a concentration in computer engineering.

JOHN NOSTA

PRESIDENT

NOSTALAB

         

First and foremost, John is a thinker. A thinker entrenched in the world of
science, medicine and innovation. John is the founder of NOSTALAB—a digital
health think tank. He’s generally regarded as one of the top global strategic
and creative thinkers in this important and expanding area. He is also one the
most popular speakers around the globe presenting his vibrant and insightful
perspective on the future of health innovation.



Unwilling to accept the status quo, he’s a contrarian with a focus the future of
health and wellness. A leading voice in the convergence of technology and
health, Nosta helps define, dissect and deliberate global trends in digital
health. He is consistently ranked among the top names in almost every digital
list and has sustained that position for several years. Beyond simply an
influencer, John is also defined as “most admired” to “top disruptor” in digital
health, life sciences and the pharmaceutical industry. He is also a member of
the Google Health Advisory Board and has penned HEALTH CRITICAL for Forbes–a top
global blog on health and technology.



John has an established reputation as a vocal advocate for strategic thinking
and creativity. He has built his career on the “science of advertising,” a
process where strategy and creativity work together for superior marketing. He
has also been recognized for his ability to translate difficult medical and
scientific concepts into material that can be more easily communicated to
consumers, clinicians and scientists. Additionally, John has distinguished
himself as a scientific thinker. Earlier in his career, John was a research
associate at Harvard Medical School and has co-authored several papers with
global thought-leaders in the field of cardiovascular physiology with a focus on
acute myocardial infarction, ventricular arrhythmias and sudden cardiac death.



John cut his teeth at the “big” agencies including Ogilvy CommonHealth, where he
has held a series of positions including Chief Creative Officer, Chief Strategic
Officer and unit President.

 

DR. GREG MOORE

CVP

MICROSOFT HEALTH & LIFE SCIENCES

             

Dr. Moore leads Microsoft’s Health efforts globally and is responsible for
product strategy, product development, and research including AI and machine
learning technology for healthcare and life sciences. He is also Microsoft’s
senior executive leading dedicated research and development collaborations with
Microsoft’s strategic alliance partners in this domain with the goal of enabling
a more open, interoperable, and AI-infused foundation for healthcare delivery
that aspires to enable access to healthcare for all globally.

Greg is an engineer (MIT PhD), practicing neuroradiologist, clinical
informaticist, neuroscientist, and innovator experienced in assembling and
inspiring highly talented teams to positively transform healthcare for the
benefit of humankind. Prior to joining Microsoft, Greg was Vice President Google
Inc, Google Cloud Healthcare & Life Sciences and founder of the healthcare
vertical for Google Cloud. Prior to his leadership appointment at Google, he was
Chief Emerging Technology and Informatics Officer at Geisinger Health System
where he also was Director of the Institute for Advanced Application and served
as Interim Chair of System Radiology. His prior appointments include Los Alamos
National Laboratory (University of California), Wayne State University School of
Medicine, Children’s Hospital of Michigan and Penn State University Hershey
Medical Center where he was a tenured Professor in the College of Medicine. Greg
currently serves on the board Hillrom Inc, and is an Adjunct Clinical Professor
of Radiology at Stanford University School of Medicine.

Moore is board certified in Diagnostic Radiology, Neuroradiology and Clinical
Informatics and holds degrees from North Park College-Chicago (BS),
Massachusetts Institute of Technology (SM-Nuclear Engineering and
PhD-Radiological Sciences), and Wayne State University School of Medicine
(MD-Doctor of Medicine) and completed residency in Diagnostic Radiology and a
fellowship in Neuroradiology, both at Penn State University Hershey Medical
Center.

BAKUL PATEL

ASSOCIATE CENTRE DIRECTOR FOR DIGITAL HEALTH

FDA

Bakul Patel is Associate Director for Digital Health, at the Center for Devices
and Radiological Health (CDRH), at the Food and Drug Administration (FDA).  Mr.
Patel leads regulatory policy and scientific efforts at the Center in areas
related to emerging and converging areas of medical devices, wireless and
information technology. This includes responsibilities for mobile health, health
information technology, cyber security, medical device interoperability, and
medical device software. 
 

Mr. Patel is the FDA liaison between the Federal Communications Commission (FCC)
and the Office of the National Coordinator (ONC). Since its inception in 2013,
Bakul chairs the International Medical Device Regulators Forum (IMDRF) “software
as a medical device” working group, a global harmonization effort.

Before joining FDA, Mr. Patel held key leadership positions working in the
telecommunications industry, semiconductor capital equipment industry, wireless
industry and information technology industry. His experience includes Lean Six
Sigma, creating long and short-term strategy, influencing organizational change,
modernizing government systems, and delivering high technology products and
services in fastpaced, technology-intensive organizations.
 

Mr. Patel earned an MS in Electronic Systems Engineering from the University of
Regina, Canada, and an MBA in International Business from The Johns Hopkins
University.

DR. SEMA SGAIER

CO-FOUNDER & EXECUTIVE DIRECTOR | SURGO FOUNDATION

ADJUNCT ASSISTANT |HARVARD TH CHAN SCHOOL OF PUBLIC HEALTH 

Dr. Sema Sgaier leads Surgo Foundation’s strategy, operations, and partner
relations. She works at the intersection of behavior, data, and technology,
drawing on her extensive experience in policy, strategy, and management of
development programs.  Sema has led several large-scale programs, as well as
research and evaluation projects, and has worked with governments in India and
Africa on public-health policy and large-scale delivery. 

Prior to joining Surgo Foundation, Sema held several roles at the Bill & Melinda
Gates Foundation. She led a portfolio on voluntary medical male circumcision for
HIV prevention across eastern and southern Africa. As part of the India Country
Office, Sema led the scale-up of the foundation’s HIV prevention program
(Avahan) in several states, managed its transition to the government of India,
and developed data platforms for decision-making. 

Before joining the Gates Foundation, Sema was a neuroscience and genomics
scholar at Harvard Medical School and a fellow with the Centre for Global Health
Research. She is an Assistant Adjunct Professor at the Harvard T.H. Chan School
of Public Health and an Affiliate Assistant Professor, Global Health at the
University of Washington. She also serves on the board of the Bill & Melinda
Gates Foundation’s Alumni Network. Sema was selected as a Rising Talent by the
Women’s Forum for the Economy and Society.  

Sema received her PhD in cellular and molecular biology (developmental genetics)
from New York University, her MA in neuroscience from Brown University, and a
BSc in molecular biology and genetics from Boğaziçi University (Istanbul).   

 

MARK O'HERLIHY

MANAGING DIRECTOR EMEA

IBM WATSON HEALTH

Head of IBM Watson Health for Europe, Middle East & Africa. As the Managing
Director, Mark holds full responsibility for the Sales & Go to Market strategy &
team, for Watson Health software products and solutions to their customers. This
includes the full portfolio of Life Sciences, Oncology, Genomics, Imaging,
Government, Value-Based Care & Population Health Management solutions.

 

Mark has a clinical background and has worked in the NHS as well as many senior
leadership positions in global, European and start-up healthcare companies
throughout his career, with over 25 years of experience in the healthcare
segment, Mark brings a wealth of experience and perspective and he is passionate
about health and social care for everyone.

PROF. GARY MARCUS

PROFESSOR OF PSYCHOLOGY AND NEURAL SCIENCE

NEW YORK UNIVERSITY

Gary Marcus, scientist, bestselling author, and entrepreneur, was CEO and
Founder of the machine-learning startup Geometric Intelligence, recently
acquired by Uber, and is known for his provocative and bold claims in artificial
intelligence, neuroscience, and cognitive science. Trained by Steven Pinker, he
received his PhD at MIT at age 23. His professional research, published in
leading journals such as Science, Nature, Cognition, and Artificial
Intelligence, has focused on the foundations of cognition in humans, animals and
machines, spanning fields from developmental psychology to neuroscience to
genetics to artificial intelligence. A special interest has been on the
challenge of endowing machines with common sense.

 

He is also well-known for his writing for the general public, including frequent
essays and op-eds for The New Yorker and The New York Times. His books include
The Algebraic Mind, The Birth of the Mind, Kluge: The Haphazard Evolution of the
Human Mind, The New York Times Bestseller, Guitar Zero and The Future of the
Brain: Essays By The World’s Leading Neuroscientists.

 

In a 2012 essay for The New Yorker, he was perhaps the first person to publicly
criticize deep learning, drawing on arguments he developed in his 2001 technical
book The Algebraic Mind. More recently, in a 2018 arXiv article, Deep Learning:
A Critical Appraisal, he asked whether deep learning might be “approaching a
wall.” The challenges he laid out there were covered everywhere from The
New York Times to Wired to The Financial Times and Wall Street Journal.

 

In another provocative 2012 essay, Moral Machines, Marcus was the first to adapt
“trolley problems” to driverless cars, anticipating much recent research on the
ethics of AI. His next book, REBOOT: Getting to AI We Can Trust, to be published
by Pantheon in Fall 2019, co-authored with Ernie Davis, calls for a fundamental
rethinking of current approaches to artificial intelligence.

PROF. DR. EFFY VAYENA

PROFESSOR

INSTITUTE OF TRANSLATIONAL MEDICINE



DR. RAMYA PALACHOLLA

LEAD SCIENTIST & FACULTY

PARTNERS HEALTHCARE & HARVARD MEDICAL SCHOOL

Ramya Palacholla is a Physician and one of the Lead Scientists at Partners
Healthcare Pivot Labs. She is also a faculty member of the Harvard Medical
School. Currently, Dr. Palacholla works with a multidisciplinary team that
develops and executes digital health strategy and research projects in
collaboration with top pharmaceutical, research and medical technology
companies. She is passionate about her research focused on validation of
innovative health technology solutions for improving patient lives. Dr.
Palacholla has published her work in several health care journals and presented
her research on innovative technologies on international platforms such as the
World Economic Forum (also presented at the G8 Summit), served as a reviewer for
health technology journals, and spoken at national conferences as a thought
leader in the field of health care research and innovation. Her cutting edge
research in this area is recognized for its high caliber, and she continues to
advance this field to new frontiers. Dr. Palacholla’s idea on an “Innovative
Tumor Response Forecasting Model in Breast Cancer Patients” was awarded the
first position in the Harvard Ideation Challenge among hundreds of submissions
received from across the country. Furthermore, the idea was also selected as one
of the top six finalists for the Boston Scientific and Google Connected Patient
Challenge, 2018, which is unquestionably a renowned platform that showcases
healthcare innovations across the globe. She was also a co-author of one of the
first books to be written on proven treatment methods for the management of
Military Sexual Trauma and PTSD in war veterans. Following these successes, Dr.
Palacholla’s research is well-known in the healthcare innovation space and has
given her opportunities to present her research work at national healthcare
conferences and summits.

PROF. WEIHONG HUANG

MOBILE HEALTH MINISTRY OF EDUCATION - CHINA MOBILE LAB

XIANGYA HOSPITAL CENTRAL SOUTH UNIVERSITY

Weihong Huang received the B.Eng. degree in automation and M.Eng. degree in
pattern recognition and smart control from Southeast University China in 1995
and 1998 respectively and the Ph.D. degree in computer science from Nanjing
University China in 2001. From 2001 to 2002, he was a Post-doctoral Research
Fellow with the CNRS University Lyon 1 France. From 2002 to 2005, he was a
lecturer with the Department of Computer Science, University of Hull, United
Kingdom. From 2005 to 2014, he was a senior lecturer with School of Computer and
Information Systems, Kingston University London, United Kingdom. Since 2016, he
was appointed as a professor and the Depute Director of the Mobile Health
Ministry of Education – China Mobile Joint Laboratory, Xiangya Hospital Central
South University, China. His research interests include mobile health,
artificial intelligence in healthcare, cognitive computing for healthcare,
semantic multimedia computing and knowledge graph applications. Prof. Huang is a
committee member of China Hospital Information Management Association, standing
committee member of the Medical and Health Big Data Evaluation and Assurance
board of the Chinese Health Information and Big Data Association, chairman of
specialized committee of information management of Hunan Health Management
Association.

ANNE O'RIORDAN

SENIOR MANAGING DIRECTOR

ACCENTURE LIFE SCIENCES

Anne is the global Industry Senior Managing Director for Accenture’s Life
Sciences business and a global client lead.  She has been with Accenture for 28
years.  Over this period she has worked across the US, Europe and Asia with
global companies transforming their business and operating models, to meet
changing market and portfolio needs.  She has been in China since 2007 and has
been on the board of the global Products Operating Group of Accenture since
2006.  She has published numerous articles over the past 20+ years. Her most
recent publication is a book entitled ‘Healthcare Disrupted: Next Generation
Business Models and Strategies@ (Wiley Feb 2016)”.   Based in Hong Kong, Ms.
O’Riordan is a member of The Women’s Foundation, the 30% Club and co-chair of
the Women of Influence Committee at the American Chamber of Commerce.

DR. ASIF JAN

GROUP DIRECTOR OF ANALYTICS IN PERSONALISED HEALTHCARE

ROCHE 



Asif Jan leads a multidisciplinary team of scientists specializing in computer
science, neuroscience, and statistics. The team implements a variety of
statistical and machine learning methods on real-world datasets (e.g. electronic
medical records, health insurance claims, disease registries) to fulfill
evidence and data analysis needs of the Neuroscience disease area at Roche.
Previously, he was Head of Data Science at Roche Diagnostics leading a team of
quantitative scientists supporting in vitro diagnostics and clinical decision
support product development, where he defined data strategy enabling the use of
real-world data. Earlier he has had a number of roles overseeing technology
strategy development, enterprise and solution architecture, and program
management at Roche and in other research organizations. Asif has vast
experience of building and leading data science teams in pharma and diagnostics
companies, and industrial research institutes, tackling complex scientific and
business problems. He strongly believes that the intersection of strategy,
technology and data science is needed to fight diseases, thereby enabling better
care for everyone.

Asif holds a PhD in Neuroscience (informatics) from the Swiss Federal Institutes
of Technology Lausanne (EPFL), Switzerland, and an MPhil in Computer Science
from the University of the West of England, Bristol, UK.

ALLESANDRO CURIONI

IBM FELLOW, VICE PRESIDENT EUROPE AND DIRECTOR

IBM RESEARCH

Dr. Alessandro Curioni is an IBM Fellow, Vice President of IBM Europe and
director of the IBM Research Lab in Zurich, Switzerland. He was also recently
appointed as the Watson IoT Research Relationship Executive.

Dr. Curioni is an internationally recognized leader in the area of
high-performance computing and computational science, where his innovative
thinking and seminal contributions have helped solve some of the most complex
scientific and technological problems in healthcare, aerospace, consumer goods
and electronics. He was a member of the winning team recognized with the
prestigious Gordon Bell Prize in 2013 and 2015.

Dr. Curioni received his undergraduate degree in Theoretical Chemistry and his
PhD from Scuola Normale Superiore, Pisa, Italy. He started at IBM Research –
Zurich as a PhD student in 1993 before officially joining as a research staff
member in 1998. His most recent position was Head of the Cognitive Computing and
Computational Sciences department.

DR. NATALIE BANNER

UNDERSTANDING PATIENT DATA LEAD

WELLCOME TRUST



Dr Natalie Banner is the Lead for Understanding Patient Data (UPD), an
initiative hosted at the Wellcome Trust to support better conversations about
how patient data is used for care and research. UPD works with patients,
charities and health professionals to champion responsible uses of data, feeding
into policy development, creating accessible resources and horizon scanning for
emerging issues that may affect public confidence in the use of health data.

 

This includes exploring emerging data-driven technologies and how to create the
right ethical and governance frameworks for these in healthcare and research.
Natalie formerly led Wellcome’s policy work on GDPR and data protection, seeking
to ensure UK legislation and regulation creates a supportive, trustworthy
environment for health research using patient and health-related data. She was
recently named in BioBeat’s “50 Movers and Shakers in BioBusiness” for 2018.

DR. STEPHANIE KUKU

SENIOR CONSULTANT

HARDIAN HEALTH

                               

Stephanie is a health technology advisor in digital health and artificial
intelligence.  She has over 15 years clinical and research experience and
trained and worked in the NHS as a surgical oncologist specialising in women’s
cancers.

 

Stephanie is an advisor and consultant in Clinical AI at the World Health
Organisation’s Department of Digital Health & Innovation.  She is the Healthcare
Lead for Women in AI (WAI), an NHS England Clinical Entrepreneur and Honorary
Senior Research Fellow at UCL where she was awarded a Doctorate in Clinical
Research.

 

During her clinical career she sat on council of a national cancer society
(BGCS) and was awarded numerous International travelling fellowships to;
Memorial Sloane Kettering Cancer Center in New York, Cancer Hospital Pernambuco
in Brazil, and Centre du Cancer Oscar Lambret in France.

 

Stephanie is a regular speaker on validation of health technology and has hosted
a US podcast (HLTH) on themes around technology and the future of health.

SALVATORE SCALZO

POLICY AND LEGAL OFFICER

EUROPEAN COMMISSION

Salvatore Scalzo has been working for more than seven years in the European
Commission. Since November 2013, he is Policy and Legal Officer in the Unit
dealing with legislation on medical devices (currently unit D4 of the
Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs).
After having dealt with the negotiations of the proposed new Regulations on
medical devices which were adopted in spring 2017, he is currently working on
the legal interpretation and implementation of those Regulations and
coordinating, among other tasks, the activities of the European Commission
Expert Groups on medical device identification and traceability and medical
software. 

AMIR SAFFARI

SVP OF AI

BENEVOLENTAI

Amir Saffari has a PhD in Machine Learning and has been working in the field of
Artificial Intelligence for more than 17 years, researching and developing ML
theory, applications, and products. He’s numerous publications in top-tier ML
conferences and journals and most of his research has been released as open
source software. He was part of Sony’s R&D team and has been involved in a few
ML startups prior to joining BenevolentAI where he is currently leading the
research and development of ML technology to drug discovery.

DANIEL NATHRATH

CO-FOUNDER AND CEO

ADA HEALTH

Daniel is a serial entrepreneur with 20 years’ experience in strategic growth
and transformational change. During his career, he’s founded several startups
around the world and served as general counsel and managing director at various
tech firms across the UK, US, Denmark and Germany. Daniel was a consultant at
the Boston Consulting Group and studied law as a Fulbright Scholar at the
University of Houston. He holds an MBA from the University of Chicago. 

CHRIS GIBSON

CO-FOUNDER AND CEO

RECURSION PHARMA

Chris Gibson, PhD, is the Co-Founder and CEO of Recursion Pharmaceuticals, a
biotech company leveraging the latest in automation, artificial intelligence and
biology to do drug discovery at scale. Chris developed the technology and
approach underlying Recursion as part of his MD/PhD graduate work in the lab of
Co-Founder Dr. Dean Li at the University of Utah. Chris left medical school to
transform this technology into the rapidly growing company it is today. Chris is
a graduate of Rice University with degrees in bioengineering and managerial
studies, as well as a graduate of an intense entrepreneurship course at Stanford
GSB. He is a Board Member of CureHHT, a patient advocacy group for Hereditary
Hemorrhagic Telangiectasia, and a member of the Rare and Undiagnosed Network
Advisory Board. Outside of work, Chris enjoys cycling on both the road and the
trails that cut through Utah’s great wilderness, as well as spending time with
family.

DR. FARZANA RAHMAN

CONSULTANT RADIOLOGIST UCLH | NHS DIGITAL

CLINICAL ADVISOR, DATA AND DIGITAL STRATEGY LEAD | THE ACADEMY OF MEDICAL ROYAL
COLLEGES



DR. SATCHIT BALSARI

ASSISTANT PROFESSOR IN EMERGENCY MEDICINE

HARVARD MEDICAL SCHOOL (BETH ISRAEL DEACONESS MEDICAL CENTER)

 


JOSE PEDRO ALMEIDA

DIRECTOR OF BIG DATA ANALYTICS AND MACHINE LEARNING

SÃO JOÃO HOSPITAL CENTER



He was named top-20 Portuguese world changer and he is a leading expert in the
real-world application of Advanced Analytics & Machine Learning to Hospital
problems, transforming sparse patient’s BigData into actionable clinical
insights. His team built one of the most outstanding Hospital Big Data platforms
currently working in EU hospitals. This platform behaves like a “Data Robot”
that captures and analyses 560 billion patient data points\minute, coming from
30 different systems, to predict and signal at-risk patients for clinical
deterioration up to 7 days in advance. This work has received some of the
highest in the industry, amongst which the 1st prize in the HIMSS Europe Digital
Healthcare 2016 Award (Barcelona), the 1st prize in the “2014 Microsoft
Worldwide Health Innovation Award (MSHUG)” (Orlando, USA) and the 2014 “Big Data
& Analytics Solution of the Year” prize by IT Europa (London, UK).

HUGUETTE DIAKABANA

CO-FOUNDER

AFRICAN ALLIANCE OF DIGITAL HEALTH NETWORKS



DR. DIVYA CHANDER

FACULTY CHAIR IN NEUROSCIENCE & FACULTY IN MEDICINE

SINGULARITY UNIVERSITY

     

Dr. Chander is a physician, neuroscientist, and futurist who trained at Harvard,
UCSD, UCSF, and the Salk Institute. She is Chair of Neuroscience and Faculty of
Medicine at Singularity University, Visiting Scholar in Medicine at Stanford
(where she was on faculty for 8 years), and Senior Non-Resident Fellow at the
Atlantic Council GeoTech Center. She has also co-founded and leads 2 companies
during the pandemic – Lucidify, a tele-neuroICU platform, and Plexxus, a company
building the world’s connected global immune system. Dr. Chander also serves on
a NASA-White House task force for COVID19, and both co-chairs and directs the
post-pandemic global health initiative for OneShared.World. Her research
interests center around mapping human consciousness, how consciousness will be
altered by human augmentation, and how mapping consciousness in humans may
enable us to recognize it in non-human, intelligent beings (both on and
off-planet). In 2004, she was a finalist for astronaut selection, and has since
maintained a passion for building medical systems in space to sustain human
exploration.

JUNAID BAJWA

CHIEF MEDICAL SCIENTIST

MICROSOFT RESEARCH

         



 

Junaid is the Chief Medical Scientist at Microsoft Research and a practising
physician in the NHS (the UK’s National Health Service). He was previously the
Global Lead for Strategic Alliances and Solutions for the Global Digital Centre
of Excellence at Merck Sharp & Dohme, where he led a range of strategic
initiatives to improve patient care, including establishment of internal
partnerships across the enterprise and external partnerships across the health
care ecosystem. He cofounded “VelocityHealth” as Europe’s first prevention
focused digital-health accelerator, in partnership with Telefonica, and led his
team to deliver the “NHS Testbed” in partnership with Verily Life Sciences (part
of Alphabet), which the Health Service Journal recognized as the “Best
Pharmaceutical Partnership with the NHS” in 2018.

Previously, Junaid has worked across primary care, secondary care, and public
health settings in addition to acting as a payer, and policy maker within the
UK, where he specialized in informatics, digital transformation, and leadership.
He has consulted for health care systems across the US, Australia, New Zealand,
Singapore, and Europe, in addition to being seconded by the NHS to work with
IBM. Junaid completed his MBA at the Imperial College Business School in London
and has studied health strategy and quality improvement at both Harvard and the
Institute of Healthcare Improvement in Boston. Academically, he is a Clinical
Associate Professor at UCL (University College London), and Visiting Scientist
at the Harvard School of Public Health.

Junaid hopes to bring his clinical, life sciences, and academic experiences
together in this new role. He hopes to help healthcare focused teams across
Microsoft, unlock the power of technology to help solve the healthcare
challenges of today, whilst reimagining a better future for tomorrow.

 

RAMATOULIE JALLOW

CONNECTOR AND ADMINISTRATOR

PAN AFRICAN WOMEN IN HEALTH

         



 

Ramatoulie is a Public Health Consultant and Health Communications Specialist.
She holds an MPH in Community Health Promotion, with an interdisciplinary
concentration in Global Health, from the University of Minnesota, USA.
Ramatoulie is a Connector and Administrator for the Pan African Women in Health
(PAWH) virtual platform which creates a space for African women health
professionals to connect and provide or receive mentorship.

Presently, she works as a Stigma Index Researcher with the Global Network for
People living with HIV (GNP+). Previously, she served as an Epidemiologist, with
the US Centers for Disease Control and Prevention, conducting surveillance of
the West Africa Ebola outbreak in Guinea and providing technical assistance to
the Ministry of Health and to the Expanded Program of Immunization’s
supplemental immunization activities for polio eradication. Prior to joining
CDC, she conducted HIV/AIDS research in Kigali, Rwanda, as a Global Health Corps
fellow, and worked as an HIV/AIDS Medical Case Manager in Minnesota, USA. As a
Consultant, she has worked on a variety of projects related to women’s
empowerment and the demographic dividend in the Sahel as well as on youth access
projects and family planning services in Senegal. Ramatoulie is an avid mentor
and an advocate for girls and women’s sexual and reproductive health rights. She
is also a member of Scientists of the Gambia, Paradise Foundation’s COVID-19
Coordination team, and EyeToo; initiatives founded by young Gambians, both in
the diaspora and at home, to encourage more youth to pursue STEM careers,
improve health messaging around COVID-19, and to address accessibility and
affordability of vision care in The Gambia, respectively. She is presently based
in Yaoundé, Cameroon.

BONIFACIA AGYEI

COUNTRY DIRECTOR OF SAFECARE, PHARMACCESS GHANA

PHARMACCESS GROUP

         



 

As highly skilled assessor and quality improvement facilitator, Bonifacia Benefo
Agyei works passionately with healthcare facilities to support improvement in
healthcare quality and patient safety using her rich experience in healthcare
system management from both public and private sectors. Bonifacia advocates for
healthcare quality improvement in Ghana using international quality standards
and digital innovations. 

Bonifacia has been working at PharmAccess since 2012 where she currently leads
and manages the entire SafeCare Program and other quality related programs
provided by PharmAccess Ghana. Among others, this includes directing and
coordinating all quality and technical services, while collaborating with public
and private partners to support the institutionalization of quality improvement
and the digitalization of healthcare in Ghana. She has a range of healthcare
management experience, in quality improvement, business development as well as
in the development and roll-out of digital innovations.

Prior to joining PharmAccess, she served as Accreditation Quality Officer and
Clinical at the National Health Insurance Authority (NHIA), Ghana after almost
ten years of experience serving in various nurse management roles and
responsibilities in public and private health facilities. She also has extensive
experience in training, mentoring, development of quality standards, manuals and
curriculum; such as for the novel maternal healthcare franchise network
(Woman360) in Ghana. Among other qualifications, Bonifacia holds a bachelor’s
degree in nursing, a master’s degree in public administration and is a Fellow in
the International Society for Quality in Health Care program (ISQua).

PROF LUCIANO FLORIDI

PROFESSOR OF PHILOSOPHY AND ETHICS OF INFORMATION AND DIRECTOR

THE UNIVERSITY OF OXFORD AND DIGITAL ETHICS LAB

Luciano Floridi is the OII’s Professor of Philosophy and Ethics of Information
at the University of Oxford, where he is also the Director of the Digital Ethics
Lab of the Oxford Internet Institute. Still in Oxford, he is a Distinguished
Research Fellow of the Uehiro Centre for Practical Ethics of the Faculty of
Philosophy, and Research Associate and Fellow in Information Policy of the
Department of Computer Science. Outside Oxford, he is Faculty Fellow of the Alan
Turing Institute (the national institute for data science) and Chair of its Data
Ethics Group; and Adjunct Professor (“Distinguished Scholar in Residence”) of
the Department of Economics, American University, Washington D.C.

 

His research concerns primarily Information and Computer Ethics (aka Digital
Ethics), the Philosophy of Information, and the Philosophy of Technology. Other
research interests include Epistemology, Philosophy of Logic, and the History
and Philosophy of Scepticism. He has published over 150 papers in these areas,
in many anthologies and peer-reviewed journals.

PROF. MARCE SALATHE

ASSOCIATE PROFESSOR

EPFL

 

Marcel Salathé is a digital epidemiologist working at the interface of
population biology, computational sciences, and the social sciences. He obtained
his PhD at ETH Zurich and spent two years as a postdoc in Stanford before
joining the faculty at Penn State in 2010 at the Center for Infectious Disease
Dynamics. In 2014, he spent half a year at Stanford as visiting assistant
professor. In the summer of 2015, Marcel became an Associate Professor at EPFL
where he heads the Digital Epidemiology Lab at the new Campus Biotech. In 2016,
he has also been appointed Academic Director of EPFL Extension School, whose
mission is to provide high quality online education in digital technology.

HILA AZADZOY

MANAGING DIRECTOR, GLOBAL HEALTH INITIATIVE

ADA HEALTH

         



 

Hila leads our Global Health Initiative to improve access to healthcare in
resource-limited countries. Before Ada, Hila was a founding member and Head of
Academics at Kiron Open Higher Education. She is a Digital Female Leader Award
recipient, an MIT Solve Member, and a talented public speaker (TEDx, Clinton
Global Initiative, UNESCO NGO Forum). “I am dedicated to using technology for
social good.”

DR. ALISON DARCY

FOUNDER AND PRESIDENT

WOEBOT HEALTH

         



 

Alison is a clinical research psychologist and health tech visionary dedicated
to creating smart, scalable and accessible mental healthcare solutions. Her work
to explore how digital treatments can help solve human problems began more than
20 years ago, when she created one of the first online support groups for people
with eating disorders.

That work led to PhD level studies in psychology at University College Dublin
and post-doctoral training at Stanford School of Medicine and with the American
Psychiatric Association. At Stanford, Alison also worked with AI pioneer Andrew
Ng to explore the intersection of AI and healthcare, leading his Health
Innovation Lab in Computer Science.

A frequent speaker on digital therapeutics design and development, barriers to
care, and engagement, Alison has authored more than 40 publications and been
awarded research grants and contracts from the NIH, the Davis Foundation and
APA. She is also currently an Adjunct Lecturer in the Psychiatry and Behavioral
Sciences Department of Stanford’s School of Medicine. Alison holds a PhD, an
MLitt and a Bachelor of Arts degree in psychology from University College
Dublin.

JOÃO ARTHUR REIS

DIRECTOR - SCIENCE, TECHNOLOGY AND INNOVATION COORDINATION

SÃO PAULO STATE GOVERNMENT

         



 

João works in the design and implementation of ST&I policy in the State of São
Paulo and has previously worked with innovative entrepreneurship and
international cooperation at the Maranhão Foundation for Research, Science and
Technology Development – FAPEMA, through Vetor Brasil’s Public Sector Trainee
Program, which develop young professionals in their careers in local and state
governments in Brazil. João holds a Bachelor’s degree in International Relations
– Federal University of Rio Grande do Sul and a M.A. in International Political
Economy – Federal University of Rio de Janeiro.

LAURA MCGORMAN

POLICY LEAD, DATA FOR GOOD

FACEBOOK

         



 


DR. ANDRE CHOW

CO-FOUNDER

DIGITAL SURGERY

Andre gained a BSc degree in Surgical Technology and graduated from Imperial
College School of Medicine in 2004. He began his surgical training at St. Mary’s
Hospital in London and in 2006 became a full member of the Royal College of
Surgeons.  In 2008 he was awarded one of three places as an Academic Clinical
Fellow, and in 2009 was appointed a Clinical Innovation Fellow at Imperial
College London. In 2010 he was awarded a prestigious Welcome Trust Research
Fellowship to pursue research in the fields of stem cell technology &
biomaterials, and completed his PhD at Imperial College in 2012.  Andre has over
30 peer-reviewed journal publications to his name and has also authored several
book chapters. He has been an invited speaker at international surgical
conferences on the subject of surgical quality assessment, and regularly
presents on medical entrepreneurship and surgical training.

DR. JAY MANDREKAR

PROFESSOR OF BIOSTATISTICS & NEUROLOGY

MAYO CLINIC

   

Jay Mandrekar, Ph.D., is the primary statistician for the Mayo Clinic Department
of Neurology, and the Divisions of Infectious Diseases and Clinical
Microbiology. He is involved in multiple clinical trials, population-based
studies and research grants in these areas.

Dr. Mandrekar’s primary research interest is in the application and extension of
statistical methods for the evaluation of the quality and domains of clinical
teaching, multiple sclerosis and other neurologic diseases, prosthetic joint
infections, and assays for viral detection.

 

RACHEL SIBANDE

PROGRAM DIRECTOR - DATA FOR DEVELOPMENT

DIGITAL IMPACT ALLIANCE, AT THE UNITED NATIONS FOUNDATION

         



 

Rachel Sibande is Program Director, Data for Development at the Digital Impact
Alliance, a unit within the United Nations Foundation. She leads sector wide Big
data for development models across countries in Africa, supporting Governments
to leverage the power of Big data for decision making. Recently, Rachel has led
the development of risk and epidemiology models for COVID19 that integrate
mobility metrics generated from Mobile Network Operator data and Geospatial
data. The models would help Governments understand where to anticipate COVID19
hotspots, stock outs and health facility burden prior. These Big Data models
have been developed for Malawi and 14 other West African Countries under the
West African Health Organisation regional block. Rachel is  also leading on the
integration of geospatial data, mobile network operator data and immunisation
data to enhance immunisation outcomes in Tanzania.She has also led the
development of resources used by practitioners in the big  data for development
space to get started deploying similar initiatives. Her work cuts across a new
space in the Big Data and AI space as it seeks to  integrate traditional digital
health data and non traditional data sets such as mobile network operator data 
largely to help understand mobility patterns of people and how they impact
health outcomes.

DR. DANIEL VERES

CHIEF MEDICAL OFFICER

TURBINE

Dániel is the creator of the first compartmentalized protein-protein interaction
database, with years of experience building computational models in order to
understand the behaviour of human cells. As a medical doctor, Daniel translates
computational results into clinical interpretations, indispensable to design
innovative and relevant treatments to defeat cancer.

CHARLES ROBERTS

CO-FOUNDER AND CHIEF PARTNERSHIPS OFFICER

FREENOME

A clinician by training, Charlie is Freenome’s Chief Partnership Officer,
focusing on mid- and longer-term relationships that will help define the
company’s future directions and revenues and works closely with the business
development team in managing corporate client accounts and institutional
collaborations. Prior to co-founding Freenome, Charlie co-founded a company that
uses circulating cell-free (cf)DNA from maternal blood samples to diagnose
chromosomal abnormalities during pregnancy. The resulting in-vitro diagnostic,
IONA, has been marketed successfully across Europe and the Middle East. Charlie
studied medicine and neuropsychology in the UK, earning a Masters degree from
Oxford with a focus on immunotherapy. He has worked in some of the UK’s leading
oncology centers, including the Royal Marsden.

EYAL TOLEDANO

CO-FOUNDER AND CTO

ZEBRA MEDICAL VISIONVISION

Eyal Toledano is co-founder and CTO of Zebra Medical Vision; Eyal focuses on
innovation in medical imaging machine vision. Graduated with Master of Science
from the MIT Media Lab. Eyal served for more than 8 years as the CTO and
Advanced Technology GM for Samsung Israel R&D (STRI/Yakum). Before co-founding
the Israeli R&D of Samsung Eyal was leading the development of challenging
projects at Sun Microsystems. Eyal completed 7 years of military service in the
IDF Elite Intelligence Technologies. Eyal still hacks code every day and enjoys
making morning sandwiches.

MAGNUS CONTEH

EXECUTIVE DIRECTOR, COMMUNITY HEALTH ACADEMY

LAST MILE HEALTH



Magnus Conteh joined the Last Mile Health team in 2018 to help lead the
Community Health Academy, which aims to reinvent the education of community
health workers – and the health system leaders who support them – for the
digital age.

Magnus brings over 25 years of senior level experience in education, global
health, and digital health to Last Mile Health. Previously, Magnus worked for
seven years at World Vision Ireland, most recently serving as the Deputy
CEO/Director of Programmes and Strategy. Notably, he led World Vision’s
involvement in the Johnson & Johnson/Janssen Ebola Vaccine trial in Sierra
Leone, which included overseeing the deployment of technology critical for the
clinical trial. In addition to serving as a member of the World Vision
International Digital Health Steering Committee, he forged multi-stakeholder
collaboratives and digital health partnerships with a number of governments,
mobile network operators, and other INGOs in Africa.Prior to joining World
Vision Ireland, he held a number of senior management positions in the National
Health Service in the UK and the Health Service Executive in Ireland, where he
served as Director for the Regional Centre of Nursing/Midwifery Education at the
University Hospital in Galway. Magnus holds a Masters of Health Science (Hons)
in Health Services Research from the National University of Ireland, Masters of
Arts in Health Service Policy and Management from Brunel University (UK), and a
Postgraduate Diploma in Management Studies from Kingston Business School at
Kingston University (UK).

DR. JON SORENSON

HEAD OF CHEMINFORMATICS

ATOMWISE



Jon Sorenson, Ph.D., is head of the cheminformatics team at Atomwise. Jon has
nearly 20 years of experience in computational biology and software leadership,
ranging from senior contributor roles to executive management of 100+ person
teams spanning computational biology and software operations. He has held senior
leadership roles at Applied Biosystems, Pacific Biosciences, Invitae and 10X
Genomics, and he is co-author on more than 30 publications and patents. At
Atomwise, Jon is thrilled to have returned to his first passion of computational
drug design, a field that he first encountered as a college intern working at
Merck Research. Before joining industry in 2000, he obtained a Bachelor of
Science in chemistry and mathematics from Harvey Mudd College, a Master of
Philosophy in theoretical chemistry from the University of Cambridge and a
Doctor of Philosophy in computational chemistry from the University of
California, Berkeley.

DR. BORIS BOGDAN

MANAGING DIRECTOR, LEAD - GLOBAL PRECISION ONCOLOGY AND PERSONALIZED HEALTHCARE
(PHC)

ACCENTURE LIFE SCIENCES



DR. OLIVER MORGAN

DIRECTOR OF HEALTH EMERGENCY AND RISK ASSESSMENT

WORLD HEALTH ORGANIZATION

Dr. Oliver Morgan is the Director of the Health Emergency Information and Risk
Assessment Department in the WHO Health Emergencies Program. From 2007 through
2016, Dr. Morgan worked for the US Centers for Disease Control and Prevention
during which time he held critical leadership positions in the Ebola response
between November 2014 and February 2016 (CDC Atlanta Ebola Response Incident
Manger and CDC Country Director in Sierra Leone).From March 2010 to October
2014, Dr. Morgan was the CDC Country Director in the Dominican Republic. Dr.
Morgan was an Epidemic Intelligence Service Officer at CDC from 2007 to 2009
with the International Emerging Infections Program, during which time he
conducted projects in Thailand, Bangladesh, Kenya, Uganda, and Guatemala. Before
joining CDC, Dr. Morgan worked for the UK Health Protection Agency, leading
epidemiological investigations of outbreaks (enteric, vaccine preventable,
hospital acquired, zoonotic, respiratory, and sexually acquired infections),
chemical and radiation exposure incidents, terrorist bombings in London, natural
disasters, and humanitarian civil conflicts. Dr. Morgan has also worked as a
consultant to WHO/PAHO in several countries. Dr. Morgan’s academic achievements
include a doctorate in epidemiology from Imperial College London and extensive
publication in peer reviewed journals and reference books.

JENNY BARNETT

CHIEF SCIENTIFIC OFFICER

CAMBRIDGE COGNITION

Named one of the 40 most influential Healthcare Technology Transformers in 2017,
Jenny is responsible for ensuring that all our neuroscience products and
services meet the highest scientific standards, as well as the practical needs
of researchers, doctors and patients.  Jenny joined Cambridge Cognition in 2008
and has worked in a variety of roles across the clinical trials and healthcare
arms of the business. She led research and development activities for
groundbreaking products such as CANTAB Mobile, an iPad-based medical device used
to test for the first signs of Alzheimer’s disease, and Cognition Kit, a mobile
and wearables platform for the remote monitoring of brain health.

Jenny has an MA in Experimental Psychology from Oxford University, a PhD in
psychiatric epidemiology from the University of Cambridge, and completed
post-doctoral work at Massachusetts General Hospital and the Broad Institute of
Harvard and MIT. She is an Honorary Research Fellow at the University of
Cambridge Department of Psychiatry, a team member of the Oulu University,
Northern Finland Birth Cohorts, and the author of more than 50 academic
publications covering topics ranging from psychology and neuroscience to
genetics and health economics.

STEVE GUISE

GLOBAL HEAD OF INFORMATICS

ROCHE PHARMACEUTICALS 

Steve Guise has been Global Head of Informatics for Roche Pharmaceuticals since
October 2016. During these nearly two years, Steve has built and led a new
informatics organization focused on business partnering and driving technology
innovation to address business challenges — to ultimately benefit patients. 

Steve joined Roche in 2008 as Basel Site Head, Pharma Research Informatics. In
2010, he became Global Head of Scientific Information Systems and Principal
Architect, Pharma Research and Early Development (pRED) Informatics. Steve was
Head of Pharma Informatics for Asia Pacific based in Shanghai and Singapore for
three years. He then took on the role of Head of Diagnostics Information
Solutions Software Center of Excellence before being appointed Global Head of
Informatics. 

Steve is passionate about finding new ways to more effectively bring medical
innovation to our patients, particularly where the application of technology can
bring about a step change.

Prior to joining Roche, Steve held various IT and management positions at Astra
Zeneca in the UK. He has a Master’s degree in Chemistry from The University of
St Andrews (UK). 

 

DR. ALLISON GARDNER

LECTURER IN DATA SCIENCE, PROGRAMME DIRECTOR FOR THE INTEGRATED DEGREE
APPRENTICESHIP IN DATA SCIENCE

KEELE UNIVERSITY

         



 

Allison lectures at Keele University in Bioinformatics and Data Science and is
the Programme Director for the Data Science Degree Apprenticeship. She is a
co-founder of Women Leading in AI. Her research is primarily focused on
algorithmic bias; gender and computing; AI Ethics and Governance of AI. She
works on the IEEE P7000 Global Initiative on the Ethics of Autonomous and
Intelligent Systems and the ISO standard on Artificial Intelligence. She speaks
internationally on AI Ethics, the need for diversity in tech and the potential
regulation and governance of AI. Allison acts as a consultant for a variety of
companies on the ethical design of autonomous and intelligent systems and
development of algorithmic impact assessments. She is also a district councillor
and an alumnus of the first cohort of the Jo Cox Women in Leadership Programme.

ANDREAS CLEVE

CO-FOUNDER AND CEO

CORTI

         



 

Andreas Cleve is Corti’s co-founder and CEO. After spending nearly a decade
working as a multi-entrepreneur in AI, Andreas founded Corti. Corti uses
advanced voice- and pattern recognition technology to assist and augment medical
professionals in predicting medical cases in real-time and provides them with
intelligent decision support. It allows them to arrive at a conclusion faster
and
to provide a better-informed treatment.

Andreas has always been incredibly passionate about the possibilities that AI
can provide to the healthcare sector and how we can leverage advanced technology
in our most vital industry. While serving as CEO of Corti, he founded Nordic.AI
and now sits as chairman of the board. Nordic.AI was created as an anchor for
the Nordic machine learning and AI community, it hosts early events and meetups,
bringing all the great Scandinavian minds together. Andreas has landed coverage
in print and broadcast outlets all

DR. ROOPA DHATT

EXECUTIVE DIRECTOR & CO-FOUNDER

WOMEN IN GLOBAL HEALTH

         



 

Dr Roopa Dhatt is a passionate advocate for gender equality in global health and
a leading voice in the movement to correct the gender imbalance in global health
leadership. Determined to build a movement to transform women’s leadership
opportunities in health, Dr Dhatt co-founded Women in Global Health in 2015.

Today, Women in Global Health has more than 25,000 supporters in more than 90
countries and continues to grow. Dr Dhatt, the Executive Director, and
the global team work with a network of WGH chapters in every region to challenge
power and privilege for gender equity in health by mobilizing a diverse group of
emerging women health leaders, by advocating to existing global health leaders
to commit to transform their own institutions, and by holding these leaders to
account.  With more than 15 chapters in all regions, Women in Global Health is
changing the conversation about women’s leadership in health at global, national
and local levels.

Dr Dhatt is particularly committed to addressing issues of power, privilege, and
intersectionality that keep many women from global health leadership roles and
to opening up spaces for the voices of these women to be heard. Women in Global
Health’s flagship Heroines of Health event provides a platform for women from
diverse backgrounds to share their stories and to advance their leadership. As
Co-Chair of the Gender Equity Hub in the Global Health Workforce Network, Women
in Global Health published Delivered by Women, Led by Men which looking
collectively for the first time at issues of leadership, decent work free from
all forms of discrimination, harassment, including sexual harassment, the gender
pay gap, and occupational segregation—across the entire health workforce. In
recognition of her work advancing gender equality in health, Dr Dhatt was
recognized in the Gender Equality Top 100, the most influential people in global
policy 2019.

Dr Dhatt is a regular speaker at global health events and has published her
views on gender equality widely, including in the Lancet. Dr Dhatt also serves
on several advisory bodies advancing gender equality in health, President
Council of PathFinder International, Ambassador for Intelligent Health (AI)
Conference, the Strategic Advisory Committee for the Global Health Workforce
Network (GHWN), and GlobeMed Advisory Board. She was formerly on the Research in
Gender and Ethics (RinGS) Advisory Board, Global Health 50/50 Advisory Council,
the Global Health Council Advisory Council, and Women Leaders in Global Health
Conference Steering Committee in 2017 and 2018. She has led global campaigns
relating to the health Sustainable Development Goals (SDGs), health and climate
change, the social determinants of health, and Universal Health Coverage (UHC),
engaging people from more than 120 countries.

DR. MARCO MARSELLA

HEAD OF THE UNIT - DG CONNECT

EUROPEAN COMMISSION

Marco Marsella is Head of Unit ‘Learning, Multilingualism and Accessibility’ in
the Directorate General for Communications Networks, Content and Technology (DG
CONNECT) of the European Commission.  

 The unit supports policy, research, innovation and deployment of learning
technologies and key enabling digital language technologies and services to
allow all European consumers and businesses to fully benefit from the Digital
Single Market. The unit is responsible for the Web Accessibility Directive which
aims to make public sector websites and mobile applications accessible to people
with impairments. The unit also promotes a better internet for children by
protecting and empowering children online, and improving the quality of content
available to them.

 He has worked on policy development, innovation and research implementation in
the areas of digital content, technologies for learning, e-inclusion, assistive
technologies and better internet for kids. Prior to joining the European
Commission, Marco worked as researcher and AI (artificial intelligence)
specialist in Italy.

 

PROF. THOMAS WIEGAND

EXECUTIVE DIRECTOR

FRAUNHOFER HHI

Thomas Wiegand is a professor in the department of Electrical Engineering and
Computer Science at the Technical University of Berlin and is jointly heading
the Fraunhofer Heinrich Hertz Institute, Berlin, Germany. He received the
Dipl.-Ing. degree in Electrical Engineering from the Technical University of
Hamburg-Harburg, Germany, in 1995 and the Dr.-Ing. degree from the University of
Erlangen-Nuremberg, Germany, in 2000. 

The projects that he co-chaired for the development of the H.264/MPEG-AVC
standard have been recognized by an ATAS Primetime Emmy Engineering Award. He
was also a recipient of a ATAS Primetime Emmy Engineering Award for the
development of H.265/MPEG-HEVC and a pair of NATAS Technology & Engineering Emmy
Awards.

AMANDEEP GILL

PROJECT LEAD, I-DAIR AND FORMER EXECUTIVE DIRECTOR, UNSG HIGH LEVEL PANEL ON
DIGITAL CORPORATION

UNITED NATIONS

UNITED NATIONS

Amandeep Singh Gill joined the Indian Foreign Service in 1992.

He has served abroad at the Indian Mission to the UN and the Conference on
Disarmament in Geneva (1994-1996, 2010-2013), the Indian Embassy in Tehran
(2001-2004) and the High Commission of India in Colombo (2004-2006). At
headquarters in New Delhi, he has served thrice in the Disarmament and
International Security Affairs Division (1998-2001, 2006-2010 and 2013-2016) as
well as in the United Nations Division (1996-1998). He served as the Head of the
Disarmament and International Security Division in the Ministry of External
Affairs from 2013 to 2016. He has also served as an expert on the UN Secretary
General’s panels of experts on the Fissile Material Cut-off Treaty (FMCT), Small
Arms and Light Weapons and on Missiles. He participated in the UN Disarmament
Fellowship programme in 1999.

He is the current Chair of the Group of the Group of Governmental Experts (GGE)
of the Convention on Certain Conventional Weapons (CCW) on Lethal Autonomous
Weapons Systems (LAWS). He is also President-designate of the 2017 Meeting of
States Parties to the Biological and Toxin Weapons Convention (BTWC).
Amandeep Singh Gill has a B. Tech in engineering from Punjab University,
Chandigarh and an Advanced Diploma in French History and Language from Geneva
University. His PhD from the Department of War Studies at King’s College, London
is on Nuclear Learning in Multilateral Forums. During 2008-2009, he was a
visiting scholar at Stanford University’s Center for International Security and
Cooperation (CISAC) on an Asia Foundation regional security studies fellowship.
As a scholar he has contributed to the Bulletin of Atomic Scientists, the Lowy
Institute, the East West Institute, the Center for a New American Security and
the Indian Economic and Social History Review.

Amandeep Singh Gill was born in 1968 in Chandigarh. He is married to Ashma Singh
and has a daughter (Bani) and a son (Ujjay). His personal interests include
creative writing, yoga and sustainable agriculture. His first book of poems in
English was published by Wisdom Tree in 2016.

DR. ANURAG AGRAWAL

DIRECTOR

INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY AT COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH

Dr. Anurag Agrawal took charge as director of CSIR Institute of Genomics &
Integrative Biology (IGIB) on 25th October 2017. He graduated in medicine from
the All India Institute of Medical Sciences in 1994, followed by specialization
in Internal Medicine, Pulmonary Disease, and Critical Care from Baylor College
of Medicine, Houston, (2003) and a PhD in physiology from Delhi University.
After serving as a faculty member of the Department of Medicine at Baylor, he
joined IGIB in 2007, where he established the Centre of Excellence for
Translational Research in Asthma & Lung disease (TRiAL) and the CSIR program for
Effective Application of Community Health efforts through new age Information
Technology (EACH-IT). His research activities include use of experimental and
computational model-systems to study disease, especially asthma. Dr Agrawal
believes health data analytics, with artificial intelligence applications, to be
the new frontier of medicine and is actively engaged in promoting the confluence
of medicine and informatics. He has more than 100 scientific publications,
mostly original research findings communicated in high-impact journals. He has
been recognized internationally, as an alumnus of Kavli Frontiers of Science
program of the US National Academy of Sciences, as well as nationally in the
form of the Shanti Swaroop Bhatnagar award (Medical Sciences, 2014), National
Bioscience award (2015), Wellcome Trust DBT India Alliance senior fellowship
(2015), Lady Tata Young Researcher Award (2010) and the Swarnjayanti Fellowship
of the Department of Science and Technology (2010). Dr. Agrawal is a member and
fellow of numerous academic societies and serves on advisory bodies at Public
Health Foundation of India, Lady Tata Memorial Trust, Centre for Cellular &
Molecular Biology, Centre for Brain Research, and Indraprastha Institute of
Information Technology, amongst others, as well as an advisor for start up
companies and healthcare organizations.

DR. ERIC OERMANN

DIRECTOR | AISINAI

INSTRUCTOR OF NEUROLOGICAL SURGERY, DEPARTMENT OF NEUROSURGERY | MOUNT SINAI
HEALTH SYSTEM

Eric Karl Oermann, M.D. is an Instructor of Neurological Surgery in the Mount
Sinai Health System and the Director of AISINAI, Mount Sinai’s artificial
intelligence research group. He studied mathematics at Georgetown University
with a focus on differential geometry. Prior to attending medical school, Dr.
Oermann spent six months with the President’s Council on Bioethics studying
human dignity under the mentorship of physician-philosopher Edmund Pellegrino,
M.D.. Dr. Oermann has won numerous awards for his scholarship including
fellowships from the American Brain Tumor Association and Doris Duke Charitable
Research Foundation where he was first exposed to neural networks and deep
learning. He has published over eighty manuscripts spanning basic research on
machine learning, deep learning, and the philosophy of medicine.

As a resident Dr. Oermann was selected as one of Forbes Magazine’s “30 Under 30”
for his work in using machine learning to develop prognostic models for cancer
patients. Dr. Oermann completed a postdoctoral fellowship at Google (Google
Health / Verily Life Sciences). He is interested in weakly supervised learning,
reinforcement learning with imperfect information, and in building artificial
neural networks that more accurately model biological neural networks (“machines
that think like humans”). As a physician, he is also interested in the
application of deep learning to solve a wide range of practical problems in the
medical sciences for improving clinical care.

 

LETIZIA GIONFRIDA

CEO & MANAGING DIRECTOR

ARTHRONICA

 


DR. JAMES KINROSS

SENIOR LECTURER AND CONSULTANT IN COLORECTAL SURGERY

ST. MARY'S HOSPITAL, IMPERIAL COLLEGE LONDON

 

Dr. James Kinross is a consultant colorectal surgeon, at St. Mary’s Hospital
London. His clinical interests are in minimally invasive and laparoscopic
surgery for the treatment of colorectal cancer. He also has an interest in
surgical nutrition and modulation of the gut microbiota by pro and prebiotics
for improved operative outcomes. He was trained in Northwest London, and he was
an NIHR Clinical Lecturer in Surgery and an Ethicon Laparoscopic Fellow in
Colorectal Surgery. He was awarded a Royal College of Surgeons of England
training fellowship during his PhD and he was funded by the Academy of Medical
Sciences as an early stage lecturer. He is a visiting Professor at the Royal
College of Surgeons of Ireland. He is currently funded by Bowel and Cancer
research and the Imperial BRC. You can follow him on Twitter at @bowelsurgeon. 

 

He performs translational research into computational and systems biology in
surgery. Specifically, he is involved in clinical trials using intra-operative
mass spectrometry (known as Real-time Electrospray Ionisation Mass Spectrometry
or REIMS) for improving precision in the surgical treatment of colorectal
cancer. This technology is also known as the iknife, and he is working on both
surgical and endoscopic applications. Mass Spectrometry Imaging (MSI) is
complimentary to REIMS and provides novel insights into tumour biology and
tumour phenotypes. Dr. Kinross’s research is establishing if metabonomic
approaches such as these can be used for stratifying the treatment of both early
and advanced cancers. 

Dr. Kinross also studies the role of the gut microbiome in the aetiology of
colon cancer, Crohn’s disease and obesity. This is because intestinal
inflammation is a common pathway across all conditions. He is performing
clinical research at Imperial College London and at the Royal Marsden Hospital.
The aim is to develop novel biomarkers for the early detection of bowel cancer,
and to develop novel therapies for its treatment based on a deeper understanding
of how the microbiota that reside in the gut influence tumour biology and the
response of cancer to treatment. As part of this I collaborate internationally
with researchers in the USA and across Europe.

Finally, he has a separate interest in the educational application of virtual
worlds and gaming technologies for surgical and medical education. He works as
part of a team that is building next generation, immersive simulators for use in
major incidents and trauma training.

 

OLIVER SMITH

STRATEGY DIRECTOR & HEAD OF ETHICS

ALPHA HEALTH, TELEFÓNICA INNOVACIÓN ALPHA

Oliver Smith is the Strategy Director & Head of Ethics at Alpha Health, the
health tech Moonshot of Telefónica Innovación Alpha.

 

Oliver propels Alpha Health’s strategy development, establishing and maintaining
strong partnerships to further its mission to deliver breakthrough solutions
which address the greatest challenges in the healthcare sector worldwide. In
addition, Oliver is the Head of Ethics at Alpha Health, ensuring the total trust
of users is at the very centre of the Moonshot’s operations.

 

Prior to joining Alpha Health in 2016, Oliver worked as the Director of Strategy
and Innovation at Guy’s and St Thomas’ Charity, Deputy Director of Health and
Wellbeing at the Department of Health and as a Policy Advisor to the Prime
Minister’s Strategy Unit.

 

DR. AMRITA KUMAR

CONSULTANT RADIOLOGIST & AI CLINICAL LEAD

FRIMLEY HEALTH NHS FOUNDATION TRUST

Dr. Amrita Kumar is a Consultant Radiologist at Frimley Health NHS Foundation
Trust, with a sub-specialist interest in breast cancer screening. She is leading
trust wide research collaboration to implement novel artificial intelligence
software for improved patient outcomes. She has been appointed as AI Clinical
Lead and is responsible for implementation and adoption of Artificial
Intelligence practice within the Trust, working in conjunction with various
stakeholders with a mission statement of patient-focused value-based healthcare.

VICTORIA MACDONALD

HEALTH AND SOCIAL CARE EDITOR

CHANNEL 4 NEWS

         



 

Victoria Macdonald is an award-winning journalist, who has been covering health
and social care issues for Channel 4 News since 1999.

She reports on changes in the NHS – the reforms and the politics – whether it is
in hospitals or in the community or, indeed in Westminster.

She closely follows the care system and how it impacts on the elderly and those
with disabilities as well as investigating issues, including mental health,
HIV/Aids and TB, and child health.

Victoria is originally from New Zealand and worked for the Sunday Telegraph
before joining Channel 4 News.

NEIL SEBIRE

CHIEF RESEARCH INFORMATION OFFICER

GREAT ORMOND STREET HOSPITAL

         



 


SUE PAISH

CEO

CANADA’S DIGITAL TECHNOLOGY SUPERCLUSTER

         



 

Sue is the CEO of Canada’s Digital Supercluster where organizations from across
Canada come together to solve some of society’s and industry’s biggest problems.
Bringing together industry, researchers and government partners, the
Supercluster
drives the development, deployment and scaling of Canadian made digital
technologies
while helping small companies scale, large organizations nimbly deploy digital
solutions
and researchers bridge the gap to commercialization. The Supercluster is:
speeding up
cancer diagnosis times so that patients get diagnoses in days rather than
months,
protecting fresh-water lakes, rivers and streams through a data platform that
measures
and manages these precious resources, and using data to predict extreme weather
events. These are just a few of the over 60 projects deployed in the past two
years.
Prior to the Supercluster, Sue led organizations through material change. While
Managing Partner of Fasken, the firm grew from one office to nine offices on
three
continents, while CEO of Pharmasave, the organization pioneered industry leading
technologies for online medication management, and while CEO of LifeLabs, Sue
led
material growth while introducing online access to test results and pre-natal
genetic
testing. With the Supercluster, Sue continues to drive business growth and
Canada’s
global competitiveness through the Supercluster’s collaborative innovation
model,
creating digital solutions better than any single organization could develop on
its own.
Sue also is the Chair of the Board of CORIX Group of Companies, and Canexia
Health
(previously Contextual Genomics), past Chair of the Business Council of British
Columbia and a Director on the Board of Own the Podium. She is a member of the
Advisory Board for Stemcell Technologies, the Expert Panel on Housing Supply and
Affordability and the Government of Canada’s COVID 19 Supply Council.
Sue’s most cherished moments are those spent exploring BC’s remarkable remote
wilderness with her husband, three daughters and her granddaughter.

DR. ALAIN DAGHER

NEUROLOGIST AND PROFESSOR

MONTREAL NEUROLOGICAL INSTITUTE, MCGILL UNIVERSITY

Dr. Dagher is an M.D./Ph.D. who studied Electrical Engineering and Medicine. He
is a Neurologist and Professor at McGill University in Montreal (clinician and
scientist). His research aims to understand brain reward systems and their role
in neurological and psychiatric illness.

 

He uses brain imaging, notably functional magnetic resonance imaging (fMRI), to
map brain activity in response to drugs or natural rewards like food and music.
He is particularly interested in figuring out what in the brain makes
individuals vulnerable to mental illness. He splits his professional life
between clinical neurology and research and teaching. He sees people with
Parkinson’s Disease in his clinic once a week. Dr. Dagher teaches medical
students and Ph.D. students in neuroscience.

DR. INDRA JOSHI

DIRECTOR OF AI

NHSX

Dr Indra Joshi is the acting Director of AI for NHSX, leading on the creation of
the NHS AI Lab. Her other responsibilities include overseeing digital health
initiatives within the NHS with a focus on data, digital health standards and
evidence.

Indra has a unique portfolio with experience stretching across policy, digital
health, national project strategy and implementation; whilst remaining true to
her professional training as an emergency medic.

She is a Founding Member of One HealthTech – a network which campaigns for the
need and importance of better inclusion of all backgrounds, skill sets and
disciplines in health technology. Alongside she is a Vice-Chair for the British
Computer Society (Health), an international speaker and consultant on digital
health, an expedition medic, and most importantly a mum to two wonderful little
munchkins.

DR. ANDREA SUPERTI-FURGA

HEAD OF GENETIC MEDICINE

LAUSANNE UNIVERSITY HOSPITAL

Andrea Superti-Furga has obtained his medical degrees at the Universities of
Genoa and Zurich and certification in Paediatrics in Italy and Switzerland. His
mentors were Professors Paolo Durand, Victor McKusick, Andrea Prader, Andres
Giedion, Richard Gitzelmann, Beat Steinmann and Sergio Fanconi.

He developed a research activity on inborn diseases in Zurich and then in New
York with Prof. Francesco Ramirez. In 2002, he was appointed Professor for
Molecular Pediatrics at the University of Lausanne; in 2004, Chairman of the
Department of Paediatrics at the University of Freiburg, Germany; in October
2010 he was awarded the Leenaards Chair of Excellence in Paediatrics at the
University of Lausanne. In 2014 and 2015 he was Director of the Department of
Paediatrics in Lausanne. Since 2016 he is Professor and Head of the Division of
Genetic Medicine at the University Hospital in Lausanne, Switzerland, that
includes a clinical section as well as a diagnostic laboratory for cytogenetics
and molecular genetics.

His clinical expertise is in paediatrics and genetics. His research activities
have been focussed mainly on genetic disorders affecting metabolism, connective
tissue, and the skeleton. His skills range from clinical assessment and
evaluation to biochemistry, metabolism, molecular biology, next-generation
sequencing, bioinformatics, and artificial intelligence.

Andrea Superti-Furga is committed to a holistic approach to children and adults
with genetic disorders and rare diseases with a comprehensive perspective that
includes the genetic and molecular bases of development and disease, the
precision medicine approach to diagnosis and treatment, and the medical, social,
economical and ethical issues around individuals with genetic diseases and their
families.

DR. ROSHANA MEHDIAN

REGISTRAR TRAUMA AND ORHOPAEDIC SURGEON AND DIRECTOR

HARDIAN HEALTH